voriconazole has been researched along with amphotericin b in 955 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 24 (2.51) | 18.2507 |
| 2000's | 366 (38.32) | 29.6817 |
| 2010's | 452 (47.33) | 24.3611 |
| 2020's | 113 (11.83) | 2.80 |
| Authors | Studies |
|---|---|
| Algueró, M; Bartroli, J; Boncompte, E; Conte, L; Forn, J; García-Rafanell, J; Merlos, M; Ramis, J; Turmo, E; Vericat, ML | 1 |
| Cardellina, JH; McCloud, TG; Meragelman, TL; Shoemaker, RH; Tucker, KD | 1 |
| Abonía, R; Delgado, P; Enriz, RD; Garibotto, FM; Insuasty, B; Juárez, S; Nogueras, M; Quiroga, J; Rodero, L; Sortino, M; Zacchino, SA | 1 |
| Alastruey-Izquierdo, A; Cuenca-Estrella, M; Monzón, A; Rodriguez-Tudela, JL | 1 |
| Dierich, MP; Lass-Flörl, C; Lugger, H; Perkhofer, S | 1 |
| Bergès, T; Bouchara, JP; Chabasse, D; Hennequin, C; Tronchin, G; Vandeputte, P | 1 |
| Bouza, E; Guinea, J; Martínez-Alarcón, J; Peláez, T; Torres-Narbona, M | 1 |
| Colombo, AL; Costa, SF; da Matta, VL; de Souza Carvalho Melhem, M; dos Anjos Martins, M; Duboc de Almeida, GM; Levin, AS; Moretti, ML; Nucci, M; Rodero, L; Souza Dias, MB | 1 |
| Aurbach, U; Cornely, O; Seifert, H; Stefanik, D | 1 |
| Cheng, S; Clancy, CJ; Clapp, W; Nguyen, KT; Nguyen, MH | 1 |
| Cao, YB; Jiang, YY; Sun, QY; Wu, QY; Xu, JM; Zhang, DZ; Zhang, J; Zhang, WN; Zhao, HQ | 1 |
| Alcázar-Fuoli, L; Cuenca-Estrella, M; Garcia-Effron, G; Melchers, WJ; Mellado, E; Rodríguez-Tudela, JL; Verweij, PE | 1 |
| Meletiadis, J; O'Shaughnessy, EM; Peter, J; Stergiopoulou, T; Walsh, TJ | 1 |
| Kang, TH; Kim, S; Park, JS; Suh, YG; Yu, KA | 1 |
| Alvarado-Ramírez, E; Torres-Rodríguez, JM | 1 |
| Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA | 1 |
| Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C | 1 |
| Bocanegra, R; Graybill, JR; Kirkpatrick, WR; Najvar, LK; Patterson, TF | 1 |
| Antachopoulos, C; Meletiadis, J; Pournaras, S; Roilides, E; Stergiopoulou, T; Walsh, TJ | 1 |
| Deising, HB; Serfling, A; Wohlrab, J | 1 |
| Calderone, R; Chauhan, N; Kruppa, M | 1 |
| Casadevall, A; Gácser, A; Martinez, LR; Nosanchuk, JD; Ntiamoah, P | 1 |
| Enriz, RD; Freile, M; Gupta, MP; Kouznetsov, VV; Sortino, M; Vargas Méndez, LY; Vásquez, Y; Zacchino, SA | 1 |
| Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C | 1 |
| Fritsche, TR; Jones, RN; Rhomberg, PR; Sader, HS | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Gutierrez, MO; Rodriguez-Tudela, JL | 1 |
| Alastruey-Izquierdo, A; Alcazar-Fuoli, L; Cuenca-Estrella, M; Mellado, E; Rodriguez-Tudela, JL | 2 |
| Boekhout, T; Curfs-Breuker, I; Fernández, CM; Illnait-Zaragozi, MT; Martínez, GF; Meis, JF | 1 |
| Aguirrebengoa, K; Arteaga, C; Chen, SC; Ellis, D; Heath, CH; Lutsar, I; Nguyen, Q; Rovira, M; Slavin, M; Troke, P | 1 |
| Hashimoto, K; Kaeriyama, M; Kimura, A; Mitsuyama, J; Narita, H; Nishikawa, H; Nomura, N; Todo, Y; Yamada, E | 1 |
| Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL | 1 |
| Chapman, SW; Cleary, JD; Garcia-Effron, G; Perlin, DS | 1 |
| Azor, M; Cano, J; Fothergill, AW; Gené, J; Guarro, J; Rinaldi, MG; Sutton, DA | 1 |
| Jacobson, MJ; Nguyen, G; Patel, R; Piper, KE; Steckelberg, JM | 1 |
| Dho, G; Esposto, MC; Gianni, C; Grancini, A; Ossi, C; Prigitano, A; Tortorano, AM; Viviani, MA | 1 |
| Chu, CC; Hsueh, PR; Ruan, SY | 1 |
| Jiang, Y; Jin, Y; Li, P; Liu, P; Sun, P; Sun, Q; Wu, Q; Xie, W; Yang, X; Zhang, D; Zhang, Y; Zhu, S | 1 |
| Alastruey-Izquierdo, A; Castelli, MV; Cuenca-Estrella, M; Cuesta, I; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
| Coleman, DC; Dudley, E; Kelly, DE; Kelly, SL; Lamb, DC; Melo, NR; Moran, GP; Smith, SN; Sullivan, DJ; Warrilow, AG | 1 |
| Fille, M; Hausdorfer, J; Hinterberger, G; Lass-Flörl, C; Mayr, A; Perkhofer, S; Speth, C | 1 |
| Bergès, T; Bouchara, JP; Chabasse, D; Ernoult, E; Larcher, G; Tronchin, G; Vandeputte, P | 1 |
| Müller, FM; Salvenmoser, S; Seidler, MJ | 1 |
| Fothergill, AW; Patterson, TF; Thompson, GR; Vallor, AC; Wickes, BL; Wiederhold, NP | 1 |
| Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD | 1 |
| Alastruey-Izquierdo, A; Cuenca-Estrella, M; Lass-Flörl, C; Perkhofer, S; Rodriguez-Tudela, JL | 1 |
| Chai, X; Dan, Z; Hu, H; Jiang, Y; Sun, Q; Wu, Q; Yu, S; Zhang, J | 1 |
| Arendrup, MC; Bruun, B; Buzina, W; Garcia-Effron, G; Jensen, HE; Lass-Flörl, C; Lundin, C; Mortensen, KL; Perlin, DS; Reiter, N | 1 |
| Dimopoulos, G; Falagas, ME; Velegraki, A | 1 |
| Alastruey-Izquierdo, A; Castelli, MV; Cuenca-Estrella, M; Cuesta, I; Monzon, A; Rodriguez-Tudela, JL | 1 |
| Guarro, J; Mariné, M; Rodríguez, MM; Ruíz-Cendoya, M | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 3 |
| Chai, X; Dan, Z; Hu, H; Wu, Q; Yu, S; Zhang, D; Zhang, J; Zhao, Q; Zou, Y | 1 |
| Beernaert, LA; Dorrestein, GM; Haesebrouck, F; Martel, A; Pasmans, F; Van Waeyenberghe, L; Vercammen, F; Verstappen, F | 1 |
| Bocanegra, R; Coalson, JJ; Graybill, JR; McConville, JT; Najvar, LK; Patterson, TF; Peters, JI; Tolman, JA; Wiederhold, NP; Williams, RO | 1 |
| Bergès, T; Bouchara, JP; Chabasse, D; Renier, G; Rocher, F; Tronchin, G; Vandeputte, P | 1 |
| Guarro, J; Mariné, M; Pastor, FJ; Serena, C | 1 |
| Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE | 1 |
| Calvo, E; Guarro, J; Pastor, FJ; Rodríguez, MM; Salas, V; Sutton, DA | 1 |
| Boikov, D; Nagappan, V; Vazquez, JA | 1 |
| Gao, C; Pang, G; Sun, S; Wang, B; Xu, Y; Zhao, D; Zhou, L | 1 |
| Brüggemann, RJ; Mavridou, E; Melchers, WJ; Mouton, JW; Verweij, PE | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chapeland-Leclerc, F; Girard, A; Hennequin, C; Lacroix, C; Noël, T; Papon, N; Ribaud, P; Socié, G | 1 |
| Badali, H; De Hoog, GS; Illnait-Zaragozi, MT; Meis, JF; Najafzadeh, MJ | 1 |
| Inamine, T; Izumikawa, K; Kakeya, H; Kohno, S; Miyazaki, T; Miyazaki, Y; Nagayoshi, Y; Saijo, T; Seki, M; Yamamoto, Y; Yamauchi, S; Yanagihara, K | 1 |
| Alastruey-Izquierdo, A; Cuenca-Estrella, M; Cuesta, I; Rodriguez-Tudela, JL; Walther, G | 1 |
| Bartley, R; Biswas, C; Chen, SC; Djordjevic, JT; Ellis, DH; Jolliffe, KA; Obando, D; Pantarat, N; Sorrell, TC; Widmer, F | 1 |
| Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Warrilow, AG; Weig, M | 1 |
| Calvo, E; Guarro, J; Mayayo, E; Pastor, FJ; Rodríguez, MM; Salas, V | 1 |
| Chai, X; Guan, Z; Hu, H; Sun, Q; Wu, Q; Yan, Y; Yu, S; Zou, Y | 1 |
| Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, N; Warrilow, AG; Weig, M | 1 |
| Guarro, J; Mayayo, E; Pastor, FJ; Pujol, I; Ruíz-Cendoya, M; Sutton, DA | 1 |
| Cao, Y; Chai, X; Hu, H; Jiang, Y; Sun, Q; Wu, Q; Zhang, D; Zhang, J; Zhao, Q; Zou, Y | 1 |
| Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Xu, J; Yu, S; Zhang, D; Zhang, J; Zou, Y | 1 |
| Aiello, S; Borghi, E; Boschi, D; Fruttero, R; Guglielmo, S; Morace, G | 1 |
| Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Zhang, D; Zhang, J; Zou, Y | 1 |
| Chai, X; Hu, H; Liao, J; Wu, Q; Xu, M; Yu, S; Zhao, Q; Zou, Y | 1 |
| Hu, Y; Shen, F; Wang, K; Wang, L; Yang, W; Zhu, J | 1 |
| Akalin, G; Bertout, S; Demirci, F; Fulcrand, P; Maillard, LT; Martinez, J; Masurier, N; Quinonéro, O; Turan-Zitouni, G | 1 |
| Cai, T; Cao, X; Cao, Y; Chu, W; Hu, W; Sun, Z; Wang, R; Yang, Y | 1 |
| Botta, M; Castagnolo, D; Donzellini, G; Posteraro, B; Sanfilippo, S; Sanglard, D; Sanguinetti, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chandrika, NT; Garneau-Tsodikova, S; Ngo, HX; Shrestha, SK | 1 |
| Garneau-Tsodikova, S; Garzan, A; Shrestha, SK | 1 |
| Chen, F; Chen, W; Lan, L; Li, B; Li, J; Liu, Y; Mao, F; Ni, S; Wei, H; Zhu, J | 1 |
| Garneau-Tsodikova, S; Howard, KC; Ngo, HX; Shrestha, SK; Thamban Chandrika, N; Tsodikov, OV | 1 |
| Garneau-Tsodikova, S; Howard, KC; Ngo, HX; Shrestha, SK; Thamban Chandrika, N | 1 |
| Han, G; Ji, C; Li, Z; Liu, N; Sheng, C; Tu, J; Wang, Y | 1 |
| Wang, SQ; Wang, YF; Xu, Z | 1 |
| Gazzola, S; Guillon, R; Le Pape, P; Logé, C; Montoir, D; Ourliac-Garnier, I; Pagniez, F; Picot, C; Planchat, A; Soklou, KE; Tonnerre, A | 1 |
| Armstrong, D; Bernard, EM; Ishimaru, T; Murphy, M | 1 |
| Haberreiter, A; Paule, I; Seidl, HP; Wildfeuer, A | 1 |
| Jones, RN; Marco, F; Messer, S; Pfaller, MA | 1 |
| Meis, JF; van 't Hek, LG; van Dalen, R; Verweij, PE; Weemaes, CM; Yntema, JB | 1 |
| McGinnis, MR; Pasarell, L | 1 |
| Denning, DW; Moore, CB; Oakley, KL | 1 |
| Cantu, RA; Fothergill, AW; Kirkpatrick, WR; Lopez-Ribot, JL; Mcatee, RK; McCarthy, DI; Patterson, TF; Revankar, SG; Rinaldi, MG; Sanche, SE | 1 |
| Cooper, CR; Fothergill, AW; McGinnis, MR; Pasarell, L; Rinaldi, MG; Sutton, DA | 1 |
| Denning, DW; Donnelly, JP; Meis, JF; Mensink, M; Rijs, AJ; Verweij, PE | 1 |
| Chandrasekar, PH; Cutright, JL; Manavathu, EK | 3 |
| Cuenca-Estrella, M; Martínez-Suárez, JV; Mellado, E; Monzón, A; Rodríguez-Tudela, JL | 1 |
| Audouin, AF; Breton, P; Germaud, P; Harousseau, JL; Milpied, N; Morin, O | 1 |
| Chandrasekar, PH; Cutright, J; Manavathu, EK | 1 |
| Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ | 1 |
| Abraham, OC; Chandrasekar, PH; Cutright, JL; Manavathu, EK | 1 |
| Johnson, EM; Szekely, A; Warnock, DW | 1 |
| Brinkman, K; Kremer, HP; Kullberg, BJ; Meis, JF; Verweij, PE | 1 |
| Bhat, N; Ghannoum, MA; Okogbule-Wonodi, I; Sanati, H | 1 |
| Jones, RN; Marco, F; Messer, SA; Pfaller, MA | 1 |
| Fothergill, AW; Revankar, SG; Rinaldi, MG; Sanche, SE; Sutton, DA | 1 |
| Amalfitano, G; Concia, E; Kwon-Chung, KJ; Luzzati, R; Mondon, P; Petter, R; Polacheck, I | 1 |
| Anaissie, EJ; Arikan, S; Lozano-Chiu, M; Paetznick, VL; Rex, JH | 1 |
| Arikan, S; Lozano-Chiu, M; Nangia, S; Paetznick, V; Rex, JH | 1 |
| Chandrasekar, PH; Cutright, J; Manavathu, E | 1 |
| Ciblak, MA; Li, RK; McGinnis, MR; Nordoff, N; Pasarell, L; Warnock, DW | 1 |
| Niki, Y | 1 |
| Chandrasekar, PH; Cutright, JL; Loebenberg, D; Manavathu, EK | 1 |
| Fothergill, AW; Kirkpatrick, WR; McAtee, RK; Patterson, TF; Rinaldi, MG | 1 |
| Arikan, S; Kocagöz, S; Sancak, B; Unal, S; Uzun, O | 1 |
| Amariglio, N; Bielorai, B; Golan, H; Kaplinisky, C; Keller, N; Mandel, M; Neumann, Y; Paswell, J; Rechavi, G; Toren, A; Weintraub, M; Wolach, B | 1 |
| Espinel-Ingroff, A | 1 |
| Leitner, I; Ryder, NS | 1 |
| Kämmerer, R; Klempien, I; Kujath, P; Muhl, E | 1 |
| Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ | 1 |
| Abraham, OC; Chandrasekar, PH; Manavathu, EK | 1 |
| Boyle, K; Espinel-Ingroff, A; Sheehan, DJ | 1 |
| Li, RK; McGinnis, MR; Nordoff, N; Pasarell, L; Warnock, DW | 1 |
| Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A | 1 |
| Diemert, D; Kunimoto, D; Rennie, R; Sand, C | 1 |
| Cuenca-Estrella, M; Gómez-López, A; Monzón, A; Rodriguez-Tudela, JL | 1 |
| Ernst, EJ; Klepser, ME; Roling, EE; Yodoi, K | 1 |
| Anaissie, E; Arndt, C; Donowitz, G; Finberg, R; Fioritoni, G; Garber, G; Greenberg, R; Hadley, S; Laverdière, M; Lazarus, HM; Lee, J; Pappas, P; Perfect, J; Petersen, F; Raffalli, J; Reboli, A; Reinhardt, J; Schuster, M; Stiff, P; Walsh, TJ; Wingard, J; Winston, DJ; Yanovich, S | 1 |
| Marr, KA | 1 |
| Dixon, CA; Goldberger, MJ; Powers, JH | 1 |
| Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Dismukes, WE; Lee, J; Walsh, TJ | 1 |
| Johnson, JR | 1 |
| Cornely, OA; Heussel, CP; Ullmann, AJ | 1 |
| Apisarnthanarak, A; Little, JR; Tebas, P | 1 |
| Bastide, JM; Dannaoui, E; Grillot, R; Mallie, M; Meletiadis, J; Piens, MA; Rigoni, AL; Tortorano, AM; Viviani, MA | 1 |
| Coco, BJ; Kirkpatrick, WR; Patterson, TF; Perea, S | 1 |
| Bennett, JE; Caillot, D; Chandrasekar, PH; de Pauw, B; Denning, DW; Durand, C; Greene, RE; Herbrecht, R; Hodges, MR; Kern, WV; Lortholary, O; Marr, KA; Oestmann, JW; Patterson, TF; Ribaud, P; Rubin, RH; Schlamm, HT; Stark, P; Sylvester, R; Thiel, E; Troke, PF; Wingard, JR | 1 |
| Garbino, J; Hirschel, B | 1 |
| Darouiche, RO; Kontoyiannis, DP; Lewis, RE; Prince, RA; Raad, II | 1 |
| Bacigalupo, A; Ferrua, MT; Gallamini, A; Ghirardo, D; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Viscoli, C | 1 |
| Blot, F; Edé, C; Nitenberg, GM | 1 |
| Karthaus, M | 2 |
| Diekema, DJ; Hollis, RJ; Maxwell, MJ; Messer, SA; Pfaller, MA | 1 |
| Herbrecht, R | 1 |
| Bernal, S; Chávez M, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Ramirez, M; Serrano, Mdel C; Valverde-Conde, A | 1 |
| Adderson, EE; Andreansky, M; Luján-Zilbermann, J; Rodriguez, CA; Woodard, P | 1 |
| Dierch, MP; Gunsilius, E; Kofler, G; Lass-Flörl, C; Speth, C; Würzner, R | 1 |
| Chan, J | 1 |
| Lipp, HP | 2 |
| Mori, T | 1 |
| Johnson, PD; Korman, TM; Stratov, I | 1 |
| Choquet, S; Chosidow, O; Consigny, S; Datry, A; Dhedin, N; Leblond, V | 1 |
| Walson, PD | 1 |
| Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Cook, C; Fernandez, C; Fraser, R; McCully, B; Schmidt, M; Shouldice, E | 1 |
| Alaggio, R; Cecchetto, G; Cesaro, S; Cusinato, R; Pillon, M; Rigobello, L; Strugo, L; Zanesco, L | 1 |
| Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 2 |
| Alfandari, S; Bauters, F; Benchikh, Z; Camus, D; Catteau, B; Cordevant, C; De Botton, S; Dei-Cas, E; Delhaes, L; Durand-Joly, I; Espinel-Ingroff, A; Rodrigue, M | 1 |
| Chaturvedi, V; Gangwar, M; Ramani, R | 1 |
| Bliss, JM; Gigliotti, F; Wellington, M | 1 |
| Gallamini, A; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Pugno, F; Viscoli, C | 1 |
| Sims-McCallum, RP | 1 |
| Bonner, D; Fung-Tomc, J; Huczko, E; Minassian, B; Washo, T | 1 |
| Fujihara, N; Ichiyama, S; Iinuma, Y; Kudo, T; Saito, T; Takakura, S | 1 |
| Denning, DW; Hope, WW | 1 |
| Capilla, J; Guarro, J; Javier Pastor, F; Ortoneda, M; Pujol, I | 1 |
| Díaz, MA; González-Vicent, M; Lassaletta, A; Madero, L; Perez, A; Sevilla, J | 1 |
| Cappelli, B; Castagnola, E; Dodero, P; Faraci, M; Machetti, M; Molinari, AC; Morreale, G; Tomà, P | 1 |
| Contu, L; La Nasa, G; Ledda, A; Littera, R; Maccioni, A; Vacca, A | 1 |
| Mehta, J; Trifilio, S; Verma, A; Williams, S; Zembower, T | 1 |
| Schwartz, S; Thiel, E | 1 |
| Höhl, R | 1 |
| Chen, E; Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, VL; Rodriguez, JR | 1 |
| Bethell, D; Goodman, TR; Hall, G; Klein, N; Pollard, AJ | 1 |
| Adou-Bryn, KD; Buisson, Y; Chandenier, J; Douchet, C; Kombila, M; Richard-Lenoble, D; Sar, B; Swinne, D; Thérizol-Ferly, M | 1 |
| Ausin, I; Badia, X; Carreras, E; Herrera, L; Roset, M | 1 |
| Casadevall, A; Cleare, W; Nosanchuk, JD; van Duin, D; Zaragoza, O | 1 |
| Alaggio, R; Calore, E; Cesaro, S; Cusinato, R; Messina, C; Pillon, M; Toffolutti, T; Zanesco, L | 1 |
| Nolard, N; Swinne, D; Van der Flaes, M; Watelle, M | 1 |
| Friedrich, W; Gahr, M; Hahn, G; Koch, A; Roesler, J; Rösen-Wolff, A | 1 |
| Bocanegera, R; Colombo, AL; Gonzalez, GM; Graybill, JR; Hernandez, S; McCarthy, DI; Najvar, LK | 1 |
| Chang, CS; Chang, HW; Chang, WN; Chien, CC; Huang, CR; Lee, PY; Lei, CB; Lu, CH | 1 |
| Al-Fattani, MA; Douglas, LJ | 1 |
| Baldassarri, I; Barchiesi, F; Fothergill, AW; Maracci, M; Rinaldi, MG; Scalise, G; Spreghini, E | 1 |
| Bonatti, H; Dierich, MP; Freund, MC; Gastl, G; Gschwendtner, A; Gunsilius, E; Kropshofer, G; Lass-Flörl, C; Petzer, A | 1 |
| Blin, N; Gaillard, F; Harousseau, JL; Milpied, N; Moreau, P; Morin, O; Morineau, N | 1 |
| Bruneel, F; Chevret, S; de Broucker, T; Lellouche, F; Régnier, B; Tattevin, P; Wolff, M | 1 |
| Kuijper, EJ; Kullberg, BJ; van 't Wout, JW; Verweij, PE | 1 |
| Gavaldá, J; Lumbreras, C | 1 |
| Klastersky, J | 1 |
| Chryssanthou, E; Sjölin, J | 1 |
| D'Antonio, D; Di Bonaventura, G; Picciani, C; Piccolomini, R; Spedicato, I | 1 |
| Chadwick, EG; Guzman-Cottrill, JA; Zheng, X | 1 |
| Balajee, SA; Gribskov, JL; Imhof, A; Marr, KA | 1 |
| Benjamin, DK; Heitman, J; Miller, JL; Perfect, JR; Schell, WA; Singh, N; Steinbach, WJ | 1 |
| Cariani, L; Drago, M; Morace, G; Scaltrito, MM | 1 |
| Alexander, BD; Brennan, K; Forrest, G; Husain, S; Muñoz, P; Singh, N; Somani, J; Wagener, MM | 1 |
| Perfect, JR | 2 |
| Marr, K | 1 |
| Birnbaum, DE; Jagiello, M; Liebold, A; Retzl, G; Wieland, T | 1 |
| Danaher, PJ | 1 |
| Lowry, CM; Marty, FM | 1 |
| Soto, J | 1 |
| García-Agudo, L; García-Martos, P; Gutiérrez-Calzada, J; Marín, P; Ruiz-Aragón, J; Saldarreaga, A | 1 |
| Del Favero, A; Kibbler, C; Marciniak, A; Mauskopf, J; Morris, S; Rogers, T; Rotstein, C; Schlamm, H; Troke, P; Wenzel, R | 1 |
| Klepser, ME; Lewis, RE; Wiederhold, NP | 1 |
| Alcazar-Fuoli, L; Buitrago, MJ; Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL | 1 |
| Bailly, E; Bastides, F; Ehrmann, S; Gissot, V; Legras, A; Magro, P; Mercier, E | 1 |
| Bastide, JM; Blancard, A; Bonnin, A; Bretagne, S; Cambon, M; Chandenier, J; Chauveau, V; Couprie, B; Datry, A; Feuilhade, M; Grillot, R; Guiguen, C; Lavarde, V; Letscher, V; Linas, MD; Mallié, M; Michel, A; Morin, O; Paugam, A; Piens, MA; Raberin, H; Tissot, E; Toubas, D; Wade, A | 1 |
| Yasuda, MA | 1 |
| Nolard, N; Swinne, D; Watelle, M | 1 |
| Chandrasekar, PH; Krishnan, S; Manavathu, EK | 1 |
| Cesaro, S; Visintin, G | 1 |
| Christmann, D; Eisenmann, B; Forestier, E; Hansman, Y; Lesens, O; Martinot, M; Remy, V | 1 |
| Leather, H | 1 |
| Antachopoulos, C; Bibashi, E; Dotis, J; Koliouskas, D; Papakonstantinou, E; Roilides, E; Tamiolaki, M | 1 |
| Eggink, CA; Klont, RR; Rijs, AJ; Verweij, PE; Wesseling, P | 1 |
| Böhme, A; Haas, A; Maschmeyer, G | 1 |
| Dierich, MP; Lass-Flörl, C; Leitner, S; Rief, A; Speth, C; Würzner, R | 1 |
| Steinbach, WJ | 2 |
| Ambegaonkar, AJ; Boucher, HW; Day, DL; Lewis, JS; Lubowski, TJ; Patterson, TF | 1 |
| Jacobs, RF; Maples, HD; Muldrew, KM; Stowe, CD | 1 |
| Auvrignon, A; Boccon-Gibod, L; Landman-Parker, J; Leverger, G; Moissenet, D; Petit, A; Tabone, MD | 1 |
| McCluskey, P; Singh, RP | 1 |
| Athanassiadou, F; Kalogera, A; Kourti, M; Papageorgiou, T; Tragiannidis, A; Velegraki, A | 1 |
| Chen, E; Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, VL; Philip, A; Rex, JH; Rodriguez, J | 1 |
| Bedini, A; Cocchi, S; Codeluppi, M; Esposito, R; Guaraldi, G; Squillace, N; Venturelli, C | 1 |
| Jagirdar, J; Scott, RS; Sutton, DA | 1 |
| Aguado, JM; Cisneros, JM; Díaz Pedroche, C; Lumbreras, C | 1 |
| Alía-Aponte, C; Baró-Tomás, T; Jiménez-Cabello, T; Lázera, MS; Morera-López, Y; Torres-Rodríguez, JM | 1 |
| Bishara, J; Peled, N; Samra, Z; Yardeni, M | 1 |
| Bonatti, H; Dierich, MP; Freund, M; Gastl, G; Griff, K; Kropshofer, G; Lass-Flörl, C; Mayr, A; Nachbaur, D; Petzer, A | 1 |
| Espinel-Ingroff, A; Fothergill, A; Ghannoum, M; Manavathu, E; Ostrosky-Zeichner, L; Pfaller, M; Rinaldi, M; Schell, W; Walsh, T | 1 |
| Colombo, GL; Morlotti, L; Serra, G | 1 |
| Bennett, JE; Boucher, HW; Denning, DW; DePauw, B; Herbrecht, R; Lortholary, O; Patterson, TF; Ribaud, P; Rubin, RH; Schlamm, HT; Troke, P; Wingard, JR | 1 |
| Bagg, J; Coulter, WA; Kuriyama, T; Lewis, MA; Ready, D; Williams, DW | 1 |
| Blijlevens, NM; Jansen, JP; Meis, JF; van't Wout, JW | 1 |
| Ballentine, CS; Glickman, RD; Graybill, JR; Harrison, JM; Kumar, N; Kurian, P; Lloyd, WC; Melendez, R; Miller, A; Miller, MM; Najvar, LK; Paris, G; Patel, AH; Pena, MA; Sponsel, WE; Trigo, Y; Trujillo, F | 1 |
| Blatny, J; Burgetova, D; Kren, L; Mudry, P; Prochazka, J; Skotakova, J; Sterba, J; Valik, D; Ventruba, J | 1 |
| Bertz, H; Finke, J; Kern, WV; Sander, A; Wagner, D | 1 |
| Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G | 1 |
| Chamilos, G; Kontoyiannis, DP | 1 |
| Conte, JV; Dropulic, LK; Girgis, R; Mcdyer, JF; Orens, JB; Shlobin, OA; Yang, SY | 1 |
| Barfield, RC; Behm, FG; Burnette, K; Eldridge, P; Hale, GA; Handgretinger, R; Knapp, K | 1 |
| Clemons, KV; Espiritu, M; Parmar, R; Stevens, DA | 1 |
| Cutler, JE; Hazen, KC; Wetter, TJ | 1 |
| Araujo, R; Pina-Vaz, C; Rodrigues, AG | 2 |
| Gøtzsche, PC; Johansen, HK; Jørgensen, KJ | 1 |
| Marik, PE; Raman, T | 1 |
| Alarcón L, P; Camacho A, J; Cruces R, P; Donoso F, A | 1 |
| Casadevall, A; Martinez, LR | 1 |
| Bal, AM | 1 |
| Dombrowski, F; Franke, A; Jentsch-Ullrich, K; Koenigsmann, M; Mohren, M; Schalk, E | 1 |
| Kamani, N; Panicker, J; Walsh, T | 1 |
| Coco, BJ; Kirkpatrick, WR; Patterson, TF | 1 |
| Agostinelli, C; Arpinati, M; Baccarani, M; Bandini, G; Bonifazi, F; Giannini, B; Paolini, S; Ricci, P; Stanzani, M; Vianelli, N | 1 |
| Allamani, M; Falagas, ME; Michalopoulos, A; Vassiloyanakopoulos, A | 1 |
| Alcalá, L; Bouza, E; Guinea, J; Peláez, T | 2 |
| Bosch, M; Cantón, E; de Llanos, R; Jarque, I; Molina, A; Pemán, J; Salavert, M | 1 |
| Amorosa, V; Bridges, CR; Isidro, AM; Pentz, WH; Rutenberg, HL; Stopyra, GA | 1 |
| Black, TA; Hare, R; Loebenberg, D; Mann, PA; McNicholas, PM; Mendrick, CA; Norris, CC; Patel, R; Sabatelli, F | 1 |
| Gilgado, F; Guarro, J; Mariné, M; Pastor, FJ; Serena, C | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL | 1 |
| Akova, M; Sahin, GO | 1 |
| Denning, DW; Dupont, B; Lode, H; Sambatakou, H | 1 |
| Brandenburg, VM; Floege, J; Guetgemann, A; Ketteler, M; Riehl, J | 1 |
| Clemons, KV; Martinez, M; Parmar, R; Stevens, DA | 1 |
| Antony, SJ; Brumble, L; Jurczyk, P | 1 |
| Agarwal, R; Singh, N | 1 |
| Colson, YL; Marty, FM; Paul, S | 1 |
| Blackwood, RA; Klein, KC | 1 |
| Pemán, J; Zaragoza, R | 1 |
| Arechavala, A; Bianchi, MH; López Daneri, G; Negroni, R; Robles, AM; Santiso, G | 1 |
| Eifinger, F; Frankenbusch, K; Kribs, A; Rengelshauseu, J; Roth, B | 1 |
| Chaturvedi, V; Cole, R; Gangwar, M; Ramani, R; Sheehan, DJ | 1 |
| Burhenne, J; Cornely, OA; Elter, T; Fätkenheuer, G; Gossmann, A; Kuchta, J; Riedel, KD; Schröder, U; Seifert, H; Sieniawski, M; Wickenhauser, C | 1 |
| Gottfredsson, M; Steingrímsdóttir, H | 1 |
| Rokicka, M | 1 |
| Selleslag, D | 1 |
| Bailey, TA; Di Somma, A; Silvanose, CD | 1 |
| Bodkin, J; Bubb, WA; Coen, M; Himmelreich, U; Kuchel, PW; Power, D; Sorrell, TC | 1 |
| Georgopoulos, A; Graninger, W; Kratzer, C; Schmoll, M; Tobudic, S | 1 |
| Manfredi, R; Sabbatani, S | 1 |
| Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
| Beck, R; Kaben, U; Tintelnot, K | 1 |
| Gopal, L; Sen, P; Sen, PR | 1 |
| Denning, DW; Gardiner, RE; Howard, SJ; Moore, CB; Park, S; Perlin, DS; Webster, I | 1 |
| Demchok, JP; Meletiadis, J; O'Shaughnessy, EM; Stergiopoulou, T; Walsh, TJ | 1 |
| Garbino, J; Roberts, C; Schnetzler, G | 1 |
| Guarro, J; Marimon, R; Mariné, M; Pastor, FJ; Serena, C | 1 |
| Campbell, C; Johnson, E; Lamagni, TL; Pezzoli, L | 1 |
| Canton, E; Espinel-Ingroff, A; Gibbs, D; Wang, A | 1 |
| Bennett, CL; Blum, W; Chamilos, G; Evens, A; Kennedy, L; Kontoyiannis, DP; McKoy, JM; Mehta, J; Mullane, K; Palella, F; Parada, J; Scheetz, MH; Tallman, MS; Trifilio, SM; Yarnold, PR | 1 |
| Maesaki, S | 2 |
| Booton, GC; Doyle, RL; Montoya, JG; Visvesvera, GS; Walia, R | 1 |
| Kofteridis, D; Koutsopoulos, A; Krasagakis, K; Maraki, S; Samonis, G; Sfakianakis, A; Stefanidou, M; Tosca, A | 1 |
| Araújo, CR; Costa, CR; e Souza, LK; Fernandes, Ode F; Nascimento, ES; Passos, XS; Sales, WS; Silva, Mdo R | 1 |
| Collins, CD; DePestel, DD; Stevenson, JG; Stuntebeck, ER | 1 |
| Avci, B; Cetinkaya, Z; Ermis, SS; Inan, UU; Kusbeci, T; Ozturk, F; Yavas, G | 1 |
| Cars, O; Johansson, A; Lignell, A; Löwdin, E; Sjölin, J | 1 |
| Benjamin, DK; Jafri, HS; Mejias, A; Patel, S; Sánchez, PJ; Santos, RP; Walsh, TJ | 1 |
| Arthington-Skaggs, B; Ellis, D; Espinel-Ingroff, A; Fothergill, A; Gibbs, DL; Iqbal, N; Messer, S; Pfaller, MA; Rinaldi, M; Wang, A | 1 |
| Aoun, N; Baixench, MT; Bretagne, S; Dannaoui, E; Desnos-Ollivier, M; Garcia-Hermoso, D; Piketty, C; Ramires, S | 1 |
| Harada, AS; Lau, W | 1 |
| Ho, DY; Lee, JD; Montoya, JG; Rosso, F | 1 |
| Alonso, N; Bajo, R; Casado, MS; de la Llana, FG; Fajardo, M; Garcia-Dominguez, M; Sanz-Rodriguez, C; Vagace, JM; Zarallo, L | 1 |
| Ament, AJ; de Groot, R; Donnelly, JP; Hübben, MW; Severens, JL; van 't Wout, J; Verweij, PE; Warris, A | 1 |
| Acharya, NR; Chidambaram, JD; Fothergill, AW; Hong, KC; Lalitha, P; Lietman, TM; Maxey, KJ; McLeod, SD; Prajna, NV; Ruiz, J; Shapiro, BL; Srinivasan, M | 1 |
| Hosoki, T; Ikuta, K; Jimbo, J; Kohgo, Y; Nishimura, K; Sano, A; Sato, K; Shindo, M; Torimoto, Y | 1 |
| Collins, CD; DePestel, DD; Erba, HP; Mackler, ER; Shehab, N; Welch, K | 1 |
| Herbrecht, R; Marciniak, A; Mauskopf, J; Roberts, CS; Schlamm, HT; Wingard, JR | 1 |
| Choe, L; Guglielmo, BJ; Inciardi, J; Martin, T; Riedel, A; Yuen, C | 1 |
| Hall, GS; Jeng, BH; Meisler, DM; Schoenfield, L | 1 |
| Drees, M; Gupta, M; Hadley, S; Wickes, BL | 1 |
| Aydin, S; Ertugrul, B; Gultekin, B; Kir, E; Uyar, G | 1 |
| Geiger, S; Herold, T; Nickenig, C; Ostermann, H; Rieger, C | 1 |
| Jarque, I; Sanz, MA | 1 |
| Denning, DW | 1 |
| Cetinkaya, Z; Ermis, SS; Inan, UU; Kiraz, N; Küsbeci, T; Oztürk, F; Yavas, GF | 1 |
| Diekema, DJ; Pfaller, MA; Procop, GW; Rinaldi, MG | 1 |
| Al-Tawfiq, JA; Amr, SS | 1 |
| Gahn, B; Gramatzki, M; Repp, R; Schub, N | 1 |
| Kaya, AD; Kiraz, N | 1 |
| Stratakos, G; Zakynthinos, S | 1 |
| Khakoo, RA; Khan, FA; Slain, D | 1 |
| Abrantes, R; Córdoba, S; Davel, G; Rodero, L; Vitale, RG; Vivot, W | 1 |
| Greene, RE; Mauskopf, J; Roberts, CS; Schlamm, HT; Zyczynski, T | 1 |
| Mian, P; Pagani, L; Spoladore, G; Vedovelli, C | 1 |
| Auler, ME; Dias, AL; Gandra, RF; Gonçalves da Silva, E; Matsumoto, FE; Melhem, MS; Paula, CR; Ruiz, LS; Szeszs, MW | 1 |
| Conti, S; Drago, M; Fanti, F; Morace, G; Polonelli, L; Scaltrito, MM | 1 |
| Carrillo-Muñoz, AJ; Casals, JB; del Valle, O; Estivill, MD; Ezkurra, PA; Giusiano, G; Quindós, G; Santos, P | 1 |
| Blaich, A; Hopt, UT; Kaffarnik, M; Utzolino, S | 1 |
| Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA | 1 |
| Bonini, A; Caira, M; Fianchi, L; Girmenia, C; Leone, G; Pagano, L; Rossi, G; Sanguinetti, M; Valentini, CG | 1 |
| Clauss, H; Samuel, R | 1 |
| Espinel-Ingroff, A; Hockey, H; Johnson, E; Troke, P | 1 |
| Arthington-Skaggs, BA; Chaturvedi, V; Ghannoum, MA; Holliday, N; Iqbal, NJ; Killian, SB; Knapp, C; Messer, SA; Ostrosky-Zeichner, L; Pfaller, MA; Ramani, R; Rex, JH; Sein, T; Vazquez, JA; Walsh, TJ | 1 |
| Boot, B; Danho, C; Huynh, A; Mejdoubi, M | 1 |
| Gil-Lamaignere, C; Maloukou, A; Roilides, E; Simitsopoulou, M; Walsh, TJ | 1 |
| Almeida, C; Martín-Mazuelos, E; Méndez, CC; Pemán, J; Serrano, MC; Valverde, A | 1 |
| Herbrecht, R; Ribaud, P; Schlamm, HT; Wingard, JR | 1 |
| Ergon, C; Metin, DY; Ozkutuk, A; Polat, SH; Yucesoy, M | 1 |
| Chryssanthou, E; Loebig, A; Sjölin, J | 1 |
| Cars, O; Lignell, A; Löwdin, E; Sjölin, J | 1 |
| Bourolias, CA; Karatzanis, AD; Kofteridis, DP; Mantadakis, E; Papazoglou, G; Samonis, G; Velegrakis, GA | 1 |
| Aragane, N; Fukuno, Y; Fukuoka, M; Hayashi, S; Kawaura, F; Kobayashi, H; Matsuishi, E; Sano, A; Tanaka, M | 1 |
| Akşit, F; Kiraz, N; Kiremitçi, A; Oz, Y | 1 |
| Lahat, Y; Sandovsky-Losica, H; Segal, E; Shwartzman, R | 1 |
| Guarro, J; Mariné, M; Ruíz-Cendoya, M | 1 |
| Antoniadis, A; Braimi, M; Dermitzakis, E; Kioumi, A; Papadakis, E; Tsitouridis, I; Vyzantiadis, TA | 1 |
| Dey, P; Gupta, A; Gupta, P; Gupta, V; Kaur, J; Sachdev, N | 1 |
| Benesch, M; Dornbusch, HJ; Lackner, H; Schwinger, W; Sovinz, P; Strenger, V; Urban, C | 1 |
| Ayala, J; Elizondo, M; González, GM | 1 |
| Dolande, M; Panizo, MM; Reviákina, V; Selgrad, S | 1 |
| Altas, K; Boekhout, T; Kantarcioğlu, AS; Yücel, A | 1 |
| Auberger, J; Bellmann, R; Buzina, W; Clausen, J; Gastl, G; Lass-Flörl, C; Nachbaur, D | 1 |
| Mircus, G; Osherov, N; Shadkchan, Y; Shalit, I | 1 |
| Hollenbach, E | 1 |
| Balasubramaniam, B; Dick, A; Johnson, E; Mayer, E; Narendran, N | 1 |
| Gafter-Gvili, A; Goldberg, E; Leibovici, L; Paul, M; Vidal, L | 1 |
| Espinel-Ingroff, A; Hockey, H; Johnson, E; Szekely, A; Troke, P | 1 |
| Jones, B; Lang, S; McCulloch, E; Mowat, E; Ramage, G; Williams, C | 1 |
| Al-Badriyeh, D; Kong, DC; Liew, D; Stewart, K | 1 |
| Alastruey-Izquierdo, A; Cuenca-Estrella, M; Hazar, V; Ogunc, D; Ongut, G; Ozhak-Baysan, B; Rodriguez-Tudela, JL; Tezcan, G; Yildiran, ST | 1 |
| Barbabietola, G; Barker, K; Flynn, E; Marciniak, A; Oppenheim, BA; Roberts, C | 1 |
| Maesaki, S; Tarumoto, N | 1 |
| Fujii, Y; Inase, N; Yoshizawa, Y | 1 |
| dos Santos Lazéra, M; Guarro, J; Pastor, FJ; Pujol, I | 1 |
| Kisac, P; Krcmery, V; Liskova, A | 1 |
| Fothergill, AW; Rinaldi, MG; Sutton, DA | 1 |
| Anaissie, E; Chang, C; Fishman, J; Horn, D; Marr, K; Neofytos, D; Olyaei, A; Pfaller, M; Steinbach, W; Webster, K | 1 |
| Kanazawa, K; Niki, Y; Takemoto, K; Ueda, Y; Yamamoto, Y; Yoshida, K | 1 |
| Fatuzzo, F; Iacobello, C; La Rosa, R; Larocca, L; Montineri, A; Nigro, L | 1 |
| Gerlach, U; Guckelberger, O; Jörres, D; Kohler, S; Neuhaus, P; Pascher, A; Pratschke, J; Sauer, IM | 1 |
| Alp, S; Arikan, S; Hascelik, G; McNicholas, P; Sancak, B | 1 |
| Baltadakis, I; Karakasis, D; Liapis, K; Manaka, K | 1 |
| Calvo, E; Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C | 1 |
| Maertens, J; Meersseman, W; Van Bleyenbergh, P | 1 |
| Asari, S; Iwatani, Y; Nishi, I; Sunada, A; Toyokawa, M | 1 |
| Ayats, J; Fernández, N; Gasch, O; Santin, M | 1 |
| Kida, M | 1 |
| Inagaki, N; Mori, T; Yasuda, H | 1 |
| Ben-Ami, R; Chamilos, G; Kontoyiannis, DP; Lamaris, GA; Lewis, RE; Samonis, G | 1 |
| Danzi, M; Marino, A; Mungiguerra, M; Pisano, L; Ricciardi, AM; Ricciardi, R | 1 |
| Baggen, L; Chisholm, J; Sharland, M; Thomas, L | 1 |
| Segal, BH | 1 |
| Pérez, P; Piñar, D; Quiles, JA; Reus, S | 1 |
| Castel, V; Gonzalez-Esteban, J; Madero, L; Sanchez de Toledo, J; Sanz-Rodriguez, C; Sevilla, J | 1 |
| Bhavna, B; Kumar, K; Narayan, SK; Roopeshkumar, VR; Swaminathan, RP | 1 |
| Joshi, A; Khattry, N; Shah, MS; Singh, R; Umesh, S | 1 |
| Kang, CI; Mandrekar, JN; Patel, R; Rouse, MS; Steckelberg, JM | 1 |
| Brilhante, RS; Cordeiro, Rde A; de Camargo, ZP; de Lima, RA; Medrano, DJ; Monteiro, AJ; Rocha, MF; Sidrim, JJ; Tavares, JL | 1 |
| Dinc, BM; Kalkanci, A; Kekilli, M; Kurt, M; Odemis, B; Oztas, E; Parlak, E; Sasmaz, N | 1 |
| Li, R; Liu, W; Wan, Z; Wang, X; Yang, J | 1 |
| Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S | 1 |
| Acharya, NR; Hong, K; Lee, S; Loh, AR; Mannis, M | 1 |
| Atienzar, M; Blanch, JJ; Escribano, E; Rodríguez, M | 1 |
| Carter, JE; Culpepper, M; Goel, S; Kahn, AG | 1 |
| Flowers, SA; Rogers, PD; Ta, M | 1 |
| Frueh, BE; Goldblum, D; Muehlethaler, K; Theoulakis, P; Zimmerli, S | 1 |
| Alastruey-Izquierdo, A; Castelli, MV; Cuesta, I; Mellado, E; Monzón, A; Rodríguez-Tudela, JL; Zaragoza, O | 1 |
| Colby, KA; Mandell, KJ | 1 |
| Bonnal, C; Bouges-Michel, C; Bretagne, S; Chochillon, C; Dannaoui, E; Datry, A; Develoux, M; Dromer, F; Matheron, J; Paugam, A | 1 |
| Ali, R; Altundal, Y; Ener, B; Hakyemez, B; Kocaeli, H; Ozçelik, T; Ozkalemkaş, F; Ozkocaman, V; Tunali, A | 1 |
| Aloisi, T; Aversa, F; Bonini, A; Caira, M; Candoni, A; Caramatti, C; Cattaneo, C; Chierichini, A; de Waure, C; Fadda, RM; Fanci, R; Ferrara, F; Fianchi, L; Invernizzi, R; Leone, G; Luppi, M; Martino, B; Melillo, L; Mitra, ME; Nosari, A; Offidani, M; Pagano, L; Pastore, D; Picardi, M; Potenza, L; Riva, M; Rossini, F; Specchia, G; Stanzani, M; Vacca, A | 1 |
| Azeredo, J; Henriques, M; Martins, M; Negri, M; Oliveira, R; Svidzinski, TI | 1 |
| Capote, M; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rojas, R; Sánchez-García, J; Serrano, J; Tabares, S; Torres, A | 1 |
| Olson, EL; Tonelli, AR | 1 |
| Bertout, S; Bourgeois, N; Bousquet, PJ; Dehandschoewercker, L; Lachaud, L; Rispail, P | 1 |
| Akin, M; Ay, Y; Balkan, C; Karapinar, B; Kavakli, K; Yilmaz, D | 1 |
| Blanch-Iribarne, P; Garcia-Ramirez, M; Martin-Carballido, S; Martinez-Ferriz, MC; Martinez-Pajares, JD; Moreno-Perez, D | 1 |
| Christen, S; Egger, SS; Gratwohl, A; Haschke, M; Krähenbühl, S; Leu, C; Meier, S | 1 |
| Alagöz, N; Bozkurt, E; Cakir, M; Cekiç, O; Imamoğlu, S; Oksüz, L; Yilmaz, OF | 1 |
| Meletiadis, J; Pournaras, S; Roilides, E; Walsh, TJ | 1 |
| Ethier, MC; Maloney, AM; Mitchell, D; Sung, L; Zaoutis, T | 1 |
| Guarro, J; Madrid, H; Pastor, J; Ruíz-Cendoya, M | 1 |
| Bakker-Woudenberg, IA; Tavakol, M; van de Sande, WW; van Vianen, W | 1 |
| Cornely, OA | 1 |
| Chang, SC; Chang, YL; Lin, KP; Sheng, WH; Wang, CP | 1 |
| Guarro, J; Pastor, FJ; Rodríguez, MM; Serena, C | 1 |
| Wingard, J | 1 |
| Choi, JH; Choi, SM; Kwon, EY; Lee, DG; Park, CM; Shin, WS; Stevens, DA; Yoo, JH | 1 |
| Chew, HF; Cohen, EJ; Jungkind, DL; Mah, DY; Raber, IM; Tokarczyk, MJ; Toll, AD | 1 |
| Li, H; Lu, Q; Wan, Z; Zhang, J | 1 |
| Akashi, K; Aoki, T; Harada, N; Iwasaki, H; Kamezaki, K; Miyamoto, T; Mori, Y; Nagafuji, K; Shimono, N; Takenaka, K; Teshima, T; Yamauchi, T; Yoshimoto, G | 1 |
| Agoglia, L; Alves, J; Araujo, A; Balbi, E; Carius, L; Covelo, M; Enne, M; Gonzalez, AC; Guedes, C; Halpern, M; Martinho, JM; Pacheco, L; Roma, J | 1 |
| Bouchara, JP; Chabasse, D; Hitoto, H; Pihet, M; Rachieru-Sourisseau, P; Weil, B | 1 |
| Segal, BH; Sherif, R | 1 |
| Fuqua, TH; Knoll, M; Said-Al-Naief, N; Sittitavornwong, S | 1 |
| Corey, M | 1 |
| Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA | 1 |
| Chen, HT; Cheng, WT; Leaw, SN; Lo, HJ; Wang, AH; Yang, YL | 1 |
| Borman, AM; Houbraken, J; Rijs, AJ; Samson, RA; Verweij, PE | 1 |
| Kim, A; Kuti, JL; Nicolau, DP | 1 |
| Boel, A; Cartuyvels, R; Magerman, K; Naesens, R; Nys, S; Vijgen, S | 1 |
| Berrak, SG; Cakir, E; Cakir, FB; Canpolat, C; Dagli, E; Karakoc, F; Uyan, ZS | 1 |
| McCormack, J; Pollard, J | 1 |
| Calvo, E; Guarro, J; Pastor, FJ; Pujol, I; Rodríguez, MM | 1 |
| Dalpke, A; Müller, FM; Salvenmoser, S; Seidler, MJ | 1 |
| Biassoni, C; Borghi, E; Cuna, T; Iatta, R; Montagna, MT; Morace, G; Sciota, R | 1 |
| Aznar, J; de Toro, M; Maite, R; Torres, MJ | 1 |
| Aversa, F; Caira, M; Candoni, A; Leone, G; Luppi, M; Martino, B; Nosari, A; Offidani, M; Pagano, L; Specchia, G; Tosti, ME; Valentini, CG | 1 |
| Belda, S; Cremades, R; Lopez, P; Rodriguez, JC; Royo, G; Ruiz-Garcia, M; Soler, L | 1 |
| Baert, K; Debacker, P; Ducatelle, R; Garner, TW; Haesebrouck, F; Martel, A; Pasmans, F; Van Rooij, P; Van Waeyenberghe, L; Vercauteren, G; Woeltjes, T | 1 |
| Aydin, F; Bayramoglu, G; Guler, NC; Kaklikkaya, N; Tosun, I | 1 |
| Guarro, J; Pastor, J; Ruíz-Cendoya, M | 1 |
| Bartlett, KH; Boekhout, T; Geertsen, E; Hagen, F; Illnait-Zaragozi, MT; Klaassen, CH; Meis, JF; Swinne, D | 1 |
| Chang, MR; Dias, AL; Gambale, V; Paula, CR; Prates, RA; Ribeiro, MS; Ruiz, Lda S; Silva, EG | 1 |
| Chen, DM; Guo, LN; Liu, Y; Lü, HX; Shi, JY; Shi, Y; Wang, H; Xi, LY; Xu, YC; Zhao, WS; Zhou, X | 1 |
| Fujiya, M; Hosoki, T; Ikuta, K; Kohgo, Y; Okamura, N; Sato, K; Torimoto, Y; Yamamoto, M | 1 |
| Bierings, MB; Melchers, WJ; Thors, VS; Verweij, PE; Wolfs, TF | 1 |
| Fujishima, K; Fukae, J; Furuya, T; Hattori, N; Hirayama, T; Noda, K; Ogaki, K; Okuma, Y | 1 |
| Ko, KS; Lee, JY; Peck, KR; Song, JH | 1 |
| Abbes, S; Ayadi, A; Ben Jemaa, M; Bouaziz, M; Cheikhrouhou, F; Chelly, H; Hammami, B; Khaled, S; Makni, F; Néji, S; Sellami, A; Sellami, H | 1 |
| Askari, E; Cáceres Agra, JJ; Jarque, I; Nicolás Franco, S | 1 |
| Bloomer, MM; Fintelmann, RE; Gilmer, W; Jeng, BH | 1 |
| Cars, O; Lignell, A; Löwdin, E; Sanglard, D; Sjölin, J | 1 |
| Andes, D; Bastulli, C; Chaturvedi, V; Diekema, DJ; Ghannoum, MA; Iqbal, N; Knapp, C; Lockhart, SR; Marchillo, K; Messer, S; Ostrosky-Zeichner, L; Paetznick, VL; Pfaller, MA; Ramani, R; Rodriguez, J; Sein, T; Walsh, TJ; Welshenbaugh, AR | 1 |
| Dag, I; Kiraz, N; Oz, Y | 2 |
| Ananda-Rajah, MR; Cheng, A; Dooley, M; Morrissey, CO; Neville, AM; Slavin, M; Spelman, T | 1 |
| Bajwa, RP; Fung, B; Garee, A; Gross, TG; Pietryga, D; Rawlinson, NJ; Skeens, M; Soni, S; Termuhlen, AM | 1 |
| Aiba, K; Dobashi, N; Kasama, K; Katsube, A; Machishima, T; Minami, J; Nishiwaki, K; Ogasawara, Y; Saito, T; Shimada, T; Sugiyama, K; Takahara, S; Takei, Y; Usui, N; Yahagi, Y; Yamaguchi, Y; Yano, S; Yokoyama, H | 1 |
| Azim, S; Fadoo, Z; Manzoor, NF | 1 |
| Ahmad, S; Chandra, J; Chowdhary, A; Kathuria, S; Khan, ZU; Khanna, G; Randhawa, HS; Roy, P; Singh, V | 1 |
| Cheah, FK; Chlebicka, NL; Goh, YT; Kurup, A; Lin, RT; Low, JG; Tan, BH; Wong, GC | 1 |
| Chen, WT; Chen, YC; Hsiao, CH; Hsueh, PR; Ko, BS; Kuo, YM; Liu, JY; Yao, M | 1 |
| Askari, E; Fernandez Guerrero, ML; Gadea, I; Prieto, E; Román, A | 1 |
| Caira, M; Fianchi, L; Pagano, L; Valentini, CG | 1 |
| Nweze, EI; Ogbonnaya, UL | 1 |
| Clemons, KV; Schwartz, JA; Stevens, DA | 2 |
| Arendrup, MC; Fuursted, K; Gahrn-Hansen, B; Howard, SJ; Jensen, RH; Johansen, HK; Knudsen, JD; Mortensen, KL | 1 |
| He, L; Ji, WB; Liang, YR; Lu, F; Lü, SC; Luo, Y; Shi, XJ; Zhao, ZM | 1 |
| Chugh, TD; Duggal, S; Jain, H; Sharma, A; Tyagi, A | 1 |
| Ilkit, M; Kiraz, N; Oz, Y; Ozdemir, HG | 1 |
| Bajaj, MS; Kashyap, S; Meel, R; Pushker, N; Sen, S | 1 |
| Biancalana, FS; Lyra, L; Schreiber, AZ | 1 |
| Chavala, SH; Ehlers, JP; Postel, EA; Woodward, JA | 1 |
| de Hoog, S; Debourgogne, A; Lozniewski, A; Machouart, M | 1 |
| Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY | 1 |
| Kullberg, BJ; Oborska, IT; Oude Lashof, AM; Pappas, PG; Rex, JH; Rothova, A; Ruhnke, M; Schlamm, HT; Sobel, JD; Viscoli, C | 1 |
| Björkholm, M; Celsing, F; Grane, P; Kalin, M | 1 |
| Asslaber, M; Buzina, W; Haas, D; Heiling, B; Hoenigl, M; Koidl, C; Krause, R; Neumeister, P; Pichler, M; Rohn, A; Salzer, HJ; Valentin, T; Zollner-Schwetz, I | 1 |
| Chang, SE; Choi, JH; Kim, MS; Lee, HM; Lee, MW; Moon, KC; Sung, HS; Won, CH | 1 |
| Banerjee, R; Dhiman, N; Henry, NK; Huskins, WC; Joshi, AY; Santillan Salas, CF; Wengenack, NL | 1 |
| Abe, S; Asada, M; Hata, K; Horii, T; Inoue, S; Matsukura, M; Miyazaki, M; Murai, N; Nakamoto, K; Shirotori, S; Tanaka, K; Watanabe, NA; Yoshimatsu, K | 1 |
| Alves, SH; Azevedo, MI; Rossato, L; Santurio, JM; Spader, TB; Tronco-Alves, GR; Venturini, TP; Weiler, CB | 1 |
| Afshari, NA; Goldhagen, BE; Majka, CP; Perfect, JR; Rebong, RA; Santaella, RM; Steinbach, WJ | 1 |
| Agrawal, S; Bali, R; Bhagol, A; Sen, R; Sharma, B; Singh, V | 1 |
| Al-Nawas, B; Karbach, J; Walter, C | 1 |
| Bassetti, M; Molinari, MP; Mussap, M; Nicco, E; Taramasso, L; Viscoli, C | 1 |
| Hamoud, S; Hayek, T; Keidar, Z | 1 |
| Hirano, K; Hosogaya, N; Ide, S; Imamura, Y; Iwanaga, N; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Mihara, T; Minematsu, A; Miyazaki, T; Morinaga, Y; Nakamura, S; Nishino, T; Takazono, T; Tashiro, M; Tashiro, T; Tsukamoto, M; Yamamoto, Y; Yanagihara, K; Yasuoka, A | 1 |
| Chu, J; Meehan, S; Patel, R; Patel, U | 1 |
| Bakhshi, S; Kabra, SK; Mandhaniya, S; Swaroop, C; Thulkar, S; Vishnubhatla, S; Xess, I | 1 |
| Labbé, AC; Laverdière, M; Levallois, J; Nadeau-Fredette, AC; Ouimet, D; Vallée, M | 1 |
| Al-Saigh, R; Meletiadis, J; Roilides, E; Velegraki, A; Walsh, TJ; Zerva, L | 1 |
| de Assis Baroni, F; Gambale, W; Paula, CR; Silva, EG | 1 |
| Castanheira, M; Diekema, DJ; Duncanson, FP; Guarro, J; Jones, RN; Pfaller, MA | 1 |
| Hayashi, T; Hosokawa, K; Ishiyama, K; Kondo, Y; Mochizuki, K; Nakao, S; Ohata, K; Okumura, H; Sugimori, N; Takami, A; Yamazaki, H | 1 |
| Alcazar-Fuoli, L; Bignell, E; Blatzer, M; Cairns, T; Grimalt, JO; Gründlinger, M; Haas, H; Lopez, JF; Puempel, T; Yasmin, S | 1 |
| Capilla, J; Gazzoni, AF; Guarro, J; Mayayo, E | 1 |
| Bocanegra, R; Kirkpatrick, WR; Kugler, AR; Najvar, LK; Patterson, TF; Perkins, K; Pfeiffer, J; Sweeney, TD; Vallor, AC; Wiederhold, NP | 1 |
| Kontoyiannis, DP; Lewis, RE; Lortholary, O; Roilides, E; Spellberg, B; Walsh, TJ | 1 |
| Campos-Herrero, MI; Horcajada, I; Medina-Rivero, F; Tandón, L | 1 |
| Dukhan, A; Paderu, P; Park, S; Perlin, DS; Senter, M; Zhao, Y | 1 |
| Niki, Y; Ohbayashi, H; Shoji, H; Takuma, T; Yamamoto, T; Yoshida, K | 1 |
| Cheng, MF; Hsieh, LY; Liou, CH; Lo, HJ; Lu, DC; Shi, ZY; Tsai, MS; Wang, AH; Wang, LS; Wu, CJ; Yang, YL | 1 |
| Bedin, M; D'Angelo, M; Gion, M; Grandesso, S; Mazzuccato, S; Sapino, B; Solinas, M | 1 |
| Babor, F; Borkhardt, A; Janßen, G; Laws, HJ; Mackenzie, C; Meisel, R; Sabir, H; Schaper, J; Schuster, F; Siepermann, M; Wessalowski, R | 1 |
| Alves, SH; Antunes, MS; Bandeira, LA; Denardi, LB; Mario, DA; Santurio, JM; Severo, LC | 1 |
| Chakrabarti, A; Jatana, M; Rudramurthy, SM; Singh, R | 1 |
| Kim, HR; Lee, MK; Yu, N | 1 |
| Bai, C; Chen, B; Huang, HD; Huang, Y; Li, Q; Wang, Q; Wu, N; Yao, XP | 1 |
| Bader, O; Gross, U; Hull, CM; Kelly, DE; Kelly, SL; Parker, JE; Warrilow, AG; Weig, M | 2 |
| Chen, TC; Chen, YC; Chen, YH; Lu, PL | 1 |
| Chen, Z; Wei, J; Yang, Q | 1 |
| Bartolesi, AM; Fanci, R; Pecile, P; Pini, G | 1 |
| Chandra, J; Ghannoum, MA; Mukherjee, PK; Pearlman, E; Sun, Y; Yu, C | 1 |
| Gárate, C; García, P; Guzmán, AM; Labarca, J; León, P; Porte, L | 1 |
| Brilhante, RS; Caetano, ÉP; Camargo, ZP; Castelo-Branco, DS; Cordeiro, RA; Fechine, MA; Lima, RA; Mesquita, JR; Monteiro, AJ; Pereira, JF; Rocha, MF; Sidrim, JJ | 1 |
| Dag, I; Kiraz, N; Kiremitci, A; Metintas, S; Oz, Y | 1 |
| Deniz, K; Karakukcu, M; Ozdemir, MA; Patiroglu, T; Tucer, B; Unal, E; Yikilmaz, A | 1 |
| Das, S; Gupta, N; Jain, S; Malik, JN | 1 |
| Bicmen, C; Doluca, M; Gulat, S; Gunduz, AT; Tuksavul, F | 1 |
| Beltran, C; Bourge, RC; Bourke, P; Castro, P; Rabagliati, R; Verdejo, H; Winter, JL | 1 |
| Clark, LP; Folio, L; Henderson, CM; Holland, SM; Kwon-Chung, KJ; Nardone, G; Peterson, SW; Riedlinger, G; Shea, Y; Sugui, JA; Zelazny, AM; Zerbe, CS | 1 |
| Baez, AA; Bonfietti, LX; Castro e Silva, DM; Martins, MA; Melhem, MS; Pukinskas, SR; Purisco, SU; Szeszs, MW | 1 |
| Harada, H; Inoue, A; Iwata, S; Kumon, Y; Ohnishi, T; Teraoka, M; Yamashita, D | 1 |
| Hayashi, Y; Kobayashi, T; Mito, T; Ohashi, Y; Shiraishi, A; Suzuki, T; Zheng, X | 1 |
| Costa, CR; de Fátima Lisboa Fernandes, O; de Paula, JA; de Souza Lino Junior, R; do Rosário Rodrigues Silva, M; Hasimoto E Souza, LK; Vinaud, MC | 1 |
| Ahmed, S; de Hoog, GS; Feng, P; Klaassen, CH; Lai, W; Lu, C; Meis, JF; Najafzadeh, MJ; Sun, J; Xi, L | 1 |
| Berghs, HAM; Carvalho, LR; Kacew, S; Martins, MA; Melhem, MSC; Mendes, RP; Moris, DV; Pimenta-Rodrigues, MV; Souza, LR; Szeszs, MW | 1 |
| Su, J; Sun, W; Xu, S; Yan, D | 1 |
| Bos, B; Buchheidt, D; Cornely, OA; Halbsguth, TV; Hallek, M; Hamprecht, A; Kahl, P; Kutsch, N; Persigehl, T; Plum, G; Spiess, B; Steinbach, A; Stippel, D; Vehreschild, JJ; Vehreschild, MJ | 1 |
| Gamaletsou, MN; Kontos, AN; Kontoyiannis, DP; Kordossis, T; Sipsas, NV; Stefanou, I; Tsiakalos, A | 1 |
| de Souza Bonfim-Mendonça, P; Fiorini, A; Godoy, JS; Nakamura, SS; Pieralisi, N; Shinobu-Mesquita, C; Svidzinski, TI; Yamada, SS | 1 |
| Chen, W; Li, L; Li, R; Liu, W; Sun, Y; Wan, Z | 1 |
| Cherian, T; Giakoustidis, A; Heaton, DN; Heneghan, M; O'Grady, J; Rela, M; Verma, A; Wendon, J; Yokoyama, S | 1 |
| Chauhan, NM; Karuppayil, SM; Raut, JS; Shinde, RB | 1 |
| Auzinger, G; Bernal, W; Heneghan, MA; López, JC; Solís-Muñoz, P; Verma, A; Wendon, J; Willars, C | 1 |
| Abu El-Naaj, I; Leiser, Y; Peled, M; Wolff, A | 1 |
| Lu, HZ; Shen, YZ; Wang, ZY | 1 |
| Choi, HJ; Ju, MY; Jung, SI; Kim, SH; Lee, K; Lee, WG; Park, YJ; Shin, JH | 1 |
| Buer, J; Dittmer, S; Hamprecht, A; Lackner, M; Rath, PM; Schemuth, H; Sedlacek, L; Steinmann, E; Steinmann, J | 1 |
| Arzeni, D; Astolfi, D; Catavitello, C; D'Antonio, D; Farina, C; Favaro, M; Fazii, P; Fontana, C; Hendrickx, M; Masciarelli, G; Pitzurra, L; Polilli, E; Savini, V; Sisti, M; Stubbe, D | 1 |
| Traynor, K | 1 |
| Abdulaziz, S; Al Jahdali, H; Baharoon, S | 1 |
| Nishiyama, Y | 1 |
| Hoenigl, M; Krause, R | 1 |
| Calvo, E; Fothergill, AW; Guarro, J; Mayayo, E; Pastor, FJ; Rinaldi, MG; Salas, V; Sutton, DA | 1 |
| Husain, S; Luong, ML; Rotstein, C | 1 |
| Al-Saigh, R; Elefanti, A; Krompa, K; Meletiadis, J; Mouton, JW; Verweij, PE; Zerva, L | 1 |
| Baršić, B; Mlinarić Missoni, E | 1 |
| Yoshida, M | 1 |
| Barkai, G; Jacoby, E; Keller, N | 1 |
| Shi, Y; Sun, HM; Xu, XY; Zhao, BL | 1 |
| Badali, H; Curfs-Breuker, I; de Hoog, GS; Deng, S; Liao, W; Meis, JF; Najafzadeh, MJ; Pan, B; Yang, L | 1 |
| Furuya, N; Mano, Y; Morishige, H; Oguri, T | 1 |
| Stevens, DA | 1 |
| Banerjee, D; Khetan, A; Mandal, SM; Saha, S; Sengupta, J | 1 |
| Datta, S; Goel, N; Oberoi, JK; Prasad, K; Raveendran, R; Wattal, C | 1 |
| Jones, B; Jose, A; Lappin, DF; Ramage, G; Sherry, L; Williams, C | 1 |
| Hamill, R; Kamili, Q; Lai, S; Lin, D; Musher, DM; Qurat-Ul-Ain, K | 1 |
| Aguirre, HD; Cataño, JC | 1 |
| Hamada, Y; Hirayama, T; Ichibe, Y; Katori, Y; Kuroyama, M; Okuma, R; Takahashi, S | 1 |
| Ahmad, S; Al-Wathiqi, F; Khan, Z | 1 |
| Agarwal, K; Chowdhary, A; Gaur, SN; Kathuria, S; Meis, JF; Randhawa, HS; Roy, P; Singh, PK | 1 |
| Charles, JI; Jeanbourquin, D; Mostofi, K | 1 |
| Chowdhary, A; Kathuria, S; Khan, N; Kumar, DA; Meis, JF; Muralidhar, S; Prakash, A; Randhawa, HS; Sharma, C; Singh, PK; Wankhede, S | 1 |
| Cuenca-Estrella, M; de Lucas, MP; Fusco-Almeida, AM; Lozano, E; Mendes-Giannini, MJ; Mesa-Arango, AC; Scorzoni, L; Zaragoza, O | 1 |
| Cano, J; Crous, PW; da Cunha, KC; Fothergill, AW; Gené, J; Guarro, J; Hoog, Sd; Madrid, H; Sutton, DA | 1 |
| Bush, JW; Del Bigio, MR; Embil, JM; Krawitz, S; McDonald, PJ; Wuerz, T | 1 |
| Bellesoeur, A; Blot, F; Chalumeau-Lemoine, L | 1 |
| Chen, HT; Chu, WL; Lin, CC; Lo, HJ; Yang, YL | 1 |
| Brock, M; Galiger, C; Ibrahim-Granet, O; Jouvion, G; Parlato, M; Savers, A | 1 |
| Hatipoglu, H; Hatipoglu, N | 1 |
| Coste, A; Eddouzi, J; Ischer, F; Kelly, S; Manai, M; Parker, JE; Sanglard, D; Vale-Silva, LA | 1 |
| Arnalich-Montiel, F; López-Arencibia, A; Lorenzo-Morales, J; Martín-Navarro, CM; Piñero, JE; Valladares, B | 1 |
| Benjamin, DK; Ericson, J; Manzoni, P | 1 |
| Bhaskaran, A; Hosseini-Moghaddam, SM; Husain, S; Rotstein, C | 1 |
| Johnston, RB; Shenefelt, PD; Thareja, S | 1 |
| Elefanti, A; Meletiadis, J; Mouton, JW; Tsakris, A; Verweij, PE; Zerva, L | 1 |
| Lai, J; McDonald, R; Pandya, V; Sutton, G | 1 |
| Monod, M; Pot, SA; Spiess, BM; Unger, L; Voelter-Ratson, K | 1 |
| Aline-Fardin, A; Buot, G; Dannaoui, E; Degulys, A; Guitard, J; Hennequin, C; Lapusan, S; Marie, JP; Rio, B | 1 |
| Amat, P; Benet, I; Bravo, D; Clari, MÁ; Costa, E; Giménez, E; Muñoz-Cobo, B; Navarro, D; Nieto, J; Remigia, MJ; Solano, C | 1 |
| Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Johnson, A; McEntee, L; Moore, CB; Richardson, M | 1 |
| Pea, F | 2 |
| Capilla, J; Fernández-Silva, F; Guarro, J; Hernández, P; Mayayo, E; Sutton, DA | 1 |
| Curfs-Breuker, I; de Hoog, GS; Feng, P; Meis, JF; Najafzadeh, MJ; Rezaei-Matehkolaei, A; Saradeghi Keisari, M; Shamsian, SA; Vicente, VA | 1 |
| Dony, A; Ducastelle, S; Ferry, T; Perpoint, T | 1 |
| Chen, H; Chen, M; Liao, W; Pan, W; Zhou, J | 1 |
| Anaissie, E; Araujo, V; Arikan-Akdagli, S; Atalla, A; Bertz, H; Cappellano, P; Carlesse, F; Cesaro, S; Cornely, OA; de Souza, CA; Galvão Castro, C; Hamerschlak, N; Härter, G; Heinz, WJ; Herbrecht, R; Hermansen, NE; Hoenigl, M; Josting, A; Kindo, A; Lortholary, O; Marr, KA; Mossad, SB; Nucci, M; Ogunc, D; Pagano, L; Pasqualotto, AC; Queiroz-Telles, F; Salles, MJ; Schaller, M; Sheppard, DC; Solza, C; Troke, PF; Vehreschild, MJ; Velasco, E | 1 |
| Bierings, MB; Boelens, JJ; Gerhardt, CE; Hol, JA; Lindemans, CA; Versluys, AB; Wildt de, A; Wolfs, TF | 1 |
| Adamski, Z; Gil, L; Komarnicki, M; Kubisiak-Michalska, A; Kubisiak-Rzepczyk, H; Mol, A; Reich, A; Zawirska, A | 1 |
| Atalay, MA; Copur Çiçek, A; Kasap Tekinşen, FF; Kaynar, L; Koç, AN; Sav, H | 1 |
| Endo, S; Fujimura, I; Kamei, K; Kato, K; Miyamoto, S; Murata, O; Nagashima, H; Nakadate, T; Nakajima, Y; Nakamura, Y; Ogino, Y; Saito, H; Sasaki, N; Shibuya, K; Suzuki, N; Terayama, Y; Utsumi, Y; Yamauchi, K; Yarita, K | 1 |
| Capilla, J; Fernández-Silva, F; Guarro, J; Mayayo, E; Sutton, D | 1 |
| Balci, I; Eksi, F; Gayyurhan, ED | 1 |
| Chang, K; Chang, TC; Chen, CY; Chen, YH; Lai, CC; Lee, KM; Lin, CY; Lin, WR; Lu, PL | 1 |
| Dasararaju, R; Many, WJ; Samant, JS | 1 |
| Al-Badriyeh, D; Dinleyici, EC; Kara, A; Kong, DC; Senol, E; Turner, SJ | 1 |
| Akata, K; Aoki, T; Fujii, M; Hisaoka, M; Ishimoto, H; Kawanami, T; Kinoshita, S; Korogi, Y; Mukae, H; Yatera, K | 1 |
| Baka, S; Kouskouni, E; Tsouma, I | 1 |
| Halderman, A; Shrestha, R; Sindwani, R | 1 |
| Dalbøge, CS; Gøtzsche, PC; Johansen, HK; Jørgensen, KJ | 1 |
| Chai, LY; Earnest, A; Herbrecht, R; Johnson, EM; Kullberg, BJ; Netea, MG; Schlamm, HT; Teerenstra, S; Troke, PF; Vonk, AG | 1 |
| Feng, XW; Qu, WX; Zhao, L | 1 |
| Beckman, EN; Garces, JC; Garcia-Diaz, JB; Keller, RA; Loss, GE; Pankey, GA; Schieffelin, JS; Staffeld-Coit, C | 1 |
| Horiuchi, C; Ikeda, T; Iwanaga, N; Kamiya, C; Katsuragi, S; Kobayashi, Y; Miyoshi, T; Neki, R; Sata, M; Tanaka, H; Yamanaka, K; Yamashita, Y; Yoshimatsu, J | 1 |
| Bandeira, TJPG; Brilhante, RSN; Cordeiro, RA; Macedo, RB; Marques, FJF; Moreira, JLB; Rocha, MFG; Sidrim, JJC; Teixeira, CEC | 1 |
| Cevallos, V; Hoover, C; Jeng, BH; Keenan, JD; Layer, N; Maxwell, AJ | 1 |
| Capilla, J; Fothergill, AW; Guarro, J; Mayayo, E; Paredes, K; Sutton, DA | 1 |
| Borghi, E; Falleni, M; Jones, B; Lappin, DF; Nile, CJ; Perdoni, F; Rajendran, R; Ramage, G; Sherry, L; Smith, K; Tosi, D; Williams, C | 1 |
| Abidi, MZ; Brumble, L; Cummins, N; Jane Hata, D; Kusne, S; Lahr, BD; Letendre, L; Litzow, M; McCullough, A; Poeschla, E; Shah, H; Sohail, MR; Vikram, HR; Walker, RC; Wendel, A; Wengenack, N; Wilhelm, M | 1 |
| Hou, J; Tu, EY | 1 |
| Choong, K; Hirst, LW; Playford, EG | 1 |
| Chishimba, L; Denning, DW; Langridge, P; Niven, RM; Powell, G | 1 |
| Chen, T; Dong, F; Guo, X; Hu, B; Hu, H; Li, S; Li, Z; Liu, G; Wang, Q; Yao, K; Zhang, Z | 1 |
| Ao, J; Cong, L; Liao, Y; Lu, X; Yang, R; Yang, S | 1 |
| Barrueta, JA; Charbonneau, C; De Salas-Cansado, M; Gao, X; Garcia-Vidal, C; Jarque, I; Ostermann, H; Solano, C; Stephens, J; Weber, B; Xue, M | 1 |
| Huang, X; Li, D; Mylonakis, E; Xi, L | 1 |
| Chang, CC; Coovadia, Y; Dorasamy, A; French, M; Lewin, S; Mahabeer, Y; Mlisana, K; Moosa, MY; Naidu, D; Ndung'u, T | 1 |
| Amano, S; Kimakura, M; Nakagawa, S; Usui, T; Yamagami, S; Yokoo, S | 1 |
| Barchiesi, F; Fiorentini, A; Gesuita, R; Mazzanti, S; Mazzocato, S; Singh, N; Skrami, E | 1 |
| Donnelly, JP; Herbrecht, R; Johnson, EM; Maertens, J; Marchetti, O; Pappas, PG; Patterson, TF; Schlamm, HT; Slavin, MA | 1 |
| Alfaya Muñoz, L; Avendaño Cantos, EM; Celis Sánchez, J; Mesa Varona, D; Romero Moraleda, L | 1 |
| Flynn, HW; Miller, D; Silva, RA; Sridhar, J; Wykoff, CC | 1 |
| Ramos, MG; Rodríguez, ZC | 1 |
| Bhanot, N; Garcia, RR; Min, Z; Narasimhan, S | 1 |
| Bhat, V; Ganesh, P; Kumar, P; Nagarjuna, M; Salins, PC; Shetty, S | 1 |
| Ahmed, Y; Albrecht, H; Siddiqui, W; Weissman, S | 1 |
| Cornely, OA; Herbrecht, R; Meems, L; Ruhnke, M; van Amsterdam, RG; Viscoli, C | 1 |
| Boucherit, K; Boucherit-Otmani, Z; Mazari, W | 1 |
| Cheng, Y; Mu, X; Nie, L; Wang, G; Yu, J | 1 |
| Borders, E; Hopps, S; Roach, A; Yuen, C | 1 |
| Li, J; Liu, B; Pan, A; Zhang, L; Zhou, S | 1 |
| Botterel, F; Bougnoux, ME; Compain, F; Dannaoui, E; Paugam, A; Sitterlé, E | 1 |
| Arron, ST; Chin-Hong, PV; He, SY; Makhzoumi, ZH; Singer, JP | 1 |
| Kumar, A; Kumar, D; Singh, S; Tilak, R | 1 |
| Ayadi, A; Bellaaj, H; Cheikhrouhou, F; Elloumi, M; Gargouri, L; Guidara, R; Makni, F; Néji, S; Sellami, H; Trabelsi, H | 1 |
| Aliyu, SH; Brown, NM; Enoch, DA; Micallef, C; Rosembert, D; Santos, R | 1 |
| Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Aguirre-Garza, M; Carolina Rojas, O; González, GM; León-Cachón, RB; Moreno-Treviño, MG; Pérez-Maya, AA | 1 |
| Bom, VL; Brown, NA; de Castro, PA; Goldman, GH; Mariné, M; Ramalho, LN; Winkelstroter, LK | 1 |
| Badali, H; de Hoog, GS; Mashedi, O; Meis, JF; Mohammadi, R | 1 |
| Aoki, V; Barbaro Del Negro, GM; Benard, G; Buccheri de Oliveira, R; Duarte, A; Giuli Santi, C; Lopes Motta, A; Nobrega de Almeida Júnior, J; Rossi, F; Sachiko Yamamoto de Figueiredo, D; Wakisaka Maruta, C | 1 |
| Kao, YY; Lo, HJ; Lo, HL; Tsao, MY; Tseng, KY; Yang, YL | 1 |
| He, C; Kang, M; Lei, Y; Xiao, YL; Xie, Y; Zhang, CY | 1 |
| Karr, JC; Lauretta, J | 1 |
| Adami, I; Cazzadori, A; Concia, E; Ferrari, S; Forni, A; Mazzaferri, F; Merighi, M; Storato, S; Tocco, P | 1 |
| Amadori, F; Ciancia, EM; Doria, R; Flammini, S; Gemignani, G; Leonildi, A; Menichetti, F; Sanguinetti, M | 1 |
| Dugar, J; Miller, D; OʼBrien, TP; Spierer, O | 1 |
| El-Azizi, M; Farag, N; Khardori, N | 1 |
| Akers, KS; Chung, KK; Graybill, JC; Mende, K; Murray, CK; Niece, KL; Rowan, MP | 1 |
| Fong, PH; Lee, VH; Seneviratne, CJ; Wong, SS | 1 |
| Barnes, R; Bow, E; Charbonneau, C; Earnshaw, S; Herbrecht, R; Kantecki, M; Maertens, J; McDade, C; Morrissey, O; Schlamm, H; Slavin, M; Weinstein, D | 1 |
| Meletiadis, J; Siafakas, N; Siopi, M; Vourli, S; Zerva, L | 1 |
| Akan, H; Atilla, E | 1 |
| Jones, B; Mowat, E; Rajendran, R; Ramage, G; Williams, C | 1 |
| Ebenezer, J; Maheswaran, S; Mathews, SS; Rupa, V | 1 |
| Basu, S; Kumar, A; Tilak, R | 1 |
| Ağca, H; Ak, S; Akalın, H; Cilo, BD; Ener, B; Özmerdiven, GE; Tunca, B | 1 |
| Cerar, T; Krivec, U; Matos, T; Pirš, M; Praprotnik, M | 1 |
| Anagnostopoulos, A; Bougiouklis, D; Meletiadis, J; Monokrousos, N; Samalidou, M; Siotou, E; Sivropoulou, A; Sotiropoulos, D; Vyzantiadis, TA | 1 |
| Gao, T; Huang, XS; Tian, CL; Xing, XW; Yan, B; Yao, Y; Yu, SY; Zhang, JT | 1 |
| Bulanda, M; Jagielski, T; Skóra, M | 1 |
| Chlebicki, MP; Kwa, AL; Lee, W; Liew, YX; Ngan, CC; Tan, AL; Teo, J; Too, IA | 1 |
| Biswas, D; Dewan, E; Kakati, B; Kotwal, A; Oberoi, A; Verma, SK | 1 |
| Chowdhary, A; Curfs-Breuker, I; de Hoog, GS; Hagen, F; Madrid, H; Meis, JF | 1 |
| Cha, SA; Chang, KY; Jin, DC; Kim, HH; Kim, HW; Kim, MH; Lim, TS; Park, HS; Wie, SH | 1 |
| da Silva, CM; de Lima Neto, RG; de Morais, VL; Domingos, Ide F; Gonçalves, SS; Leite, EP; Macêdo, DP; Neves, RP; Parahym, AM; Rolim Neto, PJ | 1 |
| Gao, L; Sun, Y | 1 |
| Chan, JF; Chen, JH; Guo, D; Lau, SK; Pan, Y; Tsang, CC; Wang, H; Woo, PC; Xiao, Y; Xu, Y; Yue, N; Zhao, Y | 1 |
| Abd-Elaal, A; Abu-Elmagd, K; Bennett, A; El-Gazzaz, G; Fujiki, M; Hashimoto, K; Kandeel, A; Khanna, A; Parsi, M; Spinner, M | 1 |
| Badali, H; Chowdhary, A; de Hoog, GS; Fakhim, H; Khodavaisy, S; Meis, JF | 1 |
| Animalu, C; Cleveland, KO; Gelfand, MS; Mazumder, S | 1 |
| Chen, D; Chen, M; Dai, C; Huang, X; Li, Y; Wang, L; Wang, X; Xu, X; Yang, L; Yao, D; Yu, C; Yu, X | 1 |
| Kauffman, CA | 1 |
| Gregg, KS; Kauffman, CA | 1 |
| Anaissie, E; Capone, D; Nouér, SA; Nucci, F; Nucci, M | 1 |
| Meletiadis, J; Siafakas, N; Siopi, M; Zerva, L | 1 |
| Chowdhary, A; Hagen, F; Kathuria, S; Meis, JF; Singh, PK | 1 |
| Beitz, A; Ehmer, U; Eser, S; Fekecs, L; Huber, W; Lahmer, T; Messer, M; Schmid, RM | 1 |
| Bouchrik, M; Boumhil, L; Iken, M; Lemkhente, Z; Lmimouni, B; Naoui, H; Uwingabiye, J; Zohoun, AG | 1 |
| Aftab, M; Almanfi, A; El-Sayed Ahmed, MM; Frazier, OH; Mallidi, HR; Singh, SK | 1 |
| Arendrup, MC; Cuenca-Estrella, M; Jensen, RH | 1 |
| Cheng, Y; Liu, Z; Song, X; Su, G; Wang, C; Zhao, J | 1 |
| Barletta, V; Bongiorni, MG; Cardinali, G; Colabella, C; Consorte, A; Corte, L; Di Paolo, A; Leonildi, A; Menichetti, F; Pasticci, MB; Roscini, L; Tascini, C; Zucchelli, G | 1 |
| Gökbolat, E; Ilkit, M; Kiraz, N; Öz, Y; Özdemir, HG; Seyedmousavi, S | 1 |
| Badali, H; Dolatabadi, S; Fakhim, H; Mirhendi, H; Nabili, M; Poorzad, N; Vaezi, A; Zarei, F | 1 |
| Alencar, LP; Bandeira, TJPG; Brilhante, RSN; Cordeiro, RA; Evangelista, AJJ; Franco, JDS; Marques, FJF; Melo, CVS; Oliveira, JS; Rocha, MFG; Serpa, R; Sidrim, JJC | 1 |
| Arends, JP; de Brauwer, E; de Greeff, SC; Haas, PJ; Hodiamont, CJ; Kuijper, EJ; Leenstra, T; Lestrade, PP; Meis, JF; Melchers, WJ; Muller, AE; Oude Lashof, AM; Rijnders, BJ; Roelofsen, E; Rozemeijer, W; Tersmette, M; Terveer, EM; van der Beek, MT; van Dijk, K; Verduin, CM; Verweij, PE; Wolfhagen, MJ | 1 |
| Capilla, J; Guarro, J; Mayayo, E; Paredes, K | 1 |
| Dabrowski, L; Graciano, AL; Kuzmic, B; Lee, JM; Tablizo, MA | 1 |
| Auvergne, L; Ben Ayed, I; Botterel, F; Caballero, MJ; Dhonneur, G; Haouache, H; Hillion, ML; Mongardon, N; Vodovar, D | 1 |
| Kachuei, R; Khodavaisy, S; Rezaie, S; Sharifynia, S | 1 |
| Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W | 1 |
| Bergami, E; Cavanna, C; Decembrino, N; Introzzi, F; Lallitto, F; Mangione, F; Marone, P; Tamarozzi, F; Tortorano, AM; Zecca, M | 1 |
| Aala, F; Amirizad, K; Aslani, N; Badali, H; Hashemi, SJ; Khodavaisy, S; Nazeri, M; Nouripour-Sisakht, S; Rezaie, S; Sorkherizi, MS | 1 |
| Ding, X; Gao, L; Liu, Z; Sun, Y; Wu, Q; Zeng, T | 1 |
| Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Koenderink, JB; Lempers, VJ; Russel, FG; van den Heuvel, JJ | 1 |
| Li, SS; Lu, MQ; Ni, SL; Tang, XY; Yang, NB; Zhang, SG | 1 |
| Bathoorn, E; Kampinga, GA; Oliveira dos Santos, C; Porte, RJ; Sinha, B; van Diepeningen, AD; Zijlstra, JG | 1 |
| Busso-Lopes, AF; Kamei, K; Lyra, L; Mikami, Y; Moretti, ML; Peron, IH; Reichert-Lima, F; Schreiber, AZ; Taguchi, H | 1 |
| Chakrabarti, A; Ghosh, A; Honnavar, P; Pamidi, U; Rastogi, V; Rudramurthy, SM | 1 |
| Altınbas, R; Ilkit, M; Kiraz, N; Ozdemir, HG; Sav, H; Seyedmousavi, S | 1 |
| Augustynowicz-Kopeć, E; Garczewska, B; Jarzynka, S; Kuś, J; Skorupa, W | 1 |
| Arslan, U; Dagi, HT; Findik, D; Senkeles, C | 1 |
| Takenaka, M | 1 |
| Kimura, S | 1 |
| Arat, M; Çevik, E; Demirel, A; Efe İris, N; Güvenç, S; Koçulu, S; Özçelik, T | 1 |
| Al-Hatmi, AM; Boekhout, T; Hamed, M; Lass-Flörl, C; Salah, H; Taj-Aldeen, SJ; Theelen, B; van Diepeningen, AD | 1 |
| Garneau-Tsodikova, S; Ngo, HX; Shrestha, SK | 1 |
| Cadirci, E; Duzgun, E; Karagoz, E; Keles, S; Turhan, V; Ugan, RA; Uyanik, MH; Yavan, I | 1 |
| Burgess, M; Caradine, K; Kothari, A; Mohan, M; Rico, JC; Shalin, SC | 1 |
| Bui, DK; Carvounis, PE | 1 |
| Shao, J; Xu, J; Zheng, X | 1 |
| Cho, SY; Choi, JH; Choi, JK; Choi, SM; Kim, SB; Kim, SH; Lee, DG; Lee, HJ; Lee, JW; Park, SH; Yoo, JH | 1 |
| Avilés-Robles, M; Ceballos-Bocanegra, A; Gómez-Ponce, C; Martínez-Rivera, Á; Reséndiz-Sánchez, J; Rodríguez-Tovar, AV | 1 |
| Alegre, LR; Carrillo-Muñoz, AJ; Cattana, ME; Córdoba, SB; de Los Ángeles Sosa, M; Fernández, MS; Giusiano, GE; Rojas, FD; Zalazar, LC | 1 |
| Gombakis, N; Hatzipantelis, E; Hatzistilianou, M; Papageorgiou, M; Papageorgiou, T; Tragiannidis, A | 1 |
| Capilla, J; Guarro, J; López-Fernández, L; Mayayo, E; Thomson, P | 1 |
| Al-Hatmi, AM; de Hoog, GS; Meis, JF; Meletiadis, J; Normand, AC; Piarroux, R; Ranque, S | 1 |
| Hasegawa, A; Kamata, H; Kano, R; Kimura, S; Lim, SY; Ooya, K; Yanai, T | 1 |
| Ahmed, SA; Behrens-Baumann, W; de Hoog, GS; Harak, H; Hofmüller, W; Seibold, M; Tammer, I; van Diepeningen, AD | 1 |
| Cen, W; Feng, W; Lv, Y; Ma, Y; Qiao, Z; Wang, Y; Xi, Z; Yang, J | 1 |
| Marzani, FC; Mojoli, F; Tavazzi, G; Via, G | 1 |
| Non, LR; Pande, A; Romee, R; Santos, CA | 1 |
| Akyürek, N; Aydın Kaynar, L; Aygencel, G; Güzel Tunçcan, Ö; Kalkancı, A; Özkurt, ZN; Ülküden, B | 1 |
| Aurbach, U; Cornely, OA; De Hoog, S; Demeter, J; Durán Graeff, L; Hamprecht, A; Kindo, A; Racil, Z; Seidel, D; Vehreschild, MJ; Wisplinghoff, H; Ziegler, M | 1 |
| Fukuda, Y; Imamura, Y; Izumikawa, K; Kakeya, H; Kohno, S; Mitsuyama, J; Miyazaki, T; Mukae, H; Nakamura, S; Nishikawa, H; Saijo, T; Takazono, T; Tanaka, A; Tashiro, M; Yamamoto, K; Yamamoto, Y; Yanagihara, K | 1 |
| Frenkel, MB; Hsu, W; Renfrow, JJ | 1 |
| Capilla, J; Guarro, J; Martin-Vicente, A | 1 |
| Denis, J; Herbrecht, R; Ledoux, MP; Toussaint, E | 1 |
| Čurová, K; Hrabovská, Z; Hrabovský, V; Pastvová, L; Schréterová, E; Siegfried, L; Takáčová, V | 1 |
| Bachellier, P; Bru, V; Gourieux, B; Herbrecht, R; Launoy, A; Levêque, D; Lutun, P; Nivoix, Y; Poulat, C; Rohr, S; Woehl, ML | 1 |
| Agurto, C; Bustamante, B; Diaz, A; Hidalgo, J; Huaroto, L; Illescas, R; Ramirez, R; Rodriguez, L | 1 |
| Bonardel, G; Guernou, M; Lussato, D; Queneau, M; Seban, RD | 1 |
| Blot, S; Bulpa, P; Dimopoulos, G; Forêt, F; Frantzeskaki, F; Kosmopoulos, M; Taccone, FS; Van den Abeele, AM; Vogelaers, D | 1 |
| Bairy, I; Baral, BP; Gokhale, S; Hamal, D; Nayak, N; Prakash, PY; Sathian, B; Sharan, NK; Subramanya, SH | 1 |
| Abbasi, SA; Bokhari, H; Hussain, Z; Imran, M; Jamil, B; Khalid, T; Mukhtar Bokhari, MT; Mukhtar Bokhari, MZ; Saeed, A | 1 |
| Baker, CJ; Brackett, J; Edwards, MS; Foster, CE; Healy, CM; Schady, DA | 1 |
| Hayashi, N; Imanishi, T; Kasagi, S; Kurimoto, C; Morinobu, A; Saegusa, J; Yamamoto, T | 1 |
| Corrêa, C; Fuentefria, AM; Goldani, LZ; Heidrich, D; Rosa, PD; Scroferneker, ML; Vettorato, G | 1 |
| Akiti, T; Barreiros, G; Cleinman, IB; Colombo, AL; Gonçalves, SS; Halpern, M; Nucci, M; Quintella, DC; Santoro-Lopes, G | 1 |
| Blot, S; Bulpa, P; Dimopoulos, G; Gomes, A; Meersseman, W; Mergulhão, P; Misset, B; Paiva, JA; Rello, J; Taccone, FS; Van den Abeele, AM; Vogelaers, D | 1 |
| Bader, O; Baretton, G; Buchheidt, D; Geibel, S; Groß, U; Jacobs, E; Ostrosky-Zeichner, L; Rößler, S; Sommer, U; Spiess, B; Stölzel, F | 1 |
| Faryal, R; Shah, AA; Siddiqui, MT; Tasneem, U | 1 |
| Albrecht-Eckardt, D; Amarsaikhan, N; Braus, GH; Kniemeyer, O; Ogel, ZB; Sasse, C | 1 |
| Gao, L; Lu, Q; Sun, Y; Tian, D; Xiang, S | 1 |
| Harris, C; Morales, MK; Shoham, S | 1 |
| Bertaccini, P; Castagnetti, F; Cavo, M; Faccioli, L; Lewis, RE; Paolucci, M; Primavera, L; Rizzello, I; Spinardi, L; Stanzani, M; Toschi, PG | 1 |
| Loiseau, PM; Pomel, S; Taravaud, A | 1 |
| Ramírez Soto, MC | 1 |
| Chen, P; Guo, W; Long, Y; Luo, M; Peng, H; Song, M; Tan, Y; Zhou, Q | 1 |
| Aquino, VR; de Azevedo, MI; Goldani, LZ; Neto, GW; Pilla, C; Wirth, F | 1 |
| Bouaziz, M; Chaabane, I; Kilani, B; Ladeb, F; Tiouiri, HB; Zayet, S | 1 |
| Hoenigl, M; Krause, R; Neumeister, P; Prattes, J; Wölfler, A | 1 |
| Goldraich, L; Husain, S; Kabbani, D; Ross, H; Rotstein, C | 1 |
| Al-Hatmi, AMS; Alves, SH; Azevedo, MI; Keller, JT; Rossato, L; Santurio, JM; Venturini, TP; Weiblen, C | 1 |
| Badali, H; Badiee, P; Boekhout, T; Diba, K; Hossaini Nasab, A; Jafarian, H; Mirhendi, H; Moghadam, AG; Mohammadi, R; Najafzadeh, MJ; Shamsizadeh, A; Soltani, J | 1 |
| Hagiwara, S; Kiyota, N; Kunikata, H; Makimura, K; Maruyama, K; Nakazawa, T; Sato, N; Taniuchi, S; Toyokawa, M; Yoshida, M | 1 |
| Chen, Y; Guo, XB; Jiang, Y; Mao, Q; Yi, XL | 1 |
| Chang, MR; Lima, GME; Mendes, RP; Negro, GMBD; Nunes, JO; Nunes, MO; Paniago, AMM; Taira, CL; Thomaz, DY; Tsujisaki, RAS | 1 |
| da Silva Ruiz, L; Gonçalves Silva, E; Latercia Tranches Dias, A; Marilia de Souza Silva, S; Rodrigues Paula, C | 1 |
| Frings, A; Geerling, G; Habbe, KJ; Kurzai, O; MacKenzie, C; Roth, M; Schrader, S; Walther, G | 1 |
| Dürig, J; Gerken, G; Rashidi-Alavijeh, J; Rath, PM; Turki, AT; Witzke, O | 1 |
| Chen, YQ; Huang, YJ; Kong, JL; Lei, DQ; Li, GS; Li, WD; Luo, J; Wang, K | 1 |
| Almaguer, M; Fernández, CM; Illnait, MT; Martínez, GF; Perurena, MR; San Juan, JL; Velar, RE | 1 |
| El Helou, G; Nunez, M; Palavecino, E | 1 |
| Bailleux, C; Gari-Toussaint, M; Gastaud, L; Hasseine, L; Martiano, D; Simon, L | 1 |
| Brizendine, KD; Cober, E; Johnson, L; Nambiar, P | 1 |
| Kooshki, P; Mahmoudabadi, AZ; Rezaei-Matehkolaei, A | 1 |
| Cai, WP; Chen, WS; Chen, XJ; He, Y; Hu, FY; Lei, HL; Li, LH; Song, WN; Tang, XP | 1 |
| Brilhante, RSN; Castelo-Branco, DSCM; Cordeiro, RA; Guedes, GMM; Rocha, MFG; Sidrim, JJC; Silva, MLQD | 1 |
| Ashworth, A; Barker, J; Felton, TW; Foden, P; Geraghty, CG; Muldoon, EG; Richardson, MD; Rodriguez-Goncer, I; Thomas, S | 1 |
| Albrieux, M; Borry, L; Garcia-Hermoso, D; Hoarau, G; Martin-Phipps, T; Peytral, J; Picot, S; Zitte-Zehler, K | 1 |
| Dai, C; Kan, J; Li, M; Shan, W; Yin, M | 1 |
| Chakrabarti, A; Kaur, K; Kumari, A; Sethi, P; Singh, R | 1 |
| Arendarczyk, A; Hendzel, P; Kurnicka, K; Pruszczyk, P; Zdończyk, O | 1 |
| Alanio, A; Bretagne, S; Catherinot, E; Garcia-Hermoso, D; Jullien, V; Lortholary, O; Pilmis, B; Scemla, A | 1 |
| Lang, R; Minion, J; Skinner, S; Wong, A | 1 |
| Al-Hatmi, AMS; Boral, H; de Hoog, GS; Erdem, E; Ilkit, M; Meis, JF; van Diepeningen, A; Yağmur, M | 1 |
| Fujita, H; Fukushima, S; Kobayashi, T; Matsumoto, T; Miyazaki, Y; Nakamura, I; Shimoinaba, M; Watanabe, Y | 1 |
| Escrig, C; Herbrecht, R; Kuessner, D; Pooley, N; Posthumus, J | 1 |
| Almeida-Paes, R; Brito-Santos, F; Coelho, RA; do Valle, ACF; Figueiredo-Carvalho, MHG; Freitas, DFS; Gutierrez-Galhardo, MC; Meyer, W; Silva, JVDS; Trilles, L; Zancopé-Oliveira, RM | 1 |
| Keniya, MV; Monk, BC; Ruma, YN; Tyndall, JDA | 1 |
| Fleming, ME; Gordon, WT; Jessie, EM; Khan, M; Malone, DL; Murray, CK; Potter, BK; Rodriguez, CJ; Shackelford, SA; Tribble, DR | 1 |
| Capilla, J; Celis, A; Guarro, J; Guevara-Suarez, M; Navarro-Rodríguez, P; Paredes, K | 1 |
| Chaves, GM; Colombo, AL; de Almeida, JJS; de Araújo Prudente, AL; de Azevedo Melo, AS; de Azevedo, MF; Fernandes, TUG; Francisco, EC; Milan, EP; Silva-Rocha, WP | 1 |
| Chang, YC; Graf, E; Green, AM | 1 |
| Lehrnbecher, T; Schmidt, S; Schubert, R; Tramsen, L | 1 |
| Kader, NA; Patil, S; Raj, AT; Seetharam, C; Sujatha, G | 1 |
| Ellis, MW; Georgescu, C; Krumpelbeck, E; Tang, J | 1 |
| Díaz, MC; Luppi, M; Olivares, R | 1 |
| Milanezi, ACM; VAN DER Sand, ST; Witusk, JPD | 1 |
| Almeida-Paes, R; Brito-Santos, F; Cardarelli-Leite, P; da Silva, SA; Fialho, MM; Fortes, ST; Lázera, MDS; Morales, BP; Nascimento, CR; Nishikawa, MM; Santos, LO; Santos, W; Trilles, L | 1 |
| Al Jalali, V; Eberl, S; Sauermann, R; Zeitlinger, M | 1 |
| Bagshaw, E; Floros, L; Kuessner, D; Posthumus, J; Sjölin, J | 1 |
| Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E | 1 |
| Fica, A; Leiva Hernández, M; Salgueiro C, C; Téllez R, M | 1 |
| Fang, JP; Huang, K; Li, Y; Liao, XY; Qiu, KY; Xu, HG; Zhou, DH | 1 |
| Alflen, A; Aranda Lopez, P; Beckert, H; Radsak, MP; Ries, F; Schild, H; Teschner, D; Theobald, M | 1 |
| Arastehfar, A; Boekhout, T; Brouwer, C; Charsizadeh, A; Daneshnia, F; Haas, PJ; Hagen, F; Khodavaisy, S; Najafzadeh, MJ; Pan, W; Roudbary, M; Salehi, MR; Zarrinfar, H; Zomorodian, K | 1 |
| Akaiwa, Y; Miyamoto, T; Norimine, S; Numahata, K; Onoue, H; Yoshizawa, K | 1 |
| Aquino, VR; Chaves, GM; Colombo, AL; de Almeida Junior, JN; de Andrade Barberino, MGM; de Queiroz Telles, F; de Tarso O Castro, P; Francisco, EC; Guimarães, T; Hahn, RC; Mendes, AVA; Padovan, ACB | 1 |
| Chaftari, AM; Hachem, R; Kontoyiannis, DP; Raad, II; Reitzel, RA; Rosenblatt, J; Vargas-Cruz, N; Wilson Dib, R | 1 |
| Fujioka, K; Hamasaki, Y; Kagami, S; Kinoshita, Y; Nagai, T; Shishido, S; Urushihara, M | 1 |
| Altintop, YA; Atalay, MA; Ergul, AB; Koc, AN | 1 |
| Balcioglu, O; Balkan, C; Dundar, M; Ercan, I; Isik, E; Koc, A; Kodedová, M; Sahin Akdeniz, E; Sychrová, H; Zimmermannová, O | 1 |
| Chen, Y; Fang, J; Yu, J; Zhang, K | 1 |
| Drover, DR; Elkomy, MH; Frymoyer, A; Hammer, GB; Purohit, PJ; Su, F; Sutherland, SM | 1 |
| Bejou, N; Marr, K; McCarty, TP; Pappas, PG; Shields, RK; Wright, WF | 1 |
| Aquino, V; Borges, R; Meneghello Fuentefria, A; Ramirez-Castrillon, M; Rosa, PDD; Zubaran Goldani, L | 1 |
| Braga, SS | 1 |
| Castanheira, M; Deshpande, LM; Messer, SA; Pfaller, MA; Rhomberg, PR | 1 |
| Danis Vijay, D; Jayanthi, S; Meenakshi, N; Meharaj, SHS; Perumal, J; Sujhithra, A | 1 |
| Li, R; Sun, L; Wan, Z; Yu, J | 1 |
| Andrade, A; Bodden-Mendoza, BA; Espinosa-Mora, JE; González, GM; Martínez-Reséndez, MF; Treviño-Rangel, RJ; Villanueva-Lozano, H | 1 |
| Cho, SY; Jung, JI; Lee, DG; Lee, KY; Park, YJ; Yi, Y | 1 |
| Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K | 1 |
| Busca, A; Calore, E; Candoni, A; Capelli, D; Castagnola, C; Cattaneo, C; Del Principe, MI; Facchin, G; Fanin, R; Klimko, N; Lazzarotto, D; Melillo, L; Nadali, G; Pagano, L; Perruccio, K; Verga, L; Zannier, ME | 1 |
| Almeida-Paes, R; Brito-Santos, F; Coelho, RA; da Silva Chaves, AL; de Oliveira, JCA; Figueiredo-Carvalho, MHG; Monteiro, RV | 1 |
| Barbieri, S; Becchetti, C; Burra, P; Cattelan, A; Cillo, U; Feltracco, P; Ferrarese, A; Germani, G; Saluzzo, F; Senzolo, M | 1 |
| Hu, J; Li, L; Yang, M; Zhang, X; Zhao, H | 1 |
| Cai, W; Li, J; Li, X; Lu, S; Ma, J; Shi, M; Xi, L; Zhang, J | 1 |
| da Silva de Bastiani, FWM; de Azevedo Melo, AS; de Castro Spadari, C; Ishida, K; Pisani, PBB | 1 |
| Bigot, J; Botterel, F; Bougnoux, ME; Dannaoui, E; Dellière, S; Fekkar, A; Guitard, J; Hennequin, C; Senghor, Y; Verdurme, L | 1 |
| Moncada, D; Ramírez, I | 1 |
| Carlesse, F; Cheng, MP; Cornely, OA; Falces-Romero, I; Hassler, A; Herbrecht, R; Jover Sáenz, A; Klimko, N; Koehler, P; Lass-Flörl, C; Lehrnbecher, T; Mareş, M; Mellinghoff, SC; Pana, Z; Salmanton-García, J; Seidel, D; Soler-Palacín, P; Wisplinghoff, H | 1 |
| Gibbons, A; Leung, EH; Yoo, SH | 1 |
| Gupta, MK; Pandey, N; Paul, P; Tilak, R | 1 |
| AlFouzan, W; Anastasiadis, E; Dhar, R; El Chaar, M; Ghaddar, A; Ghaddar, N; Halimeh, R; Yusef, H | 1 |
| Erbaş, G; Kalkanci, A; Köktürk, N; Özkurt, ZN; Pepeler, MS; Tunçcan, ÖG; Yegin, ZA; Yildirim, Z; Yildiz, Ş | 1 |
| Kauffman, CA; Schwartz, IS | 1 |
| Borman, AM; Fraser, M; Johnson, EM; Muller, J; Palmer, MD; Patterson, Z; Szekely, A; Walsh-Quantick, J | 1 |
| A Cordeiro, R; Aguiar, AL; Brilhante, RS; de Andrade, AR; de Oliveira, JS; de Sales, GS; de Sousa, JK; Medrano, DJ; Pereira, LM; Pergentino, ML; Portela, FV; Rocha, MF; Scm Castelo-Branco, D; Sidrim, JJ | 1 |
| Akashi, K; Harada, T; Hayashi, M; Imanaga, H; Kato, K; Kuriyama, T; Miyamoto, T; Mori, Y; Nishida, R; Odawara, J; Takenaka, K; Ueno, T; Yoshimoto, G | 1 |
| Enoki, Y; Ikegame, K; Izumikawa, K; Matsumoto, K; Mayumi, T; Miyazaki, T; Miyazaki, Y; Okinaka, K; Takada, T; Takesue, Y; Uchino, M; Ueda, T; Yamashita, C | 1 |
| Agarwal, R; Dhooria, S; Muthu, V; Prasad, KT; Sehgal, IS | 1 |
| Aksu, ED; Albayrak, Ö; Ataç, N; Aydın, M; Can, F; Çınar, G; Doğan, Ö; Ergönül, Ö; Güler, Ö; Hacıseyitoğlu, D; Kapmaz, M; Karakoç, Ç; Keske, Ş; Menekşe, Ş; Şahin, S; Tekin, S; Yalçın, D; Yeşilkaya, A | 1 |
| Dupont, D; Miailhes, P; Mouchel, R; Persat, F; Saison, J; Wallon, M | 1 |
| Kraft, L; Ribeiro, VST; Telles, JP; Tuon, FF | 1 |
| Bannan, A; Grant, P; Lennard, K; Post, J | 1 |
| Afshar, AR; Ahmad, TR; Bever, GJ; Li, J; Rahman, S; Wu, F | 1 |
| Arendrup, MC; Friberg, N; Guinea, J; Kahlmeter, G; Mares, M; Meletiadis, J | 1 |
| Akata, F; Atalay, T; Aydin, B; Cubuk, MO; Ertop, M; Ozmen, MC; Ucgul, A | 1 |
| Matsumoto, Y; Sugita, T; Tateyama, Y; Yamada, T; Yamasaki, Y; Yamazaki, H | 1 |
| Kakkassery, V; Kurzai, O; von Jagow, B | 1 |
| Ding, CH; Faiz, MA; Khaithir, TMN; Saarah, WR; Wahab, AA | 1 |
| Cheng, YYY; Cheung, NN; Gooskens, J; Houbraken, J; van Duinen, SG; Verweij, PE | 1 |
| Hori, D; Kishimoto, K; Kobayashi, K; Kobayashi, R; Kodama, K; Matsushima, S; Nakano, T; Sano, H; Suzuki, D; Yanagi, M | 1 |
| Chandrashekar, N; Hesarur, N; Kumari, P; Nagappa, M; Pruthi, N; Rao, S; Reddy, N; Saini, J; Santosh, V; Seshagiri, DV; Sharma, PP; Shukla, D; Sinha, S; Taly, AB | 1 |
| Han, Y; Huang, H; Lan, K; Liang, G; Lin, J; Liu, J; Pan, J; Yang, W; Zeng, L | 1 |
| Epps, KL; Epps, QJ; Young, DC; Zobell, JT | 1 |
| Brito Devoto, T; Carmona, M; Cuestas, ML; Formento, N; Gordó, M; Hermida-Alava, K; Luque, A; Sautua, F; Scandiani, M | 1 |
| Bautista-de Lucio, VM; Calvillo-Medina, RP; Campos Guillén, J; Escudero-Leyva, E; Müller-Morales, CA; Ponce-Angulo, DG; Raymundo, T | 1 |
| Aggarwal, R; Arul, A; Chaudhary, H; Dey, P; Mukhopadhyay, K; Rawat, A; Ray, S; Vignesh, P | 1 |
| Bourgeois, T; Lagrou, K; Lodewyck, T; Nulens, E; Reynders, M; Van Praet, J; Verbeke, V | 1 |
| Gharaghani, M; Taghipour, S; Zarei Mahmoudabadi, A | 1 |
| Clerkin, P; Kuzmic, B; Laningham, F; McCarty, J; Naeem, F | 1 |
| Bassetti, M; Böll, B; Brüggemann, R; Chakrabarti, A; Chen, SCA; Colombo, AL; Cornely, OA; Gangneux, JP; Hoenigl, M; Klimko, N; Koehler, P; Lass-Flörl, C; Meis, JF; Oladele, RO; Ostrosky-Zeichner, L; Patterson, TF; Perfect, JR; Persigehl, T; Verweij, PE; Vinh, DC; White, PL; Zhu, LP | 1 |
| Lam, JKW; Liao, Q | 1 |
| Abboud, C; Achcar, ME; Bidon, B; Bouchara, JP; Dabboussi, F; Dannaoui, E; Hamze, B; Hamze, M; Mallat, H; Osman, M; Papon, N; Zakaria, A | 1 |
| Barać, A; Cornely, OA; Desoubeaux, G; Falces-Romero, I; Kindo, AJ; Malaj, X; Morris, AJ; Pelletier, R; Ráčil, Z; Ruiz de Alegría Puig, C; Sal, E; Salmanton-García, J; Seidel, D; Sprute, R; Steinmann, J; Stemler, J; Thompson, GR | 1 |
| Cao, C; Huang, W; Jiang, J; Li, T; Wei, F; Zhou, C | 1 |
| Berrocal, AM; El Hamichi, S; Gold, AS; Kon Graversen, V; Murray, TG | 1 |
| Denardi, LB; Ianiski, LB; Santurio, JM; Stibbe, PC; Weiblen, C | 1 |
| Onder, S; Oz, Y | 1 |
| Hamada, N; Horiuchi, T; Ishiga, M; Itano, J; Kimura, G; Ooue, Y; Suwaki, T; Tanaka, H; Tanaka, S; Tanimoto, Y; Yuzurio, S | 1 |
| Aboutalebian, S; Fakhim, H; Hajiahmadi, S; Hakamifard, A; Hashemi, M; Mohammadi, R | 1 |
| Dong, J; Huang, D; Liang, Z; Tang, Y; Wang, K; Wang, Y; Wen, L; Yu, H; Zhang, Y | 1 |
| Cheng, KF; Cheong, KN; Chua, GT; Chui, MMC; Chung, BH; Chung, TW; Duque, JSR; Him, AHC; Ho, RS; Ho, WW; Lai, SHY; Lau, YL; Lee, M; Lee, P; Lee, R; Leung, D; Poon, RWS; Tam, S; Yuen, KY | 1 |
| Mammen, MD; Rupa, V; Sahni, RD; Varghese, GM | 1 |
| Cañete-Gibas, C; Ryan, K; Sanders, C; Sosa, N; Wiederhold, NP | 1 |
| Fatahinia, M; Kiasat, N; Mahmoudabadi, AZ; Moslem, M | 1 |
| Bajalan, Z; Hemmat, N; Javadi, A; Mohammadi, F | 1 |
| Al-Hatmi, AMS; de Hoog, GS; Li, R; Liu, X; Meng, X; Song, Y; Xue, R; Yang, Z; Yu, J | 1 |
| Alshaya, OA; Alshehri, SD; Saleh, RA | 1 |
| Bafghi, MH; Darroudi, M; Nazari, R; Zargar, M; Zarrinfar, H | 1 |
| D'agostino, M; Debourgogne, A; Frippiat, JP; Lavergne, RA; Le Pape, P; Machouart, M; Tesse, N | 1 |
| Al-Hatmi, AMS; Blaize, M; Bonnal, C; Brandenberger, M; Brun, S; Cassaing, S; Chryssanthou, E; Costa, D; Delhaes, L; Fekkar, A; Hasseine, L; Imbert, S; Kristensen, L; Mahinc, C; Normand, AC; Piarroux, R; Ranque, S; Riat, A; Rubio, E; Sautour, M; Schuttler, C; Sendid, B; Stubbe, D | 1 |
| Marchione, G; Midena, G; Parrozzani, R | 1 |
| Das, S; Garg, P; Mallick, A; Mitra, S; Priyadarshini, SR; Sharma, S | 1 |
| Buil, JB; den Dekker, BM; Festen, B; Heusinkveld, M; Melchers, M; Mooren, ERM; Schellaars, R; van Binsbergen, AL; van Bree, SHW; van Zanten, ARH; Verweij, PE | 1 |
| Aruanno, M; Born, T; Kampouri, E; Lamoth, F; Mombelli, M; Monney, P; Tozzi, P | 1 |
| Buer, J; Dittmer, S; Furnica, DT; Kirchhoff, L; Rath, PM; Steinmann, E; Steinmann, J | 1 |
| Cho, SI; Choi, SH; Kim, J; Kim, SY; Kim, WJ; Kim, YR; Koo, J; Lee, CH; Lee, H; Lee, HJ; Lee, HK; Oh, J; Ryu, SW; Shin, JH; Sohn, YH; Sung, GH | 1 |
| Paaopanchon, C; Pesee, S; Phantumvanit, P; Roytrakul, S; Samaranayake, L | 1 |
| Costa, D; Favennec, L; Gargala, G; Goupillou, P; Gueudry, J; Muraine, M; Rouzaud, C; Schneider, P | 1 |
| Abastabar, M; Aghili, SR; Badali, H; Haghani, I; Hedayati, MT; Javidnia, J; Khojasteh, S; Meis, JF; Moazeni, M; Nargesi, S; Nosratabadi, M; Shabanzadeh, S; Shokohi, T; Zaedi, A | 1 |
| Lu, F; Wang, B; Wang, Y; Xu, Y; Zhang, L; Zhang, M | 1 |
| Alegre, L; Giusiano, G; Latorre, W; Mussin, J; Rojas, FD; Sosa, MLÁ | 1 |
| Jiang, H; Jin, P; Sun, Y; Tan, J; Tan, L; Xiong, J; Yang, L | 1 |
| Bonovas, S; Houhoula, D; Markou, E; Mavrogenis, AF; Papadopoulos, DV; Piovani, D; Sokou, R; Trikoupis, I; Tsakris, A; Tsantes, AE; Tsantes, AG; Vrioni, G; Zarokostas, K | 1 |
| Jiang, Y; Li, M; Liu, J; Peng, F; Su, X; Wang, A; Wang, Y; Xu, X; Yang, L | 1 |
| Cesaro, S; Cornely, OA; Falces-Romero, I; Kindo, AJ; Klimko, N; Koehler, P; Kredics, L; Lass-Flörl, C; Meyer, E; Racil, Z; Sal, E; Salmanton-García, J; Seidel, D; Stemler, J; Wisplinghoff, H; Würstl, B | 1 |
| Agarwal, R; Biswal, M; Chakrabarti, A; Dhaliwal, N; Ghosh, A; Ghoshal, S; Jain, S; Kaur, H; Krishnamoorthi, S; Malhotra, P; Muthu, V; Rudramurthy, SM; Samujh, R; Singh, S | 1 |
| Chen, Y; Harypursat, V; Lan, K; Lu, Y; Wu, Y; Xu, X; Yang, T; Yu, J; Zeng, Q; Zhang, W; Zhao, T; Zhou, G | 1 |
| Doki, N; Fukushima, K; Funata, N; Hishima, T; Horiguchi, SI; Igarashi, A; Inamoto, K; Kaito, S; Kakihana, K; Kishida, Y; Kobayashi, T; Konishi, T; Kurosawa, S; Nagata, A; Najima, Y; Ohashi, K; Sakamaki, H; Sekiya, N; Shimizu, H; Shingai, N; Shirane, S; Toya, T; Uchida, T; Yamada, Y; Yoshifuji, K | 1 |
| Abe, M; Hirabayashi, A; Hosaka, Y; Kajihara, T; Kitamura, N; Miyazaki, Y; Nagi, M; Sugai, M; Yahara, K | 1 |
| Babaei, M; Daie Ghazvini, R; Erami, M; Fattahi, M; Getso, MI; Hashemi, SJ; Khodavaisy, S; Mehri, N; Momen-Heravi, M; Parviz, S; Raiesi, O | 1 |
| Goto, N; Hida, Y; Higashi, T; Iwasaki, H; Kodawara, T; Tsukamoto, H; Watanabe, K | 1 |
| Matsumoto, Y; Nagamachi, T; Sugita, T; Sugiyama, Y; Yamada, T; Yoshikawa, A | 1 |
| Cui, F; Kan, S; Li, X; Liu, W; Pang, Q | 1 |
| Bonnin, V; Butler, G; Cafarchia, C; Cassaing, S; Grenouillet, F; Hagen, F; Lavergne, RA; Le Pape, P; Moniot, M; Morio, F; Nourrisson, C; Poirier, P; Robert, E; Sabou, M | 1 |
| Agrawal, S | 1 |
| Cañete-Gibas, C; Patterson, HP; Sanders, CJ; Wiederhold, NP | 1 |
| Ahmed, NH; Gupta, N; Naik, R; Sidhu, N; Tandon, R; Vanathi, M | 1 |
| Alharbi, RA; Baazeem, A; Hassan, AS; Homa, M; Kannaiyan, M; Kredics, L; Krizsán, K; Manikandan, P; Mythili, A; Othaim, A; Papp, T; Sangeetha, AB; Selvam, KP; Shobana, CS; Vágvölgyi, C | 1 |
| Ding, C; He, X; Li, B; Peng, J | 1 |
| Chen, S; Chen, X; Jiang, H; Wang, J; Xu, J; Xu, L; Yang, X | 1 |
| Antachopoulos, C; Roilides, E; Simitsopoulou, M; Skoura, L; Vikelouda, K | 1 |
| Abtahi, SH; Esfahanian, F; Fekri, S; Khorshidifar, M; Nouri, H; Veisi, A | 1 |
| An, L; Jia, G; Li, L; Tan, J; Wang, Y; Yang, L | 1 |
| Bispo, PJM; Cañete-Gibas, C; Chodosh, J; Davies, EC; Oremosu, J; Ung, L; Wiederhold, NP | 1 |
| Cheng, D; Han, Q; Wang, K; Wu, H; Xiong, X; Zhuo, K | 1 |
| Chen, P; Chen, Y; Feng, Z; Gao, F; Jin, Y; Lin, W; Lu, C; Shang, Z; Wang, F; Yang, J | 1 |
| Alt, V; Mannala, GK; Riool, M; Rupp, M; Scholz, KJ; Simon, M; Walter, N | 1 |
| Charkhchian, M; Mirzadeh, M; Mohammadi, F | 1 |
| Fatahinia, M; Halvaeezadeh, M; Jalaee, GA; Mahmoudabadi, AZ | 1 |
| Carvalhaes, CG; Castanheira, M; Pfaller, MA | 1 |
| Brito Devoto, T; Cuestas, ML; Finquelievich, JL; García-Effrón, G; Hermida-Alva, K; Posse, G | 1 |
| Egger, M; Hoenigl, M; Jenks, JD; Nucci, M; Thompson, GR | 1 |
| Celis-Ramírez, AM; Contreras, A; Ehemann, K | 1 |
| Cheng, SM; Wang, JS; Xiao, YT; Xie, HT; Zhang, MC | 1 |
| Ahmad, S; Al-Sweih, N; Asadzadeh, M; Khan, Z | 1 |
| Bilal, H; Cai, L; Chen, C; Hu, H; Khan, MN; Khan, RU; Khan, S; Shafiq, M; Zeng, Y; Zhang, D | 1 |
| Aguilar-Zapata, D; Barragán-Reyes, A; Camacho, A; Cendejas, RF; Cornejo-Juárez, P; Guzmán, JMF; Hernández, MLG; Jácome, LEL; Juárez-Hernández, E; Nava-Ruiz, A; Ontañón-Zurita, D; Perales-Martínez, D; Reséndiz-Sánchez, J; Rincón-Zuno, J; Rivera-Martínez, NE | 1 |
| Chen, X; Deng, J; Fang, G; Lin, F; Pan, M; Qiu, Y; Zeng, W; Zhang, J; Zheng, F | 1 |
110 review(s) available for voriconazole and amphotericin b
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Tetrazole hybrids and their antifungal activities.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Mycoses; Pyridines; Pyrimidines; Quinolines; Structure-Activity Relationship; Tetrazoles | 2019 |
In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.
Topics: Amphotericin B; Antifungal Agents; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Triazoles; Voriconazole | 2001 |
[Clinical development of antimycotics. Medical challenges].
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Excipients; Fungi; Humans; Itraconazole; Lipopeptides; Liposomes; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Voriconazole | 2003 |
[Aspergillosis].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Biomarkers; Diagnosis, Differential; Echinocandins; Glucans; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Serologic Tests; Triazoles; Voriconazole | 2003 |
Management of Aspergillus osteomyelitis: report of failure of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Fungal; Follow-Up Studies; Humans; Immunocompetence; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Pyrimidines; Risk Assessment; Severity of Illness Index; Spondylitis; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Antifungal pharmacotherapy for neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
CNS-aspergillosis: are there new treatment options?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blood-Brain Barrier; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Male; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
[New therapeutical options for pulmonary fungal infections in non-neutropenic ICU-patients].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Fungi; Humans; Intensive Care Units; Lipopeptides; Lung Diseases, Fungal; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2003 |
[Meta-analysis on safety and efficacy of liposomal amphotericin B in the empirical treatment of febrile neutropenia].
Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fever; Humans; Liposomes; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2004 |
[New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole | 2004 |
[Invasive aspergillosis: clinical manifestations and treatment].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Caspofungin; Dermatomycoses; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Immunologic Factors; Itraconazole; Lipopeptides; Neuroaspergillosis; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Respiratory Tract Infections; Triazoles; Voriconazole | 2003 |
Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Endocarditis; Female; Follow-Up Studies; Fungemia; Fusarium; Humans; Immunocompromised Host; Infant; Leukemia, Myeloid, Acute; Liposomes; Opportunistic Infections; Pyrimidines; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Use of newer antifungal therapies in clinical practice: what do the data tell us?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2004 |
Combination antifungal therapy: where are we now, and where are we going?
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Caspofungin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Antifungal resistance: the clinical front.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Health Status; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Risk Factors; Thiazoles; Treatment Outcome; Triazoles; United States; Voriconazole | 2004 |
Pharmacological management of paracoccidioidomycosis.
Topics: Amphotericin B; Central Nervous System Fungal Infections; Drug Resistance; Fluconazole; Follow-Up Studies; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Paracoccidioidomycosis; Pyrimidines; Sulfonamides; Triazoles; Voriconazole | 2005 |
A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Echinocandins; Female; Heart Transplantation; Humans; Lipopeptides; Mediastinitis; Middle Aged; Peptides, Cyclic; Pyrimidines; Surgical Wound Infection; Triazoles; Voriconazole | 2005 |
[Update on therapy of invasive mycoses in hematology and oncology].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Drug Combinations; Echinocandins; Hematologic Neoplasms; Humans; Itraconazole; Lipopeptides; Liposomes; Mycoses; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Risk Factors; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis | 2005 |
Antifungal agents in children.
Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole | 2005 |
Combination antifungal therapy for invasive aspergillosis: utilizing new targeting strategies.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Voriconazole versus amphotericin B in cancer patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
Fungal infections in bone marrow transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Caspofungin; Drug Administration Schedule; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Postoperative Complications; Premedication; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
Zygomycoses in patients with acute leukaemia.
Topics: Amphotericin B; Antifungal Agents; Female; Humans; Immunocompromised Host; Leukemia; Male; Middle Aged; Neutropenia; Pyrimidines; Triazoles; Voriconazole; Zygomycosis | 2006 |
Fungal prosthetic mitral valve endocarditis caused by Scopulariopsis species: case report and review of the literature.
Topics: Aged; Amphotericin B; Antifungal Agents; Arterial Occlusive Diseases; Cardiac Surgical Procedures; Device Removal; Endarterectomy; Endocarditis; Fatal Outcome; Female; Femoral Artery; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Leg; Mitosporic Fungi; Mitral Valve; Mycoses; Prosthesis-Related Infections; Pyrimidines; Reoperation; Triazoles; Voriconazole | 2006 |
Treatment of invasive infections due to rare or emerging yeasts and moulds.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised Host; Mucormycosis; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Intensive Care Units; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
[The future of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole | 2007 |
Treating disseminated fusariosis: amphotericin B, voriconazole or both?
Topics: Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fever; Fusarium; Humans; Immunocompromised Host; Liposomes; Male; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
[Current indications for voriconazole in onco-hematological patients].
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Drug Resistance, Fungal; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Multicenter Studies as Topic; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Salvage Therapy; Spain; Triazoles; Voriconazole; Zygomycosis | 2007 |
[New development in the treatment of deep-seated mycoses].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
Candida endophthalmitis: focus on current and future antifungal treatment options.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Echinocandins; Endophthalmitis; Fluconazole; Flucytosine; Humans; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2007 |
Antifungal agents--clinical pharmacokinetics and drug interactions.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Echinocandins; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
Invasive candidiasis in the ICU: evidence based and on the edge of evidence.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Intensive Care Units; Itraconazole; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2008 |
Treatment of invasive candidal infections: systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Confidence Intervals; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Odds Ratio; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
[Oral antifungal agents].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Diabetes Complications; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Clinical efficacies of antifungal injections].
Topics: Amphotericin B; Antifungal Agents; Drug Delivery Systems; Echinocandins; Fluconazole; Humans; Infusions, Intravenous; Injections; Itraconazole; Lipopeptides; Liposomes; Micafungin; Mycoses; Organophosphates; Pyrimidines; Triazoles; Voriconazole | 2008 |
New therapies for fungal pneumonia.
Topics: Amphotericin B; Antifungal Agents; Fungi; Galactose; Humans; Mannans; Mycoses; Pneumonia; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Triazoles; Voriconazole | 2009 |
Diagnosis and treatment of aspergillosis in children.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Echinocandins; Fungal Vaccines; Genomics; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2009 |
Aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Debridement; Echinocandins; Humans; Immunity, Cellular; Immunity, Innate; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole | 2009 |
The role of voriconazole in the treatment of central nervous system blastomycosis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Central Nervous System Fungal Infections; Child; Child, Preschool; Humans; Infant; Magnetic Resonance Imaging; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2009 |
In vitro activity of antifungals against Zygomycetes.
Topics: Amphotericin B; Antifungal Agents; Echinocandins; Humans; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Aspergillus; DNA, Fungal; Female; Fungemia; Humans; Immunocompromised Host; Incidence; Male; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Risk Assessment; Severity of Illness Index; Survival Rate; Triazoles; Voriconazole | 2010 |
Primary invasive oral aspergillosis: an updated literature review.
Topics: Acyclovir; Aged; Amphotericin B; Antifungal Agents; Antiviral Agents; Aspergillosis; Fatal Outcome; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Mouth Diseases; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole | 2010 |
Modern antifungal therapy for neutropenic fever.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fever; Humans; Immunocompromised Host; Kidney Diseases; Lipopeptides; Liposomes; Liver Diseases; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2006 |
Traditional and emerging antifungal therapies.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole | 2010 |
Combination antifungal therapy for disseminated fusariosis in immunocompromised patients : a case report and literature review.
Topics: Adult; Alemtuzumab; Amphotericin B; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antineoplastic Agents; Combined Modality Therapy; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fever; Fusariosis; Fusarium; Granulocytes; Humans; Immunocompromised Host; Leukocyte Transfusion; Lymphoma, T-Cell, Cutaneous; Male; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole | 2011 |
Emerging infectious endocarditis due to Scedosporium prolificans: a model of therapeutic complexity.
Topics: Adult; Amphotericin B; Antifungal Agents; Communicable Diseases, Emerging; Embolectomy; Endocarditis; Fatal Outcome; Female; Femoral Artery; Humans; Immunocompromised Host; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pyrimidines; Scedosporium; Thrombosis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2011 |
Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Therapy, Combination; Echinocandins; Evidence-Based Medicine; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2011 |
Rhodotorula fungemia: two cases and a brief review.
Topics: Amphotericin B; Antifungal Agents; Catheterization, Central Venous; Female; Fungemia; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Pyrimidines; Rhodotorula; Treatment Outcome; Triazoles; Voriconazole; Wounds and Injuries | 2011 |
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Mycoses; North America; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole | 2012 |
Endophthalmitis caused by Phialophora verrucosa: a case report and literature review of Phialophora ocular infections.
Topics: Aged; Amphotericin B; Antifungal Agents; Caspofungin; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Glaucoma; Humans; Hypertension; Intravitreal Injections; Lipopeptides; Male; Phialophora; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2012 |
Treatment of refractory cerebral aspergillosis in a liver transplant recipient with voriconazole: case report and review of the literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Encephalitis; Humans; Liver Transplantation; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Antifungal therapy of aspergillosis of the central nervous system and aspergillus endophthalmitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Humans; Neuroaspergillosis; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2013 |
Pharmacoeconomic assessment of therapy for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Cost-Benefit Analysis; Empirical Research; Humans; Length of Stay; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Diagnosis of airway-invasive pulmonary aspergillosis by tree-in-bud sign in an immunocompetent patient: case report and literature review.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Biopsy; Bronchiolitis; Bronchoscopy; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Humans; Immunocompetence; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Lung; Male; Pyrimidines; Sputum; Tomography, X-Ray Computed; Triazoles; Tuberculosis, Pulmonary; Voriconazole; Young Adult | 2013 |
Bibliographical investigation (domestic and overseas) on the treatment of endogenous Candida endophthalmitis over an 11-year period.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Female; Fluconazole; Humans; Infant; Japan; Male; MEDLINE; Middle Aged; Pyrimidines; Severity of Illness Index; Time Factors; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole; Young Adult | 2013 |
Cervical spondylitis due to Phaeoacremonium venezuelense in an immunocompetent patient. A first case report.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Cervical Vertebrae; Epidural Abscess; Humans; Immunocompetence; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Species Specificity; Spondylitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
Combination antifungal therapy for invasive fungal infections in children and adults.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Caspofungin; Child; Cryptococcosis; Cryptococcus; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Pyrimidines; Triazoles; Voriconazole | 2013 |
Old and new: appropriate dosing for neonatal antifungal drugs in the nursery.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Combinations; Echinocandins; Fluconazole; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Neonatology; Pyrimidines; Triazoles; Voriconazole | 2013 |
Mold infections in lung transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bronchiolitis Obliterans; Fungi; Humans; Lung Diseases, Fungal; Lung Transplantation; Neoplasms, Squamous Cell; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2013 |
Disseminated histoplasmosis in a renal transplant patient.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow; Dermatomycoses; Histoplasmosis; Humans; Immunocompromised Host; Kidney Transplantation; Lung; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2013 |
Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Drug Therapy, Combination; Echinocandins; Humans; Practice Guidelines as Topic; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2013 |
Rhodotorula minuta as onychomycosis agent in a Chinese patient: first report and literature review.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Asian People; China; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Onychomycosis; Pyrimidines; Rhodotorula; Triazoles; Voriconazole | 2014 |
Scedosporium aurantiacum brain abscess after near-drowning in a survivor of a tsunami in Japan.
Topics: Aged; Amphotericin B; Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Delayed Diagnosis; Female; Humans; Japan; Lung Diseases, Fungal; Magnetic Resonance Imaging; Near Drowning; Pyrimidines; Scedosporium; Survivors; Tomography, X-Ray Computed; Triazoles; Tsunamis; Voriconazole | 2013 |
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2014 |
[Central nervous system infection caused by Exophiala dermatitidis in a case and literature review].
Topics: Amphotericin B; Antifungal Agents; Brain; Central Nervous System Infections; Cerebrospinal Fluid; Child; Drug Therapy, Combination; Exophiala; Fatal Outcome; Fluorouracil; Humans; Magnetic Resonance Imaging; Male; Mycoses; Radiography; Voriconazole | 2014 |
Fusarium brain abscess: case report and literature review.
Topics: Amphotericin B; Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Fatal Outcome; Female; Fusariosis; Fusarium; Humans; Immunocompromised Host; Middle Aged; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiography; Seizures; Voriconazole | 2015 |
Pseudozyma spp catheter-associated blood stream infection, an emerging pathogen and brief literature review.
Topics: Amphotericin B; Antifungal Agents; Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Female; Fluconazole; Fungemia; Humans; Middle Aged; Mycoses; Risk Factors; Voriconazole; Yeasts | 2014 |
Geotrichum capitatum septicemia: case report and review of the literature.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Fatal Outcome; Female; Geotrichosis; Geotrichum; Hospitals, University; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Tunisia; Voriconazole | 2015 |
[Thalamo-mesencephalic aspergillus abscess in a heart transplant subject: a case report and literature review].
Topics: Administration, Intravenous; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Brain Abscess; Drug Therapy, Combination; Heart Transplantation; Humans; Immunocompromised Host; Male; Mesencephalon; Thalamus; Time Factors; Treatment Outcome; Voriconazole | 2015 |
Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Flucytosine; Fungemia; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pleural Effusion; Voriconazole | 2015 |
Complications of Candidemia in ICU Patients: Endophthalmitis, Osteomyelitis, Endocarditis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Echinocandins; Echocardiography; Endocarditis; Endophthalmitis; Fluconazole; Humans; Intensive Care Units; Magnetic Resonance Imaging; Osteomyelitis; Voriconazole | 2015 |
Invasive Aspergillosis: Epidemiology, Clinical Aspects, and Treatment.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Drug Therapy, Combination; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lung Transplantation; Magnetic Resonance Imaging; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2015 |
Fusariosis.
Topics: Amphotericin B; Antifungal Agents; Fusariosis; Fusarium; Humans; Immunocompromised Host; Pneumonia; Risk Factors; Transplant Recipients; Voriconazole | 2015 |
First Case of Trichoderma longibrachiatum CIED (Cardiac Implantable Electronic Device)-Associated Endocarditis in a Non-immunocompromised Host: Biofilm Removal and Diagnostic Problems in the Light of the Current Literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Base Sequence; Biofilms; Defibrillators, Implantable; DNA, Intergenic; Endocarditis; Heart; Humans; Male; Mycoses; Sequence Analysis, DNA; Trichoderma; Voriconazole | 2016 |
A Case of Cutaneous Fusariosis of the Scrotum as a Complication of Acute Myeloid Leukemia.
Topics: Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fatal Outcome; Fusariosis; Fusarium; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Opportunistic Infections; Scrotum; Skin; Voriconazole | 2016 |
Invasive Aspergillosis in Hematological Patients.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Biomarkers; Echinocandins; Hematologic Neoplasms; Humans; Neutropenia; Opportunistic Infections; Risk Factors; Stem Cell Transplantation; Tomography, X-Ray Computed; Voriconazole | 2016 |
Pseudozyma and other non-Candida opportunistic yeast bloodstream infections in a large stem cell transplant center.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cryptococcus; Cytarabine; Dermatomycoses; Echinocandins; Exanthema; Fever; Fungemia; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunocompromised Host; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipopeptides; Male; Micafungin; Opportunistic Infections; Retrospective Studies; Saccharomyces; Salvage Therapy; Trichosporon; Ustilaginales; Vidarabine; Voriconazole; Yeasts | 2017 |
Trichosporonosis in Pediatric Patients With a Hematologic Disorder.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Child; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Lipopeptides; Male; Micafungin; Neutropenia; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Trichosporonosis; Voriconazole | 2018 |
Graded isavuconazole introduction in a patient with voriconazole allergy.
Topics: Amphotericin B; Angioedema; Antifungal Agents; Aspergillus; Desensitization, Immunologic; Drug Administration Schedule; Drug Hypersensitivity; Female; Humans; Liver Cirrhosis; Liver Transplantation; Lung; Middle Aged; Nitriles; Pulmonary Aspergillosis; Pyridines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2017 |
Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia.
Topics: Amphotericin B; Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Endophthalmitis; Female; Fungemia; Fusariosis; Fusarium; Humans; Immunocompromised Host; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2018 |
Differences in clinical ocular outcomes between exogenous and endogenous endophthalmitis caused by
Topics: Administration, Ophthalmic; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Risk Factors; Sporothrix; Sporotrichosis; Treatment Outcome; Visual Acuity; Voriconazole; Young Adult | 2018 |
Fatal Fusarium infection manifesting as osteomyelitis following previous treatment with amphotericin B in a multi-visceral transplant: Case report and review of Fusarium infections in solid organ transplantation.
Topics: Abdomen; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Fatal Outcome; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Osteomyelitis; Tomography, X-Ray Computed; Transplants; Voriconazole | 2018 |
Fungal Infection Caused by Geotrichum capitatum in a Severe Aplastic Anemia Patient: a Case Report and Review of the Literature.
Topics: Adolescent; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Female; Geotrichum; Humans; Mycoses; Severity of Illness Index; Voriconazole | 2018 |
Systematic review and network meta-analysis of clinical outcomes associated with isavuconazole versus relevant comparators for patients with invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Deoxycholic Acid; Drug Combinations; Humans; Network Meta-Analysis; Nitriles; Pyridines; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; Voriconazole | 2018 |
Trichosporon inkin meningitis in Northeast Brazil: first case report and review of the literature.
Topics: Amphotericin B; Antifungal Agents; Brazil; DNA, Ribosomal; Female; Humans; Immunocompromised Host; Meningitis, Fungal; Microbial Sensitivity Tests; Middle Aged; Sequence Analysis, DNA; Trichosporon; Trichosporonosis; Voriconazole | 2018 |
Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples - an Iranian multicentre study and a review of the literature.
Topics: Adolescent; Aged; Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Bronchoalveolar Lavage; Candida; Candidemia; Candidiasis; Caspofungin; DNA, Intergenic; Fatal Outcome; Female; Fluconazole; Genotype; Humans; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Vagina; Voriconazole | 2019 |
Successful treatment of disseminated fusariosis in a patient with acute lymphoblastic leukemia: A case report and literature review.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Female; Fusariosis; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Tigecycline; Voriconazole | 2019 |
Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.
Topics: Amphotericin B; Antifungal Agents; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leishmaniasis; Molecular Targeted Therapy; Phosphorylcholine; Sterol 14-Demethylase; Triazoles; Voriconazole | 2019 |
Central nervous system fungal infections in allogeneic stem cell transplantation. Outcome of 24 recent cases and literature review.
Topics: Adolescent; Adult; Allografts; Amphotericin B; Central Nervous System Fungal Infections; Child; Disease-Free Survival; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Survival Rate; Voriconazole | 2020 |
Geotrichum capitatum Invasive Infection Early After Liver Transplant.
Topics: Amphotericin B; Antifungal Agents; Fatal Outcome; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Fungal Infections; Liver Transplantation; Male; Middle Aged; Multiple Organ Failure; Opportunistic Infections; Saccharomycetales; Sepsis; Treatment Outcome; Voriconazole | 2020 |
Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
Topics: Adult; Amphotericin B; Antifungal Agents; Central Venous Catheters; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mortality; Neutropenia; Triazoles; Trichosporon; Trichosporonosis; Voriconazole | 2020 |
Blastomycosis.
Topics: Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Humans; Immunocompromised Host; Itraconazole; Triazoles; Voriconazole | 2020 |
Echinocandins versus non-echinocandins for empirical antifungal therapy in patients with hematological disease with febrile neutropenia: A systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Echinocandins; Febrile Neutropenia; Humans; Mycoses; Randomized Controlled Trials as Topic; Treatment Outcome; Voriconazole | 2020 |
An overview of the available treatments for chronic cavitary pulmonary aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Disease Management; Echinocandins; Humans; Itraconazole; Nitriles; Practice Guidelines as Topic; Pulmonary Aspergillosis; Pyridines; Triazoles; Voriconazole | 2020 |
Pseudozyma spp. human infections: A systematic review.
Topics: Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Humans; Itraconazole; Mycoses; Voriconazole; Yeasts | 2021 |
From bench to bedside: Perspectives on the utility of pharmacokinetics/pharmacodynamics in predicting the efficacy of antifungals in invasive candidiasis.
Topics: Amphotericin B; Animals; Antifungal Agents; Antimicrobial Stewardship; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidiasis, Invasive; Echinocandins; Fluconazole; Flucytosine; Humans; Species Specificity; Triazoles; Voriconazole | 2020 |
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST).
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Practice Guidelines as Topic; Triazoles; Voriconazole | 2020 |
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
Topics: Amphotericin B; Antifungal Agents; Azoles; Coinfection; COVID-19; Humans; Nitriles; Pulmonary Aspergillosis; Pyridines; SARS-CoV-2; Triazoles; Voriconazole | 2021 |
Inhaled Antifungal Agents for the Treatment and Prophylaxis of Pulmonary Mycoses.
Topics: Amphotericin B; Antifungal Agents; Humans; Itraconazole; Mycoses; Voriconazole | 2021 |
Aspergillus tubingensis Endocarditis: A Case Report and Review of the Literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Echinocandins; Endocarditis; Female; Humans; Microbial Sensitivity Tests; Voriconazole | 2022 |
Aspergillus spp. osteoarticular infections: an updated systematic review on the diagnosis, treatment and outcomes of 186 confirmed cases.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Microbial Sensitivity Tests; Treatment Outcome; Voriconazole | 2022 |
Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope® registry.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Hematologic Neoplasms; Humans; Registries; Trichoderma; Voriconazole | 2022 |
Central nervous system mucormycosis in a patient with hematological malignancy: A case report and review of the literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Brain Abscess; Central Nervous System; Female; Hematologic Neoplasms; Humans; Mucormycosis; Voriconazole | 2022 |
Lung infection caused by Blastoschizomyces capitatus without immunodeficiency: a case report and review of the literature.
Topics: Aged; Amphotericin B; Antifungal Agents; Dyspnea; Humans; Lung; Male; Mycoses; Pneumonia; Voriconazole | 2022 |
Disseminated
Topics: Adult; Amphotericin B; Antifungal Agents; Humans; Kidney Transplantation; Male; Voriconazole | 2023 |
Instillation of Amphotericin B by bronchoscopy combined with systemic voriconazole in advanced non-small cell lung cancer patients with chronic cavitary pulmonary aspergillosis: A case series and literature review.
Topics: Amphotericin B; Antifungal Agents; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Pulmonary Aspergillosis; Voriconazole | 2023 |
Treatment of Fusarium Infection of the Central Nervous System: A Review of Past Cases to Guide Therapy for the Ongoing 2023 Outbreak in the United States and Mexico.
Topics: Adult; Amphotericin B; Antifungal Agents; Central Nervous System; Female; Fusariosis; Fusarium; Humans; Mexico; United States; Voriconazole | 2023 |
18 trial(s) available for voriconazole and amphotericin b
| Article | Year |
|---|---|
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Chronic Disease; Female; Fever; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Pyrimidines; Survival Rate; Triazoles; Voriconazole | 2002 |
Improving the outcome of invasive aspergillosis: new diagnostic tools and new therapeutic strategies.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Deoxycholic Acid; Drug Combinations; Humans; Itraconazole; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Administration Schedule; Female; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Salvage Therapy; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Costs; Humans; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole | 2007 |
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies.
Topics: Amphotericin B; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Changes in causes of death over time after treatment for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cause of Death; Graft vs Host Disease; Humans; Neoplasms; Pyrimidines; Survival Rate; Time Factors; Triazoles; Voriconazole | 2008 |
Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia.
Topics: Amphotericin B; Australia; Cost-Benefit Analysis; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Mycoses; Neutropenia; Prospective Studies; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole; Young Adult | 2010 |
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fever; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Prospective Studies; Pyrimidines; Radiography, Thoracic; Risk Factors; Singapore; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Ocular manifestations of candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidemia; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Incidence; Male; Middle Aged; Prospective Studies; Pyrimidines; Risk Factors; Triazoles; Voriconazole; Young Adult | 2011 |
Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.
Topics: Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Mycoses; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Biomarkers; Female; Fungal Polysaccharides; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA).
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Asthma; Female; Forced Expiratory Volume; Humans; Itraconazole; Male; Middle Aged; Nebulizers and Vaporizers; Quality of Life; Voriconazole | 2015 |
Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for R
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prospective Studies; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult | 2015 |
Randomised, multicentre trial of micafungin vs. an institutional standard regimen for salvage treatment of invasive aspergillosis.
Topics: Administration, Intravenous; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Treatment Outcome; Voriconazole | 2015 |
827 other study(ies) available for voriconazole and amphotericin b
| Article | Year |
|---|---|
New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbial; Fungi; Male; Mice; Molecular Conformation; Quinazolines; Rabbits; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Triazoles | 1998 |
Antifungal flavonoids from Hildegardia barteri.
Topics: Antifungal Agents; Candida; Chromones; Flavonoids; Isoflavones; Malvaceae; Microbial Sensitivity Tests; Molecular Structure; Plants, Medicinal; Tanzania | 2005 |
Synthesis and antifungal activity of (Z)-5-arylidenerhodanines.
Topics: Antifungal Agents; Computer Simulation; Drug Design; Microbial Sensitivity Tests; Microwaves; Mitosporic Fungi; Molecular Structure; Rhodanine; Sensitivity and Specificity; Stereoisomerism; Structure-Activity Relationship; Yeasts | 2007 |
Prevalence and susceptibility testing of new species of pseudallescheria and scedosporium in a collection of clinical mold isolates.
Topics: Antifungal Agents; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Pseudallescheria; Scedosporium | 2007 |
Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2007 |
Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; DNA Primers; Genes, Fungal; Genetic Complementation Test; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Phenotype; Polyenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Fungal; RNA, Messenger; Sterols | 2007 |
In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Quality Control; Zygomycosis | 2007 |
Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia.
Topics: Amphotericin B; Antifungal Agents; Cross Infection; Fluconazole; Fungemia; Humans; Itraconazole; Microbial Sensitivity Tests; Pichia | 2007 |
In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
Topics: Antifungal Agents; Area Under Curve; Candida; Fungemia; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2007 |
A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Mutation; Oxidative Phosphorylation; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2007 |
Synthesis of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase (CYP51).
Topics: Antifungal Agents; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Triazoles | 2007 |
A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genotype; Humans; Microbial Sensitivity Tests; Tandem Repeat Sequences | 2007 |
Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Dose-Response Relationship, Drug; Drug Antagonism; Drug Interactions; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Models, Biological; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Discovery of novel indazole-linked triazoles as antifungal agents.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillus; Candida; Disease Models, Animal; Indazoles; Mice; Microbial Sensitivity Tests; Rats; Stereoisomerism; Triazoles | 2007 |
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Sporothrix; Sporotrichosis; Triazoles; Voriconazole | 2007 |
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Combined therapies in a murine model of blastoschizomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Flucytosine; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Trichosporon; Voriconazole | 2007 |
New guinea pig model of Cryptococcal meningitis.
Topics: Animals; Antifungal Agents; Cerebrospinal Fluid; Colony Count, Microbial; Cryptococcus neoformans; Disease Models, Animal; Fluconazole; Guinea Pigs; Humans; Male; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole | 2007 |
Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Colony Count, Microbial; Colorimetry; Culture Media; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Regression Analysis; Reproducibility of Results; Species Specificity; Spores, Fungal; Tetrazolium Salts; Triazoles; Vitamin K 3; Voriconazole | 2007 |
Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy.
Topics: Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Colletotrichum; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fungi; Fungicides, Industrial; Humans; In Vitro Techniques; Lipopeptides; Microbial Sensitivity Tests; Microscopy, Fluorescence; Nystatin; Plant Diseases; Skin; Triazoles | 2007 |
The Ssk1p response regulator and Chk1p histidine kinase mutants of Candida albicans are hypersensitive to fluconazole and voriconazole.
Topics: Antifungal Agents; Candida albicans; Culture Media; Drug Resistance, Fungal; Fluconazole; Histidine Kinase; Microbial Sensitivity Tests; Mutation; Phenotype; Phosphorylation; Protein Kinases; Pyrimidines; Signal Transduction; Triazoles; Voriconazole | 2007 |
Voriconazole inhibits melanization in Cryptococcus neoformans.
Topics: Animals; Antifungal Agents; Cell Line; Cryptococcus neoformans; Fluconazole; Gene Expression Regulation, Fungal; Laccase; Macrophages; Melanins; Mice; Microbial Sensitivity Tests; Phagocytosis; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2007 |
Antifungal and cytotoxic activities of some N-substituted aniline derivatives bearing a hetaryl fragment.
Topics: Aniline Compounds; Antifungal Agents; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Imines; Microbial Sensitivity Tests; Molecular Structure; National Cancer Institute (U.S.); United States | 2008 |
In vitro antifungal susceptibilities of five species of sporothrix.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis | 2008 |
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Aspergillosis; Aspergillus; Candida; Candidiasis; Catheterization, Central Venous; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fungemia; Fungi; Humans; Microbial Sensitivity Tests | 2008 |
Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Culture Media; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Reproducibility of Results; Yeasts | 2008 |
Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification.
Topics: Antifungal Agents; Aspergillus fumigatus; Fungal Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Nuclear Proteins; Phylogeny; Polymerase Chain Reaction; Sequence Analysis, DNA; Tubulin | 2008 |
In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.
Topics: Antifungal Agents; Azoles; Cryptococcosis; Cryptococcus neoformans; Cuba; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2008 |
Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Clinical Trials as Topic; Female; Health Surveys; Humans; Infant; Male; Middle Aged; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles; Voriconazole | 2008 |
In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzamidines; Candida albicans; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycoses; Specific Pathogen-Free Organisms; Treatment Outcome | 2008 |
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity | 2008 |
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.
Topics: Aged; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fungal Proteins; Fungemia; Glucosyltransferases; Humans; Lipopeptides; Membrane Proteins; Microbial Sensitivity Tests; Mutation | 2008 |
In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Fusarium; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Triazoles; Tubulin | 2008 |
In vitro activity of anidulafungin against Candida albicans biofilms.
Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests | 2008 |
Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy.
Topics: Antifungal Agents; Base Sequence; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Fusarium; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Species Specificity | 2008 |
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.
Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents.
Topics: Antifungal Agents; Candida albicans; Fluconazole; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole; Yeasts | 2008 |
Susceptibility testing and molecular classification of Paecilomyces spp.
Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; Echinocandins; Itraconazole; Microbial Sensitivity Tests; Paecilomyces; Phylogeny | 2008 |
CYP56 (Dit2p) in Candida albicans: characterization and investigation of its role in growth and antifungal drug susceptibility.
Topics: Base Sequence; Candida albicans; Cell Wall; Cytochrome P-450 Enzyme System; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Gene Deletion; Gene Expression; Genes, Fungal; Mutation; Phenotype; Recombinant Proteins; Tyrosine | 2008 |
Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Europe; Fungi; Guidelines as Topic; Humans; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Triazoles; Yeasts | 2008 |
A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata.
Topics: Antifungal Agents; Azoles; Base Sequence; Candida glabrata; Candidiasis; Codon, Nonsense; DNA, Fungal; Drug Resistance, Fungal; Ergosterol; Genes, Fungal; Guanine; Humans; Molecular Sequence Data; Polyenes | 2008 |
Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biofilms; Bronchi; Cells, Cultured; Cystic Fibrosis; Drug Resistance, Fungal; Epithelial Cells; Humans; Microbial Sensitivity Tests; Microscopy, Confocal; Microscopy, Electron, Scanning; Respiratory Tract Infections | 2008 |
Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans.
Topics: Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Fluconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Serotyping; Triazoles; Voriconazole | 2009 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae | 2009 |
In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; DNA, Fungal; Humans; Microbial Sensitivity Tests; Soil Microbiology | 2009 |
Design, synthesis, and biological evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Enzyme Inhibitors; Protein Binding; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2009 |
Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Humans; Immunohistochemistry; Injections, Intraperitoneal; Lipopeptides; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2009 |
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.
Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies | 2009 |
Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers.
Topics: Amphotericin B; Antifungal Agents; DNA, Ribosomal Spacer; Microbial Sensitivity Tests; Mucorales; Triazoles | 2009 |
Interactions between triazoles and amphotericin B in treatment of disseminated murine infection by Fusarium oxysporum.
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy, Combination; Fusarium; Male; Mice; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain | 2009 |
Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols.
Topics: Antifungal Agents; Catalytic Domain; Chemistry, Pharmaceutical; Computer Simulation; Crystallography, X-Ray; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Models, Chemical; Propanols; Protein Binding; Triazoles | 2009 |
Avian Aspergillus fumigatus strains resistant to both itraconazole and voriconazole.
Topics: Amphotericin B; Animals; Animals, Domestic; Animals, Wild; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bird Diseases; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
Inhaled voriconazole for prevention of invasive pulmonary aspergillosis.
Topics: Administration, Inhalation; Amphotericin B; Animals; Antifungal Agents; Invasive Pulmonary Aspergillosis; Mice; Mice, Inbred ICR; Pyrimidines; Triazoles; Voriconazole | 2009 |
Hypersusceptibility to azole antifungals in a clinical isolate of Candida glabrata with reduced aerobic growth.
Topics: Adult; Aerobiosis; Antifungal Agents; Azoles; Candida glabrata; Chromatography, High Pressure Liquid; Ergosterol; Female; Flow Cytometry; Genes, Fungal; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Molecular Sequence Data; Polyenes | 2009 |
Efficacy of triazoles in a murine disseminated infection by Candida krusei.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Kidney; Male; Mice; Pyrimidines; Random Allocation; Triazoles; Voriconazole | 2009 |
Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri.
Topics: Antifungal Agents; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny | 2009 |
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.
Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia | 2009 |
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Kidney; Male; Mice; Mucormycosis; Rhizopus; Triazoles | 2009 |
Assessment of the in vitro kinetic activity of caspofungin against Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida glabrata; Caspofungin; Drug Combinations; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fluconazole; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2010 |
In vitro activity of thimerosal against ocular pathogenic fungi.
Topics: Alternaria; Amphotericin B; Antifungal Agents; Aspergillus; Eye Infections, Fungal; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Natamycin; Thimerosal | 2010 |
Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene.
Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disease Models, Animal; Drug Administration Schedule; Female; Fungal Proteins; Mice; Microbial Sensitivity Tests; Mutation; Triazoles | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient.
Topics: Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Caspofungin; Child; Drug Resistance, Fungal; Echinocandins; Female; Flucytosine; Fungal Proteins; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Microbial Sensitivity Tests; Point Mutation | 2010 |
In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2010 |
Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata.
Topics: Animals; Antifungal Agents; Base Sequence; Calcineurin; Candida glabrata; Candidiasis; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Female; Fungal Proteins; Genes, Fungal; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation; Opportunistic Infections; Transcription Factors; Virulence | 2010 |
Antifungal susceptibility profile of human-pathogenic species of Lichtheimia.
Topics: Amphotericin B; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mucorales; Pyrimidines; Triazoles; Voriconazole | 2010 |
In vitro antifungal activities of bis(alkylpyridinium)alkane compounds against pathogenic yeasts and molds.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyridinium Compounds; Yeasts | 2010 |
A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Drug Resistance, Fungal; Fungal Proteins; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction | 2010 |
Experimental murine scedosporiosis: histopathology and azole treatment.
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Brain; Kidney; Mice; Mycetoma; Pyrimidines; Scedosporium; Spleen; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Synthesis and antifungal evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Fungi; Humans; Models, Molecular; Mycoses; Sterol 14-Demethylase; Triazoles | 2010 |
Identification and characterization of four azole-resistant erg3 mutants of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Drug Resistance, Fungal; Ergosterol; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; Pyrimidines; Triazoles; Voriconazole | 2010 |
In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella.
Topics: Amphotericin B; Animals; Antifungal Agents; Caspofungin; Cunninghamella; Diabetes Mellitus, Experimental; Echinocandins; Itraconazole; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2010 |
Design, synthesis and antifungal evaluation of 1-(2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)-1H-1,2,4-triazol-5(4H)-one.
Topics: Antifungal Agents; Candida albicans; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2011 |
Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives.
Topics: Antifungal Agents; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Piperazines; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles; Voriconazole | 2011 |
Synthesis and in vitro antimicrobial activities of new (cyano-NNO-azoxy)pyrazole derivatives.
Topics: Anti-Infective Agents; Antifungal Agents; Azo Compounds; Candida; Microbial Sensitivity Tests; Molecular Structure; Nitriles; Pyrazoles; Staphylococcus aureus | 2011 |
Synthesis, in vitro evaluation and molecular docking studies of new triazole derivatives as antifungal agents.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Binding Sites; Catalytic Domain; Computer Simulation; Hydrogen Bonding; Microbial Sensitivity Tests; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2011 |
New triazole derivatives as antifungal agents: synthesis via click reaction, in vitro evaluation and molecular docking studies.
Topics: Antifungal Agents; Catalysis; Catalytic Domain; Click Chemistry; Computer Simulation; Copper; Fungi; Humans; Microbial Sensitivity Tests; Triazoles | 2012 |
Synthesis and biological evaluation of vinyl ether-containing azole derivatives as inhibitors of Trichophyton rubrum.
Topics: Antifungal Agents; Azoles; Molecular Structure; Structure-Activity Relationship; Trichophyton; Vinyl Compounds | 2012 |
Synthesis and anti-Candida activity of novel 2-hydrazino-1,3-thiazole derivatives.
Topics: Animals; Antifungal Agents; Candida; Candida albicans; Cell Survival; Drug Resistance, Fungal; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Structure-Activity Relationship; Thiazoles | 2013 |
Design, synthesis, and structure-activity relationship studies of novel fused heterocycles-linked triazoles with good activity and water solubility.
Topics: Animals; Antifungal Agents; Area Under Curve; Candida; Drug Design; Drug Evaluation, Preclinical; Half-Life; Heterocyclic Compounds; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Molecular Docking Simulation; Rats; Solubility; Structure-Activity Relationship; Triazoles; Water | 2014 |
Novel Macrocyclic Amidinoureas: Potent Non-Azole Antifungals Active against Wild-Type and Resistant Candida Species.
Topics: | 2013 |
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
Topics: Antifungal Agents; Benzimidazoles; Carbon-13 Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Proton Magnetic Resonance Spectroscopy; Reactive Oxygen Species; Yeasts | 2016 |
Novel alkylated azoles as potent antifungals.
Topics: Alkylation; Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Cell Line; Ergosterol; Fungi; Hemolysis; Humans; Mice; Microbial Sensitivity Tests; Mycoses | 2017 |
Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity.
Topics: Animals; Drug Design; Enzyme Inhibitors; ERG1 Potassium Channel; HEK293 Cells; Hep G2 Cells; Humans; Inhibitory Concentration 50; Methicillin-Resistant Staphylococcus aureus; Mice; Oxidoreductases; Rats; Safety; Solubility; Structure-Activity Relationship; Water | 2018 |
Alkylated Piperazines and Piperazine-Azole Hybrids as Antifungal Agents.
Topics: 14-alpha Demethylase Inhibitors; Alkylation; Animals; Antifungal Agents; Aspergillus; Azoles; Candida albicans; Cell Line; Hemolysis; Humans; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Piperazines; Protein Conformation; Sterol 14-Demethylase | 2018 |
Novel fluconazole derivatives with promising antifungal activity.
Topics: Animals; Antifungal Agents; Candida; Cell Line; Cell Survival; Drug Design; Erythrocytes; Fluconazole; Fungi; Hemolysis; Mice; Microbial Sensitivity Tests; Structure-Activity Relationship; Voriconazole | 2018 |
Discovery of novel simplified isoxazole derivatives of sampangine as potent anti-cryptococcal agents.
Topics: Alkaloids; Antifungal Agents; Apoptosis; Biofilms; Cryptococcus neoformans; Drug Discovery; G1 Phase Cell Cycle Checkpoints; Heterocyclic Compounds, 4 or More Rings; Isoxazoles; Melanins; Microbial Sensitivity Tests; Molecular Structure; Naphthyridines; Structure-Activity Relationship; Urease | 2019 |
New azole antifungals with a fused triazinone scaffold.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Mice; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazines | 2020 |
Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Itraconazole; Lung; Male; Pyrimidines; Rats; Rats, Sprague-Dawley; Triazoles; Voriconazole | 1997 |
In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.
Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Culture Media; Fluconazole; Fungi; Griseofulvin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts | 1997 |
In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus nidulans; Child, Preschool; Granulomatous Disease, Chronic; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 1998 |
In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Triazoles; Voriconazole | 1998 |
In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; Genotype; HIV Infections; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth; North America; Pharynx; Phenotype; Pyrimidines; Triazoles; Voriconazole | 1998 |
In vitro activity of voriconazole against selected fungi.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Basidiomycota; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Environmental Microbiology; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 1998 |
Organism-dependent fungicidal activities of azoles.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Dose-Response Relationship, Drug; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
[Rare pulmonary mycoses in patients with hematologic diseases].
Topics: Acremonium; Adolescent; Adult; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Bone Marrow Transplantation; Female; Hematologic Neoplasms; Humans; Imidazoles; Leukemia, Myeloid, Acute; Lung; Lung Diseases, Fungal; Male; Middle Aged; Multiple Myeloma; Neutropenia; Penicillium; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudallescheria; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 1998 |
Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Itraconazole; Kinetics; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 1999 |
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1999 |
In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Drug Resistance, Microbial; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1999 |
In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1998 |
Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management.
Topics: Aged; Amphotericin B; Antibodies, Fungal; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; DNA, Fungal; Drug Resistance, Microbial; Female; Galactose; Humans; Mannans; Meningitis, Fungal; Mycology; Polymerase Chain Reaction; Pyrimidines; Time Factors; Triazoles; Voriconazole | 1999 |
Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Disease Models, Animal; Drug Resistance, Microbial; Fluconazole; Guinea Pigs; Male; Neutropenia; Pyrimidines; Random Allocation; Triazoles; Voriconazole | 1999 |
Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1998 |
In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 1999 |
Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Humans; Hydrogen-Ion Concentration; Itraconazole; Male; Meningitis, Fungal; Microbial Sensitivity Tests; Osmolar Concentration; Phenotype; Pyrimidines; Staining and Labeling; Temperature; Triazoles; Voriconazole | 1999 |
Optimizing voriconazole susceptibility testing of Candida: effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Glucose; Microbial Sensitivity Tests; Pyrimidines; Spectrophotometry; Time Factors; Triazoles; Voriconazole | 1999 |
Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1999 |
Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Fungemia; Guinea Pigs; Humans; Lung Diseases, Fungal; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2000 |
In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.
Topics: Amphotericin B; Antifungal Agents; Blastomyces; Coccidioides; Histoplasma; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2000 |
[Therapy of deep seated mycoses--Timing of administration and selection of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2000 |
A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole | 2000 |
Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Fluocinolone Acetonide; Glucocorticoids; Guinea Pigs; Immunocompromised Host; Immunosuppressive Agents; Male; Organ Culture Techniques; Pyrimidines; Triazoles; Voriconazole | 2000 |
Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Reference Standards; Time Factors; Triazoles; Trichosporon; Turkey; Voriconazole | 2000 |
Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Child, Preschool; Combined Modality Therapy; Drug Resistance, Microbial; Flucytosine; Granulocyte Colony-Stimulating Factor; Granulocytes; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Leukocyte Transfusion; Lung Diseases, Fungal; Male; Neutrophils; Osteomyelitis; Pyrimidines; Respiratory Burst; Ribs; Triazoles; Voriconazole | 2000 |
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2001 |
Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Drug Synergism; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2001 |
[Invasive aspergillosis on a surgical intensive care unit].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Therapy, Combination; Fatal Outcome; Female; Flucytosine; Humans; Intensive Care Units; Itraconazole; Male; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2000 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole | 2000 |
Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Microbial; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2001 |
Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Sporothrix; Sporotrichosis; Triazoles; Voriconazole | 2001 |
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole | 2001 |
Sputum isolation of Wangiella dermatitidis in patients with cystic fibrosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cystic Fibrosis; Exophiala; Female; Hemoptysis; Humans; Lung Diseases, Fungal; Magnetic Resonance Imaging; Pyrimidines; Sputum; Triazoles; Voriconazole | 2001 |
In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2001 |
Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2001 |
Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2002 |
Empirical antifungal therapy--new options, new tradeoffs.
Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever.
Topics: Amphotericin B; Antifungal Agents; Data Interpretation, Statistical; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Research Design; Treatment Outcome; Triazoles; Voriconazole | 2002 |
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Canada; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Quality Control; Thiazoles; Triazoles; United States; Voriconazole | 2002 |
Decisions about voriconazole versus liposomal amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Clinical Protocols; Data Interpretation, Statistical; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Research Design; Triazoles; Voriconazole | 2002 |
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fever; Humans; Neutropenia; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2002 |
Effect of medium composition on static and cidal activity of amphotericin B, itraconazole, voriconazole, posaconazole and terbinafine against Aspergillus fumigatus: a multicenter study.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Culture Media; France; Humans; Itraconazole; Laboratories; Microbial Sensitivity Tests; Naphthalenes; Observer Variation; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2002 |
Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Guinea Pigs; Lipopeptides; Male; Organ Culture Techniques; Peptides; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2002 |
Voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fusarium; Humans; Injections, Intravenous; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2002 |
New drugs, old drugs - dear drugs, cheap drugs.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bone Marrow Transplantation; Caspofungin; Cyclosporine; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Renal Insufficiency; Triazoles; Voriconazole | 2002 |
Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection.
Topics: Amphotericin B; Antifungal Agents; Area Under Curve; Candidiasis; Catheterization; Fluconazole; Half-Life; Microbial Sensitivity Tests; Microscopy, Electron; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Deoxycholic Acid; Drug Combinations; Drug Resistance, Fungal; Etoposide; Fatal Outcome; Humans; Immunocompromised Host; Itraconazole; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelomonocytic, Acute; Liposomes; Lung Diseases, Fungal; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole | 2002 |
Voriconazole versus amphotericin B for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Patient Dropouts; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole versus amphotericin B for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Liposomes; Pyrimidines; Triazoles; Voriconazole | 2002 |
Evaluation of Etest method for determining voriconazole and amphotericin B MICs for 162 clinical isolates of Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Humans; Microbial Sensitivity Tests; Microbiological Techniques; Pyrimidines; Triazoles; Voriconazole | 2003 |
In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.
Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2003 |
Successful treatment of disseminated fusariosis.
Topics: Amphotericin B; Child, Preschool; Female; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2003 |
Effect of increasing inoculum sizes of Aspergillus hyphae on MICs and MFCs of antifungal agents by broth microdilution method.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Humans; In Vitro Techniques; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2003 |
Comment: caspofungin acetate for treatment of invasive fungal infections.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Guinea Pigs; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2003 |
Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.
Topics: Aged; Amphotericin B; Antifungal Agents; Fusarium; Humans; Immunocompromised Host; Male; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Three drug reviews: one reformulated and one new antifungal agent and optimal dosing of the anticonvulsant gabapentin.
Topics: Acetates; Amines; Amphotericin B; Anticonvulsants; Antifungal Agents; Chemistry, Pharmaceutical; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Gabapentin; gamma-Aminobutyric Acid; Humans; Pyrimidines; Triazoles; Voriconazole | 2003 |
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.
Topics: Amphotericin B; Anti-Bacterial Agents; Aspergillus; Caspofungin; Echinocandins; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Penicillium; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2003 |
Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia.
Topics: Acute Disease; Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Female; Hepatitis; Humans; Leukemia; Lung Diseases, Fungal; Opportunistic Infections; Osteomyelitis; Pyrimidines; Remission Induction; Sacroiliac Joint; Splenic Diseases; Triazoles; Voriconazole | 2003 |
Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience.
Topics: Adolescent; Amphotericin B; Anemia, Aplastic; Anemia, Refractory; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Bone Marrow Transplantation; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Neoplasms; Humans; Leukemia, Myelomonocytic, Acute; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2003 |
In vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Spain; Triazoles; Voriconazole | 2003 |
Successful outcome of disseminated Fusarium infection with skin localization treated with voriconazole and amphotericin B-lipid complex in a patient with acute leukemia.
Topics: Adult; Amphotericin B; Antifungal Agents; Burkitt Lymphoma; Dermatomycoses; Drug Therapy, Combination; Female; Fusarium; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Flow cytometry antifungal susceptibility testing of Aspergillus fumigatus and comparison of mode of action of voriconazole vis-à-vis amphotericin B and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Flow Cytometry; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2003 |
Successful treatment of Acremonium fungemia with voriconazole.
Topics: Acremonium; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Female; Fungemia; Humans; Lymphoma, Mantle-Cell; Middle Aged; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2003 |
Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Neutropenia; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
In vitro activity of ravuconazole against Zygomycetes, Scedosporium and Fusarium isolates.
Topics: Amphotericin B; Antifungal Agents; Fungi; Fusarium; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Thiazoles; Triazoles; Voriconazole | 2003 |
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Invasive aspergillosis: current and future challenges in diagnosis and therapy.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2004 |
In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Resistance, Fungal; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Quinazolines; Sensitivity and Specificity; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2004 |
Successful treatment of invasive aspergillosis with oral voriconazole following intravenous liposomal amphotericin in a child with acute lymphoblastic leukemia.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Humans; Infusions, Intravenous; Liposomes; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant.
Topics: Adolescent; Amphotericin B; Bone Marrow Transplantation; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Humans; Leukemia; Lipopeptides; Liposomes; Male; Peptides; Peptides, Cyclic; Pneumonia; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2004 |
Voriconazole for the treatment of disseminated nodular cutaneous aspergillosis in a patient affected by acute myeloid leukemia.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Dermatomycoses; Female; Humans; Leukemia, Myeloid, Acute; Pyrimidines; Triazoles; Voriconazole | 2004 |
Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lipopeptides; Lung; Middle Aged; Peptides, Cyclic; Pyrimidines; Tomography, X-Ray Computed; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2004 |
In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Fungi; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Spain; Terbinafine; Triazoles; Voriconazole | 2004 |
In vitro activity of anidulafungin against selected clinically important mold isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Echinocandins; Fungi; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Resolution of orbitocerebral aspergillosis during combination treatment with voriconazole and amphotericin plus adjunctive cytokine therapy.
Topics: Amphotericin B; Antifungal Agents; Blindness; Brain Diseases; Child, Preschool; Cytokines; Drug Therapy, Combination; Female; Humans; Neuroaspergillosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2004 |
In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia.
Topics: Africa; Amphotericin B; Antifungal Agents; Cambodia; Cryptococcosis; Cryptococcus neoformans; Developing Countries; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Pyrimidines; Risk Assessment; Sampling Studies; Triazoles; Voriconazole | 2004 |
Effects of voriconazole on Cryptococcus neoformans.
Topics: Amphotericin B; Animals; Antibodies, Monoclonal; Antifungal Agents; Cell Line; Cryptococcus neoformans; Levodopa; Melanins; Mice; Microbial Sensitivity Tests; Microscopy, Electron; Phagocytosis; Polysaccharides; Pyrimidines; Triazoles; Voriconazole | 2004 |
Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Child; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Geotrichosis; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Liposomes; Male; Mycoses; Myelodysplastic Syndromes; Peptides; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole | 2004 |
In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2004 |
Successful elimination of an invasive Aspergillus nidulans lung infection by voriconazole after failure of a combination of caspofungin and liposomal amphotericin B in a boy with chronic granulomatous disease.
Topics: Adolescent; Amphotericin B; Aspergillosis; Aspergillus nidulans; Caspofungin; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Granulomatous Disease, Chronic; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Risk Assessment; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Alternatives to amphotericin B for Candida rugosa infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Colony Count, Microbial; Fluconazole; Kidney; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Organ Size; Pyrimidines; Spleen; Survival Analysis; Triazoles; Voriconazole | 2004 |
Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Serotyping; Taiwan; Triazoles; Voriconazole | 2004 |
Pfizer's Vfend as effective in treating candidemia as two-drug standard of care according to study.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Pyrimidines; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Penetration of Candida biofilms by antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Colony Count, Microbial; Culture Media; Diffusion; Fluconazole; Flucytosine; Microscopy, Electron, Scanning; Mutation; Pyrimidines; Staphylococcus epidermidis; Triazoles; Voriconazole | 2004 |
In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Drug Combinations; Drug Synergism; Flucytosine; Kinetics; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2004 |
Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Base Sequence; Bronchoalveolar Lavage Fluid; DNA Primers; DNA, Fungal; Humans; Leukemia; Middle Aged; Neoplasms; Polymerase Chain Reaction; Pyrimidines; Transplantation; Triazoles; Voriconazole | 2004 |
Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis, Allergic Bronchopulmonary; Caspofungin; Echinocandins; Fatal Outcome; Female; Humans; Kidney Transplantation; Lipopeptides; Lymphoma, Non-Hodgkin; Middle Aged; Mucormycosis; Peptides, Cyclic; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2004 |
Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Guinea Pigs; Lipopeptides; Lipoproteins; Lung; Lung Diseases, Fungal; Micafungin; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2004 |
Successful treatment of brain aspergillosis with voriconazole.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Brain Diseases; Critical Care; Female; Humans; Immunocompromised Host; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2004 |
Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Liposomes; Mycoses; Neoplasms; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Post-antifungal effect of amphotericin B and voriconazole against Aspergillus fumigatus analysed by an automated method based on fungal CO2 production: dependence on exposure time and drug concentration.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Carbon Dioxide; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2004 |
In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Fluconazole; Hematologic Neoplasms; Humans; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Models, Biological; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Determination of antifungal drug susceptibilities of Aspergillus species by a fluorescence-based microplate assay.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Fluoresceins; Fluorescence; Fluorescent Dyes; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2005 |
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Calcineurin Inhibitors; Caspofungin; Cyclosporine; Echinocandins; Humans; Immunosuppressive Agents; Lipopeptides; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2004 |
In vitro testing of Aspergillus fumigatus clinical isolates for susceptibility to voriconazole, amphotericin B and itraconazole: comparison of sensititre versus NCCLS M38-A using two different inocula.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Itraconazole; Microbial Sensitivity Tests; Predictive Value of Tests; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole | 2004 |
Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Female; Humans; Itraconazole; Male; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Transplantation; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Heart Transplantation; Humans; Lung Diseases, Fungal; Middle Aged; Myocardial Ischemia; Postoperative Complications; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2005 |
Caspofungin versus liposomal amphotericin B for empirical therapy.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Infusions, Intravenous; Lipopeptides; Liposomes; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Caspofungin versus liposomal amphotericin B for empirical therapy.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Survival Rate; Triazoles; Voriconazole | 2005 |
[Voriconazol and liposomal amphotericin B: true evidence of their differences with regard to effectiveness and safety].
Topics: Amphotericin B; Antifungal Agents; Humans; Liposomes; Meta-Analysis as Topic; Pyrimidines; Triazoles; Voriconazole | 2005 |
[In vitro activity of amphotericin B, itraconazole and voriconazole against 20 species of Aspergillus using the Sensititre microdilution method].
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2005 |
Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cost Savings; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Health Care Costs; Humans; Immunocompromised Host; Pyrimidines; Triazoles; Voriconazole | 2005 |
In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Colorimetry; Fluorescence; Fusarium; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Species Specificity; Triazoles; Voriconazole | 2005 |
Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Cerebral aspergillosis in the critically ill: two cases of successful medical treatment.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Intensive Care Units; Lipopeptides; Male; Middle Aged; Neuroaspergillosis; Peptides, Cyclic; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2005 |
In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2005 |
In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida glabrata; Candida tropicalis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Pichia; Pyrimidines; Saccharomyces cerevisiae; Species Specificity; Triazoles; Voriconazole | 2005 |
A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Dose-Response Relationship, Drug; Hyphae; Pyrimidines; Triazoles; Voriconazole | 2005 |
Combination antifungal therapy for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Economic effects of aspergillosis management in high-risk patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cost-Benefit Analysis; Hospitalization; Humans; Insurance, Health, Reimbursement; Pyrimidines; Triazoles; United States; Voriconazole | 2005 |
Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Fungemia; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Trichosporon; Voriconazole | 2005 |
Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Cornea; Corneal Transplantation; Fusarium; Humans; Itraconazole; Keratitis; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2005 |
In vitro activities of amphotericin B and voriconazole against aleurioconidia from Aspergillus terreus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Humans; Hyphae; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2005 |
Cost advantage of voriconazole over amphotericin B deoxycholate for primary treatment of invasive aspergillosis.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Deoxycholic Acid; Drug Combinations; Economics, Pharmaceutical; Humans; Injections, Intravenous; Multicenter Studies as Topic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2005 |
Intravenous voriconazole therapy in a preterm infant.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Humans; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Disseminated fusarium infection in two neutropenic children].
Topics: Amphotericin B; Antifungal Agents; Child; Drug Combinations; Fatal Outcome; Female; Fusarium; Humans; Immunocompromised Host; Leukemia, Lymphoid; Leukemia, Myeloid; Male; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2005 |
Scedosporium prolificans sclerokeratitis 10 years after pterygium excision with adjunctive mitomycin C.
Topics: Amphotericin B; Antibiotics, Antineoplastic; Antifungal Agents; Chemotherapy, Adjuvant; Drug Therapy, Combination; Eye Infections, Fungal; Humans; Keratitis; Male; Middle Aged; Mitomycin; Mycetoma; Naphthalenes; Postoperative Complications; Pterygium; Pyrimidines; Scedosporium; Scleritis; Terbinafine; Triazoles; Voriconazole | 2005 |
Treatment of disseminated aspergillosis with voriconazole/liposomal amphotericin B in a child with leukemia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Child, Preschool; Humans; Male; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2005 |
In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus; Drug Synergism; Echinocandins; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Invasive pulmonary and cerebral aspergillosis in a patient with Weil's disease.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Brain Diseases; Drug Therapy, Combination; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole; Weil Disease | 2005 |
Lung infection due to opportunistic fungus, Phialemonium obovatum, in a bone marrow transplant recipient: an emerging infection with fungemia and Crohn disease-like involvement of the gastrointestinal tract.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Bone Marrow Transplantation; Drug Resistance, Fungal; Fungemia; Gastrointestinal Diseases; Graft vs Host Disease; Granuloma; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Spain; Treatment Outcome; Triazoles; Voriconazole | 2005 |
DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; DNA Fingerprinting; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Soil Microbiology; Spain; Triazoles; Voriconazole | 2005 |
Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
Topics: Academic Medical Centers; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Israel; Itraconazole; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2005 |
Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Austria; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Genes, Fungal; Hematologic Neoplasms; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Organ Transplantation; Peptides, Cyclic; Prevalence; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Paecilomyces; Pyrimidines; Quality Control; Triazoles; Voriconazole | 2005 |
[Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Mycoses; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
In vitro susceptibility of oral Candida to seven antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mouth Diseases; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2005 |
Economic evaluation of voriconazole in the treatment of invasive aspergillosis in the Netherlands.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cost-Benefit Analysis; Decision Trees; Humans; Markov Chains; Netherlands; Pyrimidines; Triazoles; Voriconazole | 2005 |
Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbits.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Echinocandins; Electroretinography; Endophthalmitis; Eye Infections, Fungal; Follow-Up Studies; Lipopeptides; Lipoproteins; Micafungin; Ophthalmoscopy; Peptides, Cyclic; Pyrimidines; Rabbits; Retina; Triazoles; Vitreous Body; Voriconazole | 2005 |
Successful treatment of aspergillus brain abscess in a child with acute lymphoblastic leukemia and liver failure.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Brain Abscess; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Liver Failure, Acute; Magnetic Resonance Imaging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Remission Induction; Triazoles; Voriconazole | 2005 |
Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis.
Topics: Aged; Amphotericin B; Anemia, Aplastic; Ascomycota; Aspergillosis; Body Fluids; Caspofungin; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Mycoses; Peptides, Cyclic; Pyrimidines; Saccharomycetales; Shock, Septic; Triazoles; Voriconazole | 2005 |
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emerging; Dermatomycoses; Disease Susceptibility; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Sinusitis; Transplantation Conditioning; Triazoles; Viscera; Voriconazole | 2005 |
Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Fungemia; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycoses; Neutropenia; Paecilomyces; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Mediastinal mass due to Aspergillus fumigatus after lung transplantation: a case report.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cystic Fibrosis; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Magnetic Resonance Imaging; Mediastinal Diseases; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Recurrence; Thoracoscopy; Triazoles; Voriconazole | 2005 |
Autologous transplantation of CD133 selected hematopoietic progenitor cells for treatment of relapsed acute lymphoblastic leukemia.
Topics: AC133 Antigen; Amphotericin B; Antifungal Agents; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Caspofungin; Child; Combined Modality Therapy; Contraindications; Dexamethasone; Drug Therapy, Combination; Echinocandins; Glycoproteins; Humans; Immunomagnetic Separation; Lipopeptides; Male; Mercaptopurine; Methotrexate; Peptides; Peptides, Cyclic; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Vincristine; Voriconazole; Zygomycosis | 2007 |
Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Central Nervous System Fungal Infections; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Echinocandins; Lipopeptides; Lipoproteins; Liposomes; Micafungin; Mice; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Comparison between Aspergillus fumigatus conidia and hyphae susceptibilities to amphotericin B, itraconazole, and voriconazole by use of the mold rapid susceptibility assay.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Hyphae; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2005 |
Human albumin promotes germination, hyphal growth and antifungal resistance by Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Drug Resistance, Fungal; Growth Substances; Hyphae; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Serum Albumin; Triazoles; Voriconazole | 2005 |
[Invasive multisystemic aspergillosis in an immunocompetent child: case report].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Deoxycholic Acid; Drug Combinations; Fatal Outcome; Humans; Immunocompromised Host; Male; Pyrimidines; Triazoles; Voriconazole | 2006 |
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts | 2006 |
Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Biomass; Caspofungin; Cryptococcus neoformans; Dose-Response Relationship, Drug; Echinocandins; Enzyme-Linked Immunosorbent Assay; Fluconazole; Formazans; Lipopeptides; Melanins; Microbial Sensitivity Tests; Microscopy, Confocal; Peptides, Cyclic; Plankton; Pyrimidines; Triazoles; Voriconazole | 2006 |
Candidaemia secondary to intravascular catheter colonisation?
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Equipment Contamination; Humans; Pyrimidines; Triazoles; Voriconazole | 2006 |
Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Central Nervous System Fungal Infections; Drug Administration Schedule; Humans; Immunocompetence; Male; Pyrimidines; Recurrence; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Disease Models, Animal; Drug Therapy, Combination; Guinea Pigs; Liposomes; Male; Pyrimidines; Triazoles; Voriconazole | 2006 |
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B.
Topics: Adult; Amphotericin B; Antifungal Agents; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Aspergillus fumigatus tricuspid native valve endocarditis in a non-intravenous drug user.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Endocarditis; Heart Valve Diseases; Humans; Male; Pulmonary Embolism; Pyrimidines; Sepsis; Triazoles; Tricuspid Valve; Voriconazole | 2006 |
Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole | 2006 |
Spondylodiscitis caused by Candida krusei: case report and susceptibility patterns.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Discitis; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Middle Aged; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2006 |
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Guinea Pigs; Humans; Kidney; Liver; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Spleen; Survival Analysis; Triazoles; Trichosporon; Voriconazole | 2006 |
In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Synergism; Echinocandins; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Peptides, Cyclic; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2006 |
Unclear fever 7 weeks after renal transplantation in a 56-year-old patient.
Topics: Abscess; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biopsy, Fine-Needle; Caspofungin; Contraindications; Cyclosporine; Delayed Graft Function; Drug Interactions; Echinocandins; Fever of Unknown Origin; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lipopeptides; Male; Middle Aged; Mycophenolic Acid; Peptides, Cyclic; Postoperative Complications; Prednisone; Pyrimidines; Radionuclide Imaging; Stenotrophomonas maltophilia; Surgical Wound Infection; Thyroiditis; Triazoles; Ultrasonography; Voriconazole | 2006 |
Efficacy of Abelcet alone, or in combination therapy, against experimental central nervous system aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Central Nervous System Infections; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Kidney; Mice; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2006 |
Successful use of combination antifungal therapy in the treatment of coccidioides meningitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Coccidioides; Coccidioidomycosis; Diagnosis, Differential; Drug Therapy, Combination; Humans; Male; Meningitis, Fungal; Pyrimidines; Triazoles; Voriconazole | 2006 |
Amphotericin B is still the drug of choice for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Lung Diseases, Fungal; Pyrimidines; Research Design; Triazoles; Voriconazole | 2006 |
Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Bone Marrow Transplantation; Cefepime; Cephalosporins; Combined Modality Therapy; Cunninghamella; Daunorubicin; Drug Resistance, Multiple, Fungal; Female; Humans; Imatinib Mesylate; Immunocompromised Host; Lung Diseases, Fungal; Middle Aged; Neutropenia; Piperazines; Pneumonectomy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Transplantation Conditioning; Triazoles; Vancomycin; Vincristine; Voriconazole; Zygomycosis | 2006 |
Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.
Topics: Administration, Cutaneous; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillosis; Aspergillus flavus; Bone Marrow Transplantation; Combined Modality Therapy; Debridement; Dermatomycoses; Disease Susceptibility; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Injections, Subcutaneous; Nystatin; Postoperative Complications; Pyrimidines; Skin; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
[Clinical cases in medical mycology. Case no. 21].
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Endophthalmitis; Exophiala; Female; Fungemia; Humans; Itraconazole; Middle Aged; Mycoses; Opportunistic Infections; Osteolysis; Pregnancy; Pregnancy Complications, Infectious; Pyrimidines; Recurrence; Th2 Cells; Triazoles; Voriconazole | 2006 |
Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dermatomycoses; Drug Resistance, Fungal; Female; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Pyrimidines; Triazoles; Voriconazole | 2006 |
Application of fluorescent probes to study structural changes in Aspergillus fumigatus exposed to amphotericin B, itraconazole, and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Benzenesulfonates; Fluorescent Dyes; Itraconazole; Microbial Sensitivity Tests; Microscopy, Fluorescence; Propidium; Pyrimidines; Triazoles; Voriconazole | 2006 |
Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman.
Topics: Adult; Amphotericin B; Antifungal Agents; Arthritis; Aspergillus fumigatus; Brain; Brain Abscess; Caspofungin; Chromatography, Liquid; Echinocandins; Female; Humans; Lipopeptides; Magnetic Resonance Imaging; Mass Spectrometry; Neuroaspergillosis; Paranasal Sinus Diseases; Peptides, Cyclic; Pyrimidines; Staphylococcus aureus; Triazoles; Voriconazole | 2006 |
Disseminated invasive aspergillosis in a patient with acute leukaemia.
Topics: Acute Kidney Injury; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bacteremia; Caspofungin; Chlamydophila Infections; Chlamydophila pneumoniae; Doxorubicin; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Lipopeptides; Liposomes; Lung Diseases, Fungal; Medical Futility; Methotrexate; Middle Aged; Neuroaspergillosis; Peptides, Cyclic; Pneumonia, Bacterial; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Streptococcal Infections; Triazoles; Vincristine; Voriconazole | 2006 |
AmBisome treatment of fungal sinusitis in severe immunocompromised patient with acute lymphoblastic leukemia relapsed after autologous peripheral blood transplantation.
Topics: Adult; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Combined Modality Therapy; Cytarabine; Cytomegalovirus Infections; Enterococcus faecalis; Fatal Outcome; Humans; Idarubicin; Immunocompromised Host; Immunoglobulins, Intravenous; Liposomes; Male; Mycoses; Peripheral Blood Stem Cell Transplantation; Pneumonia; Postoperative Complications; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pseudomonas putida; Pulmonary Edema; Pyrimidines; Sinusitis; Staphylococcus epidermidis; Transplantation, Autologous; Triazoles; Voriconazole | 2006 |
A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B.
Topics: Abscess; Amphotericin B; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Cytarabine; Foot Dermatoses; Fusarium; Humans; Imatinib Mesylate; Immunocompromised Host; Liposomes; Male; Middle Aged; Muscular Diseases; Onychomycosis; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Reoperation; Rituximab; Teniposide; Triazoles; Voriconazole | 2006 |
Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole.
Topics: Air Sacs; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Bird Diseases; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Falconiformes; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Antifungal effects on metabolite profiles of medically important yeast species measured by nuclear magnetic resonance spectroscopy.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Caspofungin; Echinocandins; Indicator Dilution Techniques; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2006 |
In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp.
Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Azoles; Chlorhexidine; Communicable Diseases, Emerging; Drug Synergism; Fluconazole; Guanidines; Humans; Microbial Sensitivity Tests; Mycoses; Polymers; Pyrimidines; Triazoles; Trichoderma; Voriconazole | 2006 |
Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Male; Middle Aged; Panophthalmitis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
[Keratomycosis due to Cylindrocarpon lichenicola].
Topics: Aged; Amphotericin B; Antifungal Agents; Clematis; Eye Infections, Fungal; Fusarium; Humans; Hypocreales; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Injections; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Visual Acuity; Vitreous Body; Voriconazole | 2006 |
Multi-azole resistance in Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Itraconazole; Lipopeptides; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2006 |
Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Drug Antagonism; Drug Combinations; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Invasive aspergillosis: is treatment with "inexpensive" amphotericin B cost saving if "expensive" voriconazole is only used on demand?
Topics: Acute Kidney Injury; Amphotericin B; Antifungal Agents; Aspergillosis; Cost-Benefit Analysis; Decision Trees; Humans; Models, Economic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Effect of antifungal treatment in a murine model of blastoschizomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Geotrichosis; Geotrichum; Immunocompromised Host; Immunosuppressive Agents; Kidney; Liver; Male; Mice; Microbial Sensitivity Tests; Pyrimidines; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole | 2007 |
Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.
Topics: Air Microbiology; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Cross Infection; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole; Water Microbiology | 2007 |
Unexplained increase in Paecilomyces variotii blood culture isolates in the UK.
Topics: Amphotericin B; Antifungal Agents; Blood; Caspofungin; Diagnosis, Differential; Echinocandins; Equipment Contamination; False Positive Reactions; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Paecilomyces; Peptides, Cyclic; Pyrimidines; Species Specificity; Triazoles; United Kingdom; Voriconazole | 2006 |
Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, cas
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; Triazoles; Voriconazole | 2007 |
Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy.
Topics: Adolescent; Adult; Aged; Amphotericin B; Child; Child, Preschool; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2007 |
A case of successful treatment of cutaneous Acanthamoeba infection in a lung transplant recipient.
Topics: Acanthamoeba; Acute Disease; Amebiasis; Amphotericin B; Animals; Antiprotozoal Agents; Chemistry, Pharmaceutical; Female; Humans; Injections, Intravenous; Lipids; Lung Transplantation; Middle Aged; Postoperative Complications; Pyrimidines; Skin Diseases, Parasitic; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Invasive cutaneous infection with Geotrichum candidum: sequential treatment with amphotericin B and voriconazole.
Topics: Aged, 80 and over; Amphotericin B; Antifungal Agents; Diabetes Mellitus; Geotrichosis; Geotrichum; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2007 |
Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Hospitals; Humans; Intensive Care Units; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2007 |
Pharmacoeconomic analysis of liposomal amphotericin B versus voriconazole for empirical treatment of febrile neutropenia.
Topics: Amphotericin B; Antifungal Agents; Decision Support Techniques; Economics, Pharmaceutical; Fever; Health Care Costs; Humans; Liposomes; Neutropenia; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2007 |
The effects of caspofungin and voriconazole in experimental Candida endophthalmitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Cornea; Disease Models, Animal; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Itraconazole; Lipopeptides; Peptides, Cyclic; Pyrimidines; Rabbits; Triazoles; Voriconazole | 2007 |
A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Colony Count, Microbial; Half-Life; Microbial Sensitivity Tests; Microbial Viability; Models, Biological; Pyrimidines; Triazoles; Voriconazole | 2007 |
Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dermatomycoses; Echinocandins; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Culture Media; Disk Diffusion Antimicrobial Tests; Echinocandins; Fungi; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2007 |
Acquired resistance to echinocandins in Candida albicans: case report and review.
Topics: Adult; Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Genotype; HIV Infections; HIV-1; Humans; Lipopeptides; Lipoproteins; Male; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Peptides, Cyclic; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2007 |
Successful treatment and limb salvage of mucor necrotizing fasciitis after kidney transplantation with posaconazole.
Topics: Alcaligenes; Amphotericin B; Amputation, Surgical; Antifungal Agents; Cefazolin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Resistance, Multiple, Fungal; Escherichia coli Infections; Fatal Outcome; Fluconazole; Gangrene; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg; Leg Ulcer; Male; Middle Aged; Mucor; Mucormycosis; Penicillanic Acid; Phosphatidylcholines; Phosphatidylglycerols; Piperacillin; Postoperative Complications; Pyrimidines; Renal Dialysis; Reoperation; Sepsis; Skin Transplantation; Tazobactam; Triazoles; Voriconazole | 2007 |
Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Female; Fusarium; Humans; Lipopeptides; Mycoses; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Cost-Benefit Analysis; Costs and Cost Analysis; Data Interpretation, Statistical; Decision Trees; Drug Combinations; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Models, Economic; Models, Statistical; Netherlands; Pyrimidines; Reproducibility of Results; Survival Analysis; Triazoles; Voriconazole | 2007 |
Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Corneal Ulcer; Echinocandins; Eye Infections, Fungal; Fusarium; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Natamycin; Peptides, Cyclic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2007 |
[Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cord Blood Stem Cell Transplantation; Echinocandins; Fatal Outcome; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Mucormycosis; Peptides, Cyclic; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole | 2007 |
Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.
Topics: Amphotericin B; Antifungal Agents; Female; Fever; Health Care Costs; Hospitalization; Humans; Male; Middle Aged; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2007 |
The fusarium keratitis outbreak: not done yet?
Topics: Adult; Amphotericin B; Antifungal Agents; Child; Combined Modality Therapy; Corneal Ulcer; Disease Outbreaks; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusarium; Humans; Keratoplasty, Penetrating; Microbial Sensitivity Tests; Mycoses; Natamycin; Pyrimidines; Triazoles; Voriconazole | 2007 |
Lecythophora mutabilis prosthetic valve endocarditis in a diabetic patient.
Topics: Amphotericin B; Antifungal Agents; Aortic Valve; Ascomycota; Diabetes Complications; Drug Combinations; Endocarditis; Heart Valve Prosthesis; Humans; Male; Middle Aged; Molecular Sequence Data; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Prosthesis-Related Infections; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Treatment of two postoperative endophthalmitis cases due to Aspergillus flavus and Scopulariopsis spp. with local and systemic antifungal therapy.
Topics: Aged; Amphotericin B; Antifungal Agents; Ascomycota; Aspergillus flavus; Caspofungin; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Humans; Lipopeptides; Male; Postoperative Complications; Pyrimidines; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole | 2007 |
Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
Topics: Aged; Amphotericin B; Antifungal Agents; Cross Infection; Drug Therapy, Combination; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2007 |
Comparison of 2 studies of treatment of invasive aspergillosis.
Topics: Amphotericin B; Aspergillosis; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis.
Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Corneal Ulcer; Disease Models, Animal; Eye Infections, Fungal; Fusarium; Itraconazole; Mycoses; Pyrimidines; Rabbits; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Culture Media; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Time Factors; Triazoles; Voriconazole | 2007 |
Aspiration cytology of brain abscess from a fatal case of cerebral phaeohyphomycosis due to Ramichloridium mackenziei.
Topics: Aged; Amphotericin B; Antifungal Agents; Ascomycota; Biopsy, Needle; Brain Abscess; Central Nervous System Fungal Infections; Combined Modality Therapy; Diabetes Complications; Diabetes Mellitus; Fatal Outcome; Female; Humans; Lupus Erythematosus, Systemic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia-Lymphoma, Adult T-Cell; Lipopeptides; Liposomes; Male; Peptides, Cyclic; Pyrimidines; Transplantation Conditioning; Transplantation, Homologous; Triazoles; Voriconazole | 2007 |
In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Ear Diseases; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2007 |
Adjuvant endobronchial amphotericin B for refractory invasive pulmonary aspergillosis: evidence is scarce but promise does exist.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Chemotherapy, Adjuvant; Drug Evaluation; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lung Diseases, Fungal; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2008 |
Comparative cost-effectiveness of voriconazole and amphotericin B in treatment of invasive pulmonary aspergillosis.
Topics: Amphotericin B; Aspergillosis; Cost-Benefit Analysis; Decision Trees; Humans; Lung Diseases, Fungal; Models, Economic; Pyrimidines; Survival Rate; Triazoles; Voriconazole | 2007 |
Managing Candida endophthalmitis (Recurrent Candida albicans endophthalmitis in an immunocompromised host. Vol. 42[1]).
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Humans; Immunocompromised Host; Postoperative Complications; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2007 |
Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Child; Child, Preschool; Fluconazole; Flucytosine; Hospitals, Public; Humans; Infant; Infant, Newborn; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole | 2007 |
In vitro activity (MIC and MFC) of voriconazole, amphotericin B, and itraconazole against 192 filamentous fungi: the GISIA-2 study.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Pyrimidines; Rhodotorula; Triazoles; Trichosporon; Voriconazole | 2008 |
Successful multimodal therapy of invasive pulmonary and central nervous system aspergillosis in a neutropenic surgical patient: case report and review of the literature.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Drug Combinations; Drug Therapy, Combination; Female; Humans; Middle Aged; Neuroaspergillosis; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Triazoles; Voriconazole | 2008 |
Scedosporiosis in patients with acute leukemia: a retrospective multicenter report.
Topics: Acute Disease; Adolescent; Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Child; Child, Preschool; Humans; Leukemia; Male; Middle Aged; Mycetoma; Pyrimidines; Retrospective Studies; Scedosporium; Triazoles; Voriconazole | 2008 |
Simultaneous mold infections in an orthotopic heart transplant recipient.
Topics: Amphotericin B; Antibodies, Monoclonal; Antifungal Agents; Aspergillus fumigatus; Basiliximab; Cardiomyopathy, Dilated; Debridement; Dermatomycoses; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Mucormycosis; Prosthesis-Related Infections; Pulmonary Aspergillosis; Pyrimidines; Recombinant Fusion Proteins; Rhizopus; Triazoles; Voriconazole | 2008 |
Multilaboratory testing of antifungal combinations against a quality control isolate of Candida krusei.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Laboratories; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Triazoles; Voriconazole | 2008 |
Cervical spondylodiscitis caused by Blastoschizomyces capitatus.
Topics: Adult; Amphotericin B; Antifungal Agents; Cervical Vertebrae; Dipodascus; Discitis; Female; Humans; Leukemia, Myeloid, Acute; Mycoses; Neck; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Ultrasonography; Voriconazole | 2009 |
Interaction of amphotericin B lipid formulations and triazoles with human polymorphonuclear leucocytes for antifungal activity against Zygomycetes.
Topics: Absidia; Adult; Amphotericin B; Antifungal Agents; Drug Combinations; Drug Interactions; Humans; Hyphae; Liposomes; Microbial Sensitivity Tests; Neutrophils; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2008 |
Comparison of E-Test, disk diffusion and a modified CLSI broth microdilution (M 38-A) method for in vitro testing of itraconazole, fluconazole and voriconazole against dermatophytes.
Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Aspergillus; Disk Diffusion Antimicrobial Tests; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Comparison of disk diffusion, E-test and broth microdilution test in determination of susceptibility of Aspergillus species to amphotericin B, itraconazole and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Disk Diffusion Antimicrobial Tests; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Post-antifungal effect of amphotericin B and voriconazole against germinated Aspergillus fumigatus conidia.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Carbon Dioxide; Dose-Response Relationship, Drug; Microbial Viability; Pyrimidines; Spores, Fungal; Time Factors; Triazoles; Voriconazole | 2008 |
Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Dose-Response Relationship, Drug; Drug Antagonism; Humans; Microbial Sensitivity Tests; Microbial Viability; Models, Biological; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2008 |
Non-Candida albicans Candida mediastinitis of odontogenic origin in a diabetic patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Diabetes Mellitus, Type 2; Female; Humans; Mediastinitis; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2008 |
Disseminated infection by Bipolaris spicifera in an immunocompetent subject.
Topics: Adult; Amphotericin B; Ascomycota; DNA, Fungal; DNA, Ribosomal; Humans; Immunocompetence; Itraconazole; Lymph Nodes; Male; Mycoses; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2008 |
[Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Interactions; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2008 |
Antifungal activity against Candida albicans of nikkomycin Z in combination with caspofungin, voriconazole or amphotericin B.
Topics: Aminoglycosides; Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Combined therapy in treatment of murine infection by Fusarium solani.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Drug Therapy, Combination; Echinocandins; Fusarium; Immunocompromised Host; Kidney; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mycoses; Pyrimidines; Spleen; Survival Analysis; Triazoles; Voriconazole | 2008 |
Rhino-cerebral zygomycosis resistant to antimycotic treatment: a case report.
Topics: Aged; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Central Nervous System Diseases; Drug Resistance, Fungal; Fatal Outcome; Humans; Male; Methylprednisolone; Purpura, Thrombocytopenic, Idiopathic; Pyrimidines; Rhinitis; Rhizopus; Triazoles; Voriconazole; Zygomycosis | 2009 |
Endogenous mycotic endophthalmitis in an immunocompetent patient.
Topics: Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Fluorescein Angiography; Fundus Oculi; Humans; Immunocompetence; Injections; Male; Pyrimidines; Treatment Outcome; Triazoles; Vision Disorders; Vitrectomy; Vitreous Body; Voriconazole; Zygomycosis | 2009 |
Effective management of pulmonary aspergillosis invading the thoracic spine in a child with high risk ALL requiring allogeneic bone marrow transplantation.
Topics: Adoptive Transfer; Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Bone Marrow Transplantation; Caspofungin; Child; Echinocandins; Female; Graft vs Host Disease; Granulocytes; Humans; Lipopeptides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography, Thoracic; Spine; Triazoles; Voriconazole | 2008 |
Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fluconazole; Humans; Infant; Infant, Newborn; Itraconazole; Lipopeptides; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Thiazoles; Triazoles; Voriconazole; Young Adult | 2008 |
Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Humans; Infant; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Pyrimidines; Triazoles; Venezuela; Voriconazole; Young Adult | 2009 |
Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Azoles; Cryptococcus; Culture Media; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Bronchoalveolar Lavage Fluid; Drug Resistance, Fungal; Fanconi Anemia; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Diseases, Fungal; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult | 2008 |
In vitro synergy of caspofungin with licensed and novel antifungal drugs against clinical isolates of Fusarium spp.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Fusarium; Humans; Hyphae; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Tacrolimus; Terbinafine; Triazoles; Voriconazole | 2009 |
Five-year retrospective review of guideline-based management of fungal endophthalmitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Costs; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Flucytosine; Guideline Adherence; Health Care Costs; Humans; Male; Medical Audit; Middle Aged; Mycoses; Practice Guidelines as Topic; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2008 |
Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2008 |
Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Biofilms; Caspofungin; Echinocandins; Formazans; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Mycelium; Oxidation-Reduction; Pyrimidines; Spores, Fungal; Triazoles; Voriconazole | 2008 |
Disseminated fusariosis caused by Fusarium verticillioides in an acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation.
Topics: Amphotericin B; Antifungal Agents; Child; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2009 |
A multi-centre comparison of nursing staff time required for the preparation and administration of liposomal amphotericin B and amphotericin B deoxycholate vs. voriconazole.
Topics: Amphotericin B; Antifungal Agents; Costs and Cost Analysis; Deoxycholic Acid; Drug Combinations; Humans; Pyrimidines; Time Management; Triazoles; United Kingdom; Voriconazole | 2009 |
Evaluation of the Neo-Sensitabs diffusion method for determining the antifungal susceptibilities of Cryptococcus gattii isolates, using three different agar media.
Topics: Agar; Amphotericin B; Antifungal Agents; Cryptococcus; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2008 |
Voriconazole and posaconazole resistant Candida pelliculosa fungemia after cardiac surgery.
Topics: Amphotericin B; Antifungal Agents; Candida; Cardiac Surgical Procedures; Child; Drug Resistance, Multiple, Fungal; Fungemia; Humans; Infant; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole | 2009 |
Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Exophiala; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Deoxycholic Acid; Drug Combinations; Female; Fungi; Hematopoietic Stem Cell Transplantation; Humans; Logistic Models; Male; Middle Aged; Mucorales; Mycoses; North America; Prevalence; Prospective Studies; Pyrimidines; Risk Factors; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Comparative study on the efficacy of liposomal amphotericin B and voriconazole in a murine pulmonary aspergillosis model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Disease Models, Animal; Lung; Male; Mice; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
[Saccharomyces cerevisiae fungemia associated with multifocal pneumonia in a patient with alcohol-related hepatic cirrhosis].
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Liver Cirrhosis, Alcoholic; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Radiography; Saccharomyces cerevisiae; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Successful treatment of invasive sphenoidal, pulmonary and intracerebral aspergillosis after multivisceral transplantation.
Topics: Adult; Amphotericin B; Aspergillosis; Cerebrum; Female; Flucytosine; Humans; Immunocompromised Host; Intestines; Kidney Transplantation; Lung Diseases, Fungal; Neuroaspergillosis; Pyrimidines; Sphenoid Sinus; Triazoles; Voriconazole | 2009 |
Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Synergism; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2008 |
Cerebral aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Brain; Brain Abscess; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mood Disorders; Myelodysplastic Syndromes; Personality; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2009 |
Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Humans; Kidney; Lipopeptides; Male; Micafungin; Mice; Microbial Sensitivity Tests; Mycetoma; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles; Voriconazole | 2009 |
In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Humans; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole | 2009 |
[Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Caspofungin; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Leukoencephalopathy, Progressive Multifocal; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
[Two cases of mycoses associated with hematologic disease].
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cunninghamella; Fatal Outcome; Humans; Liposomes; Male; Mucormycosis; Myelodysplastic Syndromes; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
[Case of pulmonary mycoses associated with malignant lymphoma during chemotherapy].
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Immunocompromised Host; Lung Diseases, Fungal; Lymphoma; Male; Middle Aged; Muscle Neoplasms; Prednisolone; Psoas Muscles; Pyrimidines; Treatment Outcome; Triazoles; Vincristine; Voriconazole | 2008 |
Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Disease Models, Animal; Drosophila; Fungi; Humans; Itraconazole; Mice; Mucor; Pyrimidines; Rhizopus; Triazoles; Virulence; Voriconazole; Zygomycosis | 2009 |
[In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2009 |
[Conservative management with new antifungals in a case of Candida prosthetic valve endocarditis].
Topics: Amphotericin B; Antifungal Agents; Bioprosthesis; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Endocarditis; Heart Valve Prosthesis; Humans; Lipopeptides; Liposomes; Male; Middle Aged; Photosensitivity Disorders; Postoperative Complications; Prosthesis-Related Infections; Pyrimidines; Triazoles; Voriconazole | 2010 |
Compassionate use study of caspofungin in children with proven or suspected invasive mycosis or persistent febrile neutropenia.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Infant; Infant, Newborn; Lipopeptides; Male; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Salvage Therapy; Triazoles; Voriconazole | 2009 |
Isolated cerebral aspergilloma in a young immunocompetent patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Brain Edema; Female; Humans; Muscle Weakness; Pyrimidines; Seizures; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Subcutaneous mycosis and fungemia by Aureobasidium pullulans: a rare pathogenic fungus in a post allogeneic BM transplant patient.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Fungemia; Humans; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2010 |
Anidulafungin treatment of candidal central nervous system infection in a murine model.
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Central Nervous System Infections; Disease Models, Animal; Echinocandins; Female; Mice; Pyrimidines; Triazoles; Voriconazole | 2009 |
In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
Topics: Amphotericin B; Antifungal Agents; Antitubercular Agents; Caspofungin; Coccidioides; Coccidioidomycosis; Drug Synergism; Echinocandins; Ethambutol; Fluconazole; Humans; Isoniazid; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole | 2009 |
Systemic phaeohyphomycosis resembling primary sclerosing cholangitis caused by Exophiala dermatitidis.
Topics: Amphotericin B; Antifungal Agents; Cholangitis, Sclerosing; Diagnosis, Differential; Exophiala; Female; Humans; Lymph Nodes; Mycoses; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2009 |
In vitro interactions between antifungals and methotrexate against Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Interactions; Itraconazole; Methotrexate; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2009 |
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole | 2009 |
Practice patterns in the management of fungal corneal ulcers.
Topics: Administration, Topical; Amphotericin B; Antifungal Agents; Corneal Ulcer; Debridement; Drug Costs; Drug Therapy, Combination; Humans; Mycoses; Natamycin; Ophthalmology; Patients; Practice Patterns, Physicians'; Pyrimidines; Surveys and Questionnaires; Treatment Outcome; Triazoles; Voriconazole | 2009 |
[Cryptococcal meningitis with a fatal outcome in an immunocompetent adult].
Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Drainage; Drug Therapy, Combination; Fatal Outcome; Fluconazole; Headache; Hearing Loss, Bilateral; Humans; Immunocompetence; Intracranial Hypertension; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Spinal Puncture; Triazoles; Voriconazole | 2010 |
Primary renal zygomycotic infarction mimicking renal neoplasia in an immunocompetent patient.
Topics: Adrenalectomy; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Humans; Immunocompetence; Kidney Diseases; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole; Zygomycosis | 2009 |
Keratitis resulting from Thielavia subthermophila Mouchacca.
Topics: Amphotericin B; Antifungal Agents; Child; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Mycoses; Pyrimidines; Retrospective Studies; Sordariales; Triazoles; Voriconazole | 2009 |
Penetrating keratoplasty for invasive fungal keratitis resulting from a thorn injury involving Phomopsis species.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Ascomycota; Cataract; Cataract Extraction; Corneal Ulcer; Eye Infections, Fungal; Eye Injuries, Penetrating; Gardening; Humans; Keratitis; Keratoplasty, Penetrating; Male; Middle Aged; Plant Diseases; Postoperative Care; Pyrimidines; Reoperation; Triazoles; Voriconazole | 2009 |
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Fungemia; Itraconazole; Laboratories, Hospital; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole; Yeasts | 2010 |
[Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy].
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillus flavus; Caspofungin; Chemotherapy, Adjuvant; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Injections, Intraventricular; Lipopeptides; Male; Neuroaspergillosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2009 |
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Prospective Studies; Pyrimidines; Registries; Survival Rate; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Blood; Candida tropicalis; Candidiasis; Catheterization; Cell Adhesion; Cells, Cultured; Enzymes; Epithelial Cells; Equipment and Supplies; Fluconazole; Fungal Proteins; Hemolysin Proteins; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Urine; Virulence Factors; Voriconazole | 2010 |
A 19-year-old man with progressive lung infiltrates.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Bronchoscopy; Fatal Outcome; Humans; Leukemia, Myeloid, Acute; Lung; Lung Diseases, Fungal; Male; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole; Young Adult; Zygomycosis | 2009 |
Antifungal susceptibility of 205 Candida spp. isolated primarily during invasive Candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and Etest methods.
Topics: Amphotericin B; Antifungal Agents; Automation; Candida; Candidiasis; Fluconazole; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pyrimidines; Statistics as Topic; Triazoles; Voriconazole | 2010 |
A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Female; Fungi; Hematologic Neoplasms; Humans; Infant; Lipopeptides; Male; Mycoses; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Management of obstructive renal failure caused by bilateral renal aspergilloma in an immunocompetent newborn.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Bladder Exstrophy; Humans; Infant, Newborn; Male; Nephrostomy, Percutaneous; Pyrimidines; Renal Insufficiency; Treatment Outcome; Triazoles; Ureterostomy; Voriconazole | 2010 |
Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Prevalence; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2010 |
An outbreak of early-onset endophthalmitis caused by Fusarium species following cataract surgery.
Topics: Aged; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Disease Outbreaks; Drug Therapy, Combination; Endophthalmitis; Eye Evisceration; Eye Infections, Fungal; Female; Fusarium; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Mycoses; Phacoemulsification; Postoperative Complications; Pyrimidines; Retrospective Studies; Triazoles; Turkey; Visual Acuity; Vitrectomy; Voriconazole | 2009 |
Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumi
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Colorimetry; Confidence Intervals; Drug Therapy, Combination; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Monte Carlo Method; Pyrimidines; Triazoles; Voriconazole | 2010 |
Alternaria sinusitis in children with acute myeloid leukemia: case reports from the Childhood Acute Myeloid Leukemia Infection Research Group.
Topics: Adolescent; Alternaria; Amphotericin B; Antifungal Agents; Child, Preschool; Female; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Pyrimidines; Sinusitis; Triazoles; Voriconazole | 2010 |
Evaluation of antifungal therapy in a neutropenic murine model of Neoscytalidium dimidiatum infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Colony Count, Microbial; Disease Models, Animal; Kidney; Male; Mice; Mycoses; Neutropenia; Pyrimidines; Sepsis; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2010 |
The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Hyphae; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Spores, Fungal; Tetrazolium Salts; Triazoles; Voriconazole | 2010 |
Current controversies in treating invasive zygomycosis.
Topics: Amphotericin B; Antifungal Agents; Cunninghamella; Drug Therapy, Combination; Humans; Lung Diseases, Fungal; Mucormycosis; Pyrimidines; Triazoles; Voriconazole | 2010 |
Resolution of secondary pulmonary alveolar proteinosis following treatment of rhinocerebral aspergillosis.
Topics: Aged; Amphotericin B; Antifungal Agents; Female; Humans; Magnetic Resonance Imaging; Neuroaspergillosis; Pulmonary Alveolar Proteinosis; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Efficacy of voriconazole in a murine model of invasive paecilomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Citrus paradisi; Colony Count, Microbial; Diet; Immunocompromised Host; Kidney; Liver; Male; Mice; Mycoses; Paecilomyces; Pyrimidines; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Antifungal management.
Topics: Amphotericin B; Antifungal Agents; Cord Blood Stem Cell Transplantation; Echinocandins; Humans; Leukemia; Lung; Male; Middle Aged; Neutropenia; Postoperative Complications; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2010 |
Immunomodulatory effects of antifungal agents on the response of human monocytic cells to Aspergillus fumigatus conidia.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Cell Line; Cell Survival; Echinocandins; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunologic Factors; Lipopeptides; Micafungin; Monocytes; Pyrimidines; Spores, Fungal; Triazoles; Tumor Necrosis Factor-alpha; Voriconazole | 2010 |
Post-traumatic fungal keratitis caused by Carpoligna sp.
Topics: Adult; Amphotericin B; Antifungal Agents; Base Sequence; Corneal Injuries; Corneal Ulcer; DNA, Fungal; Eye Infections, Fungal; Eye Injuries; Humans; Lacerations; Male; Mitosporic Fungi; Molecular Sequence Data; Natamycin; Polymerase Chain Reaction; Pyrimidines; RNA, Fungal; RNA, Ribosomal, 28S; Triazoles; Voriconazole | 2010 |
In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2010 |
Successful allogeneic stem cell transplantation in two patients with acute myelogenous leukaemia and invasive aspergillosis by antifungal combination therapy.
Topics: Amphotericin B; Antifungal Agents; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Lipopeptides; Micafungin; Middle Aged; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Cellulitis and nodular skin lesions due to Fusarium spp in liver transplant: case report.
Topics: Amphotericin B; Biopsy; Cellulitis; Fusarium; Graft Rejection; Hepatitis C; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Acremonium strictum fungaemia in a paediatric immunocompromised patient: diagnosis and treatment difficulties.
Topics: Acremonium; Amphotericin B; Antifungal Agents; Blood; Child; Fever; Fungemia; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2010 |
Characterization of yeasts colonizing in healthy individuals.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Carrier State; Female; Fluconazole; Human Experimentation; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Pyrimidines; Taiwan; Triazoles; Voriconazole; Yeasts; Young Adult | 2011 |
Identification of Paecilomyces variotii in clinical samples and settings.
Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Flucytosine; Fungal Proteins; Genes, rRNA; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Paecilomyces; Pyrimidines; RNA, Fungal; RNA, Ribosomal, 5.8S; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole | 2010 |
Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Cohort Studies; Echinocandins; Female; Hospital Costs; Humans; Infusions, Intravenous; Invasive Pulmonary Aspergillosis; Length of Stay; Lipopeptides; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; United States; Voriconazole | 2011 |
Comparison of Vitek identification and antifungal susceptibility testing methods to DNA sequencing and Sensititre YeastOne antifungal testing.
Topics: Amphotericin B; Candida; DNA, Fungal; DNA, Ribosomal Spacer; Fluconazole; Humans; Microbial Sensitivity Tests; Mycological Typing Techniques; Pyrimidines; Triazoles; Voriconazole | 2011 |
Invasive respiratory aspergillosis is a treatable disease with early diagnosis and aggressive therapy.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Early Diagnosis; Echinocandins; Female; Fever; Hematologic Neoplasms; Humans; Lipopeptides; Male; Neutropenia; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Aspergillus endocarditis 2003-2009.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Child; Child, Preschool; Endocarditis; Humans; Immunocompromised Host; Infant; Male; Middle Aged; Pyrimidines; Retrospective Studies; Surgical Procedures, Operative; Triazoles; Voriconazole; Young Adult | 2011 |
Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Male; Mice; Pyrimidines; Triazoles; Voriconazole | 2010 |
Effects of caspofungin, Candida albicans and Aspergillus fumigatus on toll-like receptor 9 of GM-CSF-stimulated PMNs.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Caspofungin; CD11b Antigen; Cells, Cultured; Echinocandins; Gene Expression; Gene Expression Profiling; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunologic Factors; Interleukin-8; Lipopeptides; Neutrophils; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Toll-Like Receptors; Triazoles; Up-Regulation; Voriconazole | 2010 |
Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Geotrichum; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
Characterization of Candida parapsilosis complex isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Candidemia; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Pyrimidines; Random Amplified Polymorphic DNA Technique; Triazoles; Voriconazole | 2011 |
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study).
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Guideline Adherence; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Generation of mutants in Candida albicans with reduced susceptibility to caspofungin: influence on other antifungal products.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole | 2010 |
Developing a safe antifungal treatment protocol to eliminate Batrachochytrium dendrobatidis from amphibians.
Topics: Amphotericin B; Animals; Antifungal Agents; Anura; Chytridiomycota; Clinical Protocols; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Bloodstream yeast infections in a university hospital in Northeast Turkey: a 4-year survey.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candida; Candidemia; Child; Child, Preschool; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Turkey; Voriconazole | 2011 |
Combined therapy against murine-disseminated infection by Fusarium verticillioides.
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy, Combination; Fusarium; Mice; Mycoses; Pyrimidines; Survival Rate; Triazoles; Voriconazole | 2011 |
In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.
Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Animals; Antifungal Agents; Cryptococcus gattii; Environmental Microbiology; Fluconazole; Flucytosine; Genotype; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2010 |
Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Lung; Mice; Mice, Inbred BALB C; Mice, SCID; Pyrimidines; Rodent Diseases; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole; Yeasts | 2011 |
In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Echinocandins; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Successful treatment of systemic Geotrichum capitatum infection by liposomal amphotericin-B, itraconazole, and voriconazole in a Japanese man.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Geotrichosis; Humans; Itraconazole; Japan; Male; Middle Aged; Pyrimidines; Remission Induction; Triazoles; Voriconazole | 2010 |
Pulmonary aspergillosis caused by a pan-azole-resistant Aspergillus fumigatus in a 10-year-old boy.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Azoles; Chemoprevention; Child; Drug Resistance, Multiple, Fungal; Hematopoietic Stem Cell Transplantation; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
[Cryptococcal meningitis successfully treated with liposomal amphotericin B and voriconazole in an elderly patient].
Topics: Administration, Oral; Aged, 80 and over; Amphotericin B; Antigens, Fungal; Cerebrospinal Fluid; Cryptococcus neoformans; Drug Therapy, Combination; Female; Humans; Liposomes; Meningitis, Cryptococcal; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Catheter-Related Infections; Catheterization, Central Venous; Drug Administration Routes; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Antifungal susceptibility of bloodstream Candida isolates in Sfax hospital: Tunisia.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Lipopeptides; Male; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Triazoles; Tunisia; Voriconazole | 2011 |
Case collection study of the safety of AmBisome in association with voriconazole in the treatment of patients with invasive fungal infection.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Combinations; Female; Humans; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Mycoses; Pyrimidines; Survival Analysis; Triazoles; Voriconazole; Young Adult | 2010 |
Recurrent Lecythophora mutabilis keratitis and endophthalmitis after deep anterior lamellar keratoplasty.
Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Corneal Transplantation; Corneal Ulcer; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Microscopy, Acoustic; Middle Aged; Mycoses; Phialophora; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2011 |
Voriconazole-induced inhibition of the fungicidal activity of amphotericin B in Candida strains with reduced susceptibility to voriconazole: an effect not predicted by the MIC value alone.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Drug Interactions; Drug Resistance, Fungal; Fungal Proteins; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Drug Combinations; Echinocandins; Enzyme-Linked Immunosorbent Assay; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
The evaluation of in vitro pharmacodynamic properties of amphotericin B, voriconazole and caspofungin against A. fumigatus isolates by the conventional and colorimetric time-kill assays.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Tetrazolium Salts; Time Factors; Triazoles; Voriconazole | 2011 |
Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematology; Hospital Costs; Humans; Length of Stay; Lipopeptides; Male; Middle Aged; Models, Economic; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2011 |
Disseminated Rhizomucor pusillus causing early multiorgan failure during hematopoietic stem cell transplantation for severe aplastic anemia.
Topics: Amphotericin B; Anemia, Aplastic; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Mucormycosis; Multiple Organ Failure; Pyrimidines; Rhizomucor; Triazoles; Voriconazole | 2011 |
Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies: analysis of eight patients.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Biopsy; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole | 2011 |
Successful management of invasive aspergillosis with voriconazole and amphoteracin B therapy in a patient with acute mycloid leukemia (AML-M2).
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Child; Fever; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Bipolaris hawaiiensis as etiologic agent of allergic bronchopulmonary mycosis: first case in a paediatric patient.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Aspergillus fumigatus; beta-Glucans; Bronchi; Bronchoalveolar Lavage Fluid; Bronchoscopy; Child; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Female; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Mycological Typing Techniques; Phylogeny; Prednisone; Pyrimidines; Sequence Analysis, DNA; Sputum; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Oral Candida isolates among HIV-infected subjects in Nigeria.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Nigeria; Pyrimidines; Triazoles; Voriconazole | 2011 |
Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Colony Count, Microbial; Deoxycholic Acid; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Micafungin; Mice; Mice, Inbred DBA; Pyrimidines; Triazoles; Voriconazole | 2011 |
A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Child; Child, Preschool; Denmark; Drug Resistance, Fungal; Female; Hospitals; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; Pyrimidines; Respiratory System; Respiratory Tract Infections; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Diagnosis and treatment of fungal infection after liver transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Liver Transplantation; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Eye Infections, Fungal; Fungi; Fusarium; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Invasive aspergillosis of orbit in immunocompetent patients: treatment and outcome.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Infant; Itraconazole; Magnetic Resonance Imaging; Male; Middle Aged; Orbital Diseases; Paranasal Sinus Diseases; Pyrimidines; Retrospective Studies; Tomography, X-Ray Computed; Triazoles; Voriconazole; Young Adult | 2011 |
In vitro evaluation of the type of interaction obtained by the combination of terbinafine and itraconazole, voriconazole, or amphotericin B against dematiaceous molds.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fungi; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2011 |
Delayed recalcitrant fungal endophthalmitis secondary to Curvularia.
Topics: Abscess; Aged; Amphotericin B; Ascomycota; Cataract Extraction; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Female; Humans; Mycoses; Pyrimidines; Recurrence; Triazoles; Vitrectomy; Vitreous Body; Voriconazole | 2011 |
Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology.
Topics: Amphotericin B; Antifungal Agents; Environmental Microbiology; Fusariosis; Fusarium; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole | 2011 |
Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Brain; Caspofungin; Cerebrum; Echinocandins; Humans; Larynx; Lipopeptides; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Neuroaspergillosis; Paranasal Sinuses; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Sweden; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
Disseminated Geosmithia argillacea infection in a patient with gastrointestinal GvHD.
Topics: Amphotericin B; Antibodies, Monoclonal; Antifungal Agents; Eurotiales; Fatal Outcome; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infliximab; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 2012 |
Breakthrough disseminated fusariosis in an immunocompromised patient on voriconazole therapy.
Topics: Aged; Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fusariosis; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Pyrimidines; Triazoles; Voriconazole | 2012 |
Fatal post-operative Trichoderma longibrachiatum mediastinitis and peritonitis in a paediatric patient with complex congenital cardiac disease on peritoneal dialysis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child, Preschool; Echinocandins; Fatal Outcome; Female; Heart Defects, Congenital; Humans; Immunocompromised Host; Lipopeptides; Mediastinitis; Mycoses; Peritoneal Dialysis; Peritonitis; Postoperative Complications; Pyrimidines; Spleen; Triazoles; Trichoderma; Voriconazole | 2011 |
In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds.
Topics: Aminopyridines; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Cell Line; Echinocandins; Fluconazole; Fungi; Fusarium; Humans; Isoxazoles; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Paecilomyces; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Yeasts | 2011 |
In vitro synergisms obtained by amphotericin B and voriconazole associated with non-antifungal agents against Fusarium spp.
Topics: Amphotericin B; Antifungal Agents; Drug Synergism; Fungi; Fusarium; Ibuprofen; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Broth microdilution and time-kill testing of Caspofungin, voriconazole, amphotericin B and their combinations against clinical isolates of Candida krusei.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2012 |
Polyhexamethylene biguanide and calcineurin inhibitors as novel antifungal treatments for Aspergillus keratitis.
Topics: Amphotericin B; Animals; Aspergillosis; Aspergillus fumigatus; Biguanides; Calcineurin Inhibitors; Corneal Ulcer; Cyclosporine; Disinfectants; Drug Synergism; Eye Infections, Fungal; Immunosuppressive Agents; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Prospective Studies; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2011 |
Rhinocerebral mucormycosis: a diagnostic challenge and therapeutic dilemma in immunocompetent host.
Topics: Adult; Amphotericin B; Antifungal Agents; Central Nervous System Fungal Infections; Eye Infections, Fungal; Female; Humans; Hyphae; Immunocompetence; Male; Maxilla; Middle Aged; Mucormycosis; Nose Diseases; Orbit; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole | 2012 |
Evaluation of saliva flow rates, Candida colonization and susceptibility of Candida strains after head and neck radiation.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Colony Count, Microbial; Dental Caries; Drug Resistance, Fungal; Female; Fluconazole; Head and Neck Neoplasms; Humans; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Pyrimidines; Radiation Injuries; Saliva; Salivary Glands; Secretory Rate; Triazoles; Voriconazole; Xerostomia | 2012 |
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Communicable Disease Control; Cross Infection; Echinocandins; Female; Fluconazole; Hospitals; Humans; Italy; Itraconazole; Lipopeptides; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Recurrent Saccharomyces cerevisiae fungemia in an otherwise healthy patient.
Topics: Abdominal Pain; Adult; Amphotericin B; Antifungal Agents; Chills; Diagnosis, Differential; Female; Fever; Fluconazole; Flucytosine; Fungemia; Headache; Humans; Nausea; Pyrimidines; Recurrence; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2011 |
Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Female; Fungal Proteins; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Mutation; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2012 |
Subcutaneous dematiaceous fungal infection.
Topics: Acute Kidney Injury; Aged; Amphotericin B; Antifungal Agents; Chromoblastomycosis; Combined Modality Therapy; Costa Rica; Diagnosis, Differential; Humans; Immunocompromised Host; Immunosuppressive Agents; Itraconazole; Kidney Transplantation; Leg; Male; Phaeohyphomycosis; Pneumonia; Pyrimidines; Soil Microbiology; Triazoles; Voriconazole | 2011 |
Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Diffusion Chambers, Culture; Echinocandins; Galactose; Humans; Lipopeptides; Mannans; Microbial Sensitivity Tests; Pulsatile Flow; Pyrimidines; Species Specificity; Spores, Fungal; Triazoles; Voriconazole | 2012 |
Voriconazole, combined with amphotericin B, in the treatment for pulmonary cryptococcosis caused by C. neoformans (serotype A) in mice with severe combined immunodeficiency (SCID).
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Therapy, Combination; Lung; Lung Diseases, Fungal; Mice; Mice, SCID; Pyrimidines; Severe Combined Immunodeficiency; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.
Topics: Acylation; Aminopyridines; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Fusarium; Glycosylphosphatidylinositols; Humans; Inositol; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2012 |
Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Drug Therapy, Combination; Fatal Outcome; Fungemia; Humans; Leukemia, Myeloid, Acute; Male; Pyrimidines; Triazoles; Trichosporon; Trichosporonosis; Voriconazole; Young Adult | 2012 |
Mevalonate governs interdependency of ergosterol and siderophore biosyntheses in the fungal pathogen Aspergillus fumigatus.
Topics: Amphotericin B; Animals; Aspergillus fumigatus; Biomass; Biosynthetic Pathways; Enoyl-CoA Hydratase; Ergosterol; Ferric Compounds; Gene Deletion; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Fungal; Gene Silencing; Genes, Fungal; Hydroxamic Acids; Hydroxymethylglutaryl CoA Reductases; Iron Deficiencies; Ligases; Lovastatin; Mevalonic Acid; Mice; Microbial Sensitivity Tests; Oxidative Stress; Pulmonary Aspergillosis; Pyrimidines; Siderophores; Triazoles; Up-Regulation; Virulence; Voriconazole | 2012 |
Efficacy of intrathecal administration of liposomal amphotericin B combined with voriconazole in a murine model of cryptococcal meningitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Colony Count, Microbial; Cryptococcus neoformans; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Injections, Spinal; Male; Meningitis, Cryptococcal; Mice; Pyrimidines; Triazoles; Voriconazole | 2012 |
Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis.
Topics: Administration, Inhalation; Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Chemoprevention; Colony Count, Microbial; Cortisone; Cyclophosphamide; Disease Models, Animal; Guinea Pigs; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Lung; Male; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2012 |
How does antifungal pharmacology differ for mucormycosis versus aspergillosis?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Cell Membrane; Cell Wall; Drug Resistance, Multiple, Fungal; Ergosterol; Gene Duplication; Genome, Fungal; Genomic Instability; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Species Specificity; Triazoles; Virulence Factors; Voriconazole | 2012 |
Expression turnover profiling to monitor the antifungal activities of amphotericin B, voriconazole, and micafungin against Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Echinocandins; Fungal Proteins; Gene Expression Profiling; Gene Expression Regulation, Fungal; Humans; Lipopeptides; Micafungin; Pyrimidines; RNA, Messenger; Transcriptome; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Measurement of antifungal drug levels in cerebrospinal fluid for cryptococcal meningoencephalitis.
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Meningoencephalitis; Microbial Sensitivity Tests; Organophosphates; Pyrimidines; Triazoles; Voriconazole | 2012 |
Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Taiwan; Triazoles; Trichosporon; Trichosporonosis; Voriconazole | 2012 |
[Study on in vitro susceptibility of Candida spp. isolated from blood culture].
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Risk Factors; Triazoles; Voriconazole | 2012 |
Invasive aspergillosis in pediatric oncology patients: a rare event with poor prognosis--case analysis to plan better targeted prophylactic or therapeutic measurement.
Topics: Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole | 2012 |
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole.
Topics: Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2013 |
The first Korean case of candidemia due to Candida dubliniensis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Catheterization, Central Venous; Female; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2012 |
Pseudomembranous necrotizing tracheobronchial aspergillosis: an analysis of 16 cases.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Bronchoscopy; Caspofungin; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2012 |
Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Azoles; Base Sequence; Biological Transport; Candida glabrata; Drug Resistance, Multiple, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Microbial Sensitivity Tests; Mutation, Missense; Pyrimidines; Saccharomyces cerevisiae; Sequence Analysis, DNA; Sterol 14-Demethylase; Sterols; Triazoles; Voriconazole | 2012 |
Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Fatal bronchial invasion of Scopulariopsis brevicaulis in an acute monocytic leukemia patient.
Topics: Adult; Amphotericin B; Bronchi; Caspofungin; DNA, Fungal; DNA, Ribosomal; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Genes, rRNA; Histocytochemistry; Humans; Leukemia, Monocytic, Acute; Lipopeptides; Lung; Lung Diseases, Fungal; Molecular Sequence Data; Pyrimidines; Radiography, Thoracic; RNA, Fungal; RNA, Ribosomal, 18S; Scopulariopsis; Sequence Analysis, DNA; Tomography, X-Ray Computed; Treatment Failure; Triazoles; Voriconazole | 2012 |
Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Resistance, Multiple, Fungal; Etoposide; Fatal Outcome; Female; Fusariosis; Fusarium; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Mitoxantrone; Neutropenia; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Premedication; Pyrimidines; Recurrence; Salvage Therapy; Transplantation, Homologous; Triazoles; Voriconazole | 2013 |
Characterization of fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Corneal Ulcer; Disease Models, Animal; Disease Outbreaks; Drug Resistance, Fungal; Epithelium, Corneal; Eye Infections, Fungal; Fusariosis; Fusarium; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microscopy, Confocal; Natamycin; Pyrimidines; Triazoles; Virulence; Voriconazole | 2012 |
Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Brain; Caspofungin; Cyclophosphamide; Deoxycholic Acid; Drug Combinations; Echinocandins; Endothelial Cells; Heart; Immunosuppression Therapy; Intercellular Adhesion Molecule-1; Kidney; Lipopeptides; Lung; Male; Mice; Nephrosis; Neuroaspergillosis; P-Selectin; Pyrimidines; Triazoles; Voriconazole | 2012 |
[Susceptibility to azoles and amphotericin B of isolates of Candida spp. Experience of a university health network, between 2004 and 2010].
Topics: Amphotericin B; Antifungal Agents; Candida; Chile; Cohort Studies; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2012 |
Histoplasmosis in HIV-positive patients in Ceará, Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Caspofungin; CD4 Lymphocyte Count; Echinocandins; Female; Fluconazole; Histoplasma; Histoplasmosis; Humans; Itraconazole; L-Lactate Dehydrogenase; Lipopeptides; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2013 |
Multiple fungal brain abscesses in a child with acute lymphoblastic leukemia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus niger; Brain Abscess; Child, Preschool; Female; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2012 |
Frequency of fungal isolation and antifungal susceptibility pattern of the fungal isolates from nasal polyps of chronic rhinosinusitis patients at a tertiary care centre in north India.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Female; Fungi; Humans; Immunoglobulin E; Incidence; India; Itraconazole; Male; Middle Aged; Mucins; Mycoses; Nasal Polyps; Pyrimidines; Retrospective Studies; Rhinitis, Allergic, Perennial; Sinusitis; Tertiary Healthcare; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus.
Topics: Amphotericin B; Candida; Colorimetry; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Triazoles; Voriconazole | 2012 |
Zygomycosis over-infection during voriconazole therapy for aspergillosis in a heart transplant patient, successfully treated with liposomal amphotericin and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Debridement; Drug Therapy, Combination; Heart Transplantation; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2012 |
Aspergillus tanneri sp. nov., a new pathogen that causes invasive disease refractory to antifungal therapy.
Topics: Adolescent; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Cluster Analysis; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Granulomatous Disease, Chronic; Humans; Itraconazole; Lung; Male; Mice; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Phylogeny; Pyrimidines; Sequence Analysis, DNA; Tomography, X-Ray Computed; Treatment Failure; Triazoles; Voriconazole; Young Adult | 2012 |
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven
Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Candidemia; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pichia; Pyrimidines; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
[Intraventricular cryptococcoma successfully treated with liposomal amphotericin B and voriconazole: a case report].
Topics: Amphotericin B; Humans; Liposomes; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Middle Aged; Positron-Emission Tomography; Pyrimidines; Triazoles; Voriconazole | 2012 |
Effect of photodynamic therapy with methylene blue on Acanthamoeba in vitro.
Topics: Acanthamoeba castellanii; Amebiasis; Amebicides; Amphotericin B; Animals; Antifungal Agents; Drug Therapy, Combination; Enzyme Inhibitors; Guanidines; Humans; In Vitro Techniques; Keratitis; Methylene Blue; Mice; Mice, Inbred C57BL; Photochemotherapy; Photosensitizing Agents; Polymers; Pyrimidines; Riboflavin; Triazoles; Ultraviolet Therapy; Voriconazole | 2012 |
Effects of Pimenta pseudocaryophyllus (Gomes) L. R. Landrum, on melanized and non-melanized Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Fungal Capsules; Humans; Melanins; Microbial Sensitivity Tests; Pimenta; Plant Extracts; Pyrimidines; Triazoles; Voriconazole | 2012 |
In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Nitriles; Phialophora; Pyridines; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
Prevalence and antifungal susceptibility of Candida parapsilosis complex isolates collected from oral cavities of HIV-infected individuals.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Caspofungin; Echinocandins; Female; Fluconazole; HIV Infections; Humans; Lipopeptides; Male; Microbial Sensitivity Tests; Mouth; Mycological Typing Techniques; Polymorphism, Restriction Fragment Length; Pyrimidines; Triazoles; Voriconazole | 2012 |
Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Cross Infection; DNA, Fungal; DNA, Intergenic; Drug Resistance, Multiple, Fungal; Female; Flucytosine; Genetic Variation; Genotype; Hemolysin Proteins; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Peptide Hydrolases; Phospholipases; Pyrimidines; Triazoles; Trichosporon; Trichosporonosis; Urinary Tract Infections; Virulence Factors; Voriconazole | 2012 |
Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fever; Fungal Proteins; Germany; Humans; Leukemia, Myeloid, Acute; Male; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Pyrimidines; Sequence Analysis; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Successful salvage therapy of refractory HIV-related cryptococcal meningitis with the combination of liposomal amphotericin B, voriconazole, and recombinant interferon-γ.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; HIV Infections; Humans; Interferon-gamma; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Caspofungin; Colony Count, Microbial; Dentures; Diabetes Complications; Echinocandins; Female; Fluconazole; Humans; Hypertension; Kidney Failure, Chronic; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Mycology; Nystatin; Phenotype; Pyrimidines; Renal Dialysis; Time Factors; Triazoles; Voriconazole | 2013 |
Interaction of the echinocandin caspofungin with amphotericin B or voriconazole against Aspergillus biofilms in vitro.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Biofilms; Caspofungin; Colorimetry; Coloring Agents; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Tetrazolium Salts; Triazoles; Voriconazole | 2012 |
Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2.
Topics: Amino Acid Sequence; Amphotericin B; Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Pyrimidines; Saccharomyces cerevisiae; Steroid Isomerases; Sterols; Triazoles; Voriconazole | 2012 |
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Cyclosporine; Drug Resistance, Multiple, Fungal; Drug Synergism; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2012 |
Voriconazole hepatotoxicity in severe liver dysfunction.
Topics: Adult; Aged; Amphotericin B; Analysis of Variance; Antifungal Agents; Aspergillosis; Chemical and Drug Induced Liver Injury; Cohort Studies; Female; Humans; Liver; Liver Function Tests; Male; Middle Aged; Observation; Pyrimidines; Triazoles; Voriconazole | 2013 |
The surgical management of rhinocerebral mucormycosis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brain Diseases; Cause of Death; Combined Modality Therapy; Diagnosis, Differential; Fatal Outcome; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Maxillary Sinusitis; Middle Aged; Mucormycosis; Nose Diseases; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2013 |
Penicillium marneffei chylous ascites in acquired immune deficiency syndrome: a case report.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Alkynes; Amphotericin B; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Chylous Ascites; Cyclopropanes; Diagnosis, Differential; Humans; Male; Middle Aged; Mycoses; Penicillium; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2012 |
Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Republic of Korea; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Colistin; Cystic Fibrosis; Drug Evaluation, Preclinical; Drug Synergism; Echinocandins; Exophiala; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
An atypical, pigment-producing Metschnikowia strain from a leukaemia patient.
Topics: Amphotericin B; Antifungal Agents; Base Sequence; DNA, Fungal; DNA, Ribosomal; Fluconazole; Humans; Italy; Leukemia; Male; Metschnikowia; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Phylogeny; Pigments, Biological; Pyrazines; Sequence Analysis, DNA; Sputum; Voriconazole | 2013 |
Meningitis outbreak challenges hospital pharmacies.
Topics: Amphotericin B; Antifungal Agents; Drug Contamination; Drug Monitoring; Drug Therapy, Combination; Humans; Meningitis, Fungal; Pharmacy Service, Hospital; Pyrimidines; Triazoles; Voriconazole; Workforce | 2012 |
Combination antifungal therapy for invasive pulmonary aspergillosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Invasive Pulmonary Aspergillosis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2012 |
[Photo quiz: basic mycology].
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Pyrimidines; Triazoles; Voriconazole | 2012 |
MIC values of voriconazole are predictive of treatment results in murine infections by Aspergillus terreus species complex.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Galactose; Male; Mannans; Mice; Microbial Sensitivity Tests; Prognosis; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2013 |
Inhibitory and fungicidal effects of antifungal drugs against Aspergillus species in the presence of serum.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Echinocandins; Humans; Microbial Sensitivity Tests; Pyrimidines; Serum; Triazoles; Voriconazole | 2013 |
Two rare cases of central nervous system opportunistic mycoses.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillus nidulans; Cryptococcus neoformans; Female; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Neuroaspergillosis; Opportunistic Infections; Pregnancy; Pregnancy Complications, Infectious; Rare Diseases; Treatment Outcome; Voriconazole | 2012 |
[Infectious diseases: progress in diagnosis and treatment. Topics: IV. Towards containing infectious diseases: 3. Development of new antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
[Combination antifungal therapy in hematopoietic stem cell transplantation patients].
Topics: Amphotericin B; Antifungal Agents; Child; Dermatomycoses; Drug Therapy, Combination; Fusariosis; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lung Diseases, Fungal; Male; Nasopharyngeal Diseases; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2013 |
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Reflections on the approach to treatment of a mycologic disaster.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Cladosporium; Humans; Mucormycosis; Mycoses; Pyrimidines; Rhizopus; Rhodotorula; Triazoles; Voriconazole | 2013 |
Schizophyllum commune: a new organism in eye infection.
Topics: Administration, Topical; Adult; Amphotericin B; Antifungal Agents; Cornea; Corneal Transplantation; DNA, Fungal; DNA, Ribosomal Spacer; Humans; Keratitis; Male; Molecular Sequence Data; Mycoses; Polymerase Chain Reaction; Pyrimidines; Schizophyllum; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Flucytosine; Humans; Incidence; India; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Dose-Response Relationship, Drug; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Triazoles; Voriconazole | 2013 |
Cerebral Scedosporium apiospermum infection presenting with intestinal manifestations.
Topics: Amphotericin B; Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Colitis, Ulcerative; Histocytochemistry; Humans; Male; Microscopy; Middle Aged; Psychosurgery; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
Disseminated paracoccidioidomycosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Humans; Male; Paracoccidioidomycosis; Pyrimidines; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Voriconazole | 2013 |
Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Genes, Fungal; Humans; Kuwait; Microbial Sensitivity Tests; Phylogeny; Pyrimidines; Statistics, Nonparametric; Triazoles; Voriconazole | 2013 |
Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycoses.
Topics: Amphotericin B; Antifungal Agents; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Pyrimidines; Schizophyllum; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Genotype; Humans; India; Itraconazole; Microbial Sensitivity Tests; Nitriles; Phenotype; Phylogeny; Polymerase Chain Reaction; Pyridines; Pyrimidines; Sequence Analysis, DNA; Tertiary Care Centers; Triazoles; Voriconazole; Young Adult | 2013 |
Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile.
Topics: Amphotericin B; Animals; Antifungal Agents; Caenorhabditis elegans; Candida; Candidiasis; Fluconazole; Lepidoptera; Pyrimidines; Triazoles; Voriconazole | 2013 |
In vitro antifungal susceptibility and molecular identity of 99 clinical isolates of the opportunistic fungal genus Curvularia.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Drug Resistance, Multiple, Fungal; Echinocandins; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Pyrimidines; Triazoles; Voriconazole | 2013 |
Outcomes of persons with blastomycosis involving the central nervous system.
Topics: Amphotericin B; Azoles; Biopsy; Blastomyces; Blastomycosis; Central Nervous System Fungal Infections; Humans; Magnetic Resonance Imaging; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Excavated pneumonia: an unusual suspect.
Topics: Adult; Amphotericin B; Antifungal Agents; Azoles; Communicable Diseases, Emerging; Fatal Outcome; Febrile Neutropenia; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Pyrimidines; Respiratory Distress Syndrome; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Species distribution and drug susceptibilities of Candida isolates in TSARY 2010.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candida; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Hospitals; Humans; Microbial Sensitivity Tests; Pyrimidines; Taiwan; Triazoles; Voriconazole | 2013 |
Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time bioluminescence imaging.
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Echinocandins; Luminescent Measurements; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2013 |
Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
Topics: Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azoles; Base Sequence; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Polyenes; Pyrimidines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sequence Analysis, DNA; Triazoles; Tunisia; Voriconazole | 2013 |
Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.
Topics: Acanthamoeba castellanii; Amebicides; Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Aza Compounds; Chlorhexidine; Colorimetry; Drug Combinations; Fluoroquinolones; HeLa Cells; Humans; Macrophages; Mice; Moxifloxacin; Ophthalmic Solutions; Parasitic Sensitivity Tests; Pyrimidines; Quinolines; Triazoles; Voriconazole | 2013 |
Amphotericin B- and voriconazole-echinocandin combinations against Aspergillus spp.: Effect of serum on inhibitory and fungicidal interactions.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Interactions; Echinocandins; Fungal Proteins; Humans; Microbial Sensitivity Tests; Pyrimidines; Serum; Triazoles; Voriconazole | 2013 |
Management of Fusarium keratitis and its associated fungal iris nodule with intracameral voriconazole and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fusariosis; Humans; Iris Diseases; Keratitis; Male; Middle Aged; Mycetoma; Voriconazole | 2014 |
Evaluation of the conjunctival fungal flora and its susceptibility to antifungal agents in healthy horses in Switzerland.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Conjunctiva; Eurotium; Female; Fluconazole; Fungi; Horses; Itraconazole; Male; Miconazole; Microbial Sensitivity Tests; Switzerland; Voriconazole | 2014 |
Acremonium sclerotigenum-Acremonium egyptiacum: a multi-resistant fungal pathogen complicating the course of aplastic anaemia.
Topics: Acremonium; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2014 |
An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Echinocandins; Female; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Phosphoproteins; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Superinfection; Transplantation, Homologous; Triazoles; Viral Matrix Proteins; Voriconazole; Young Adult | 2014 |
In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2013 |
Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense.
Topics: Acremonium; Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Echinocandins; Male; Mice; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2013 |
In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2013 |
Disseminated fusariosis with immune reconstitution syndrome and cracking mycotic aortic aneurysm in a 55-year-old patient with acute myeloid leukaemia.
Topics: Amphotericin B; Aneurysm, Infected; Antifungal Agents; Female; Fusariosis; Humans; Immune Reconstitution Inflammatory Syndrome; Immunocompromised Host; Leukemia, Myeloid, Acute; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2013 |
Improvement in the outcome of invasive fusariosis in the last decade.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Female; Fusariosis; Humans; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult | 2014 |
Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fusariosis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lipopeptides; Logistic Models; Male; Mycoses; Neutrophils; Prospective Studies; Pyrimidines; Retrospective Studies; Risk; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2014 |
Scedosporium prolificans fungaemia in a patient with acute lymphoblastic leukaemia.
Topics: Allografts; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Drug Substitution; Fatal Outcome; Female; Fluconazole; Fungemia; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Scedosporium; Triazoles; Voriconazole; Young Adult | 2013 |
[Three cases of fungemia caused by Blastoschizomyces capitatus].
Topics: Adult; Amphotericin B; Antifungal Agents; Caspofungin; Child; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Lymphoma, B-Cell; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Saccharomycetales; Triazoles; Voriconazole; Young Adult | 2013 |
In vitro evaluation of antifungal drug combinations against Sarocladium (Acremonium) kiliense, an opportunistic emergent fungus resistant to antifungal therapies.
Topics: Acremonium; Amphotericin B; Anidulafungin; Antifungal Agents; Drug Combinations; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2014 |
In vitro susceptibility of Candida species to four antifungal agents assessed by the reference broth microdilution method.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Turkey; Voriconazole | 2013 |
Acute meningitis caused by Cladosporium sphaerospermum.
Topics: Aged; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Cladosporium; Drug Therapy, Combination; Humans; Male; Meningitis, Fungal; Pyrimidines; Taiwan; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Perplexity of a fungus in the sinus.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Ascomycota; Benzenesulfonates; Brain Abscess; Central Nervous System Fungal Infections; Chronic Disease; Coloring Agents; Debridement; Epidural Abscess; Frontal Lobe; Frontal Sinus; Humans; Lactic Acid; Male; Phenols; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey.
Topics: Amphotericin B; Antifungal Agents; Cost-Benefit Analysis; Economics, Pharmaceutical; Humans; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Turkey; Voriconazole | 2013 |
Disseminated pulmonary penicilliosis in a rheumatoid arthritis patient.
Topics: Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Echinocandins; Humans; Hydrocortisone; Lipopeptides; Lung; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Fatal lower limb infection by Trichosporon asahii in an immunocompetent patient.
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Edema; Fatal Outcome; Female; Humans; Immunocompetence; Leg; Middle Aged; Trichosporonosis; Voriconazole | 2013 |
Chronic granulomatous invasive fungal sinusitis: an evolving approach to management.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Granuloma; Humans; Male; Pyrimidines; Sinusitis; Triazoles; Voriconazole | 2014 |
Successful treatment of larynx-tracheobronchial-pulmonary aspergillosis in an immunocompetent host.
Topics: Amphotericin B; Bronchi; Bronchoscopy; Female; Fiber Optic Technology; Humans; Immunocompetence; Larynx; Middle Aged; Pulmonary Aspergillosis; Tomography, X-Ray Computed; Trachea; Voriconazole | 2014 |
Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Brain Abscess; Debridement; Female; Humans; Immunosuppression Therapy; Itraconazole; Lung Abscess; Male; Middle Aged; Opportunistic Infections; Organ Transplantation; Phaeohyphomycosis; Retrospective Studies; Time Factors; Voriconazole; Young Adult | 2014 |
Antifungal susceptibility of Candida isolates at one institution.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Health Facilities; Humans; Itraconazole; Japan; Lipopeptides; Micafungin; Time Factors; Voriconazole | 2014 |
The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cyclosporine; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2014 |
Efficacy and safety of antifungal additives in Optisol-GS corneal storage medium.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Cell Count; Chondroitin Sulfates; Colony Count, Microbial; Complex Mixtures; Cornea; Culture Media, Serum-Free; Dextrans; Drug Combinations; Drug Contamination; Endothelium, Corneal; Gentamicins; Humans; Microbial Sensitivity Tests; Organ Preservation; Organ Preservation Solutions; Pyrimidines; Tissue Donors; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Experimental treatment of Curvularia infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Disease Models, Animal; Immunocompromised Host; Male; Mice; Mycoses; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Biological Assay; Candida albicans; Candidemia; Drug Resistance, Fungal; Gene Expression Profiling; Genetic Variation; Humans; Lepidoptera; Pyrimidines; Survival Analysis; Triazoles; Virulence; Voriconazole | 2014 |
Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphotericin c
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Echinocandins; Female; Fungi; History, 21st Century; Humans; Male; Middle Aged; Mucormycosis; United States; Voriconazole; Young Adult | 2014 |
Intrastromal antifungal injection with secondary lamellar interface infusion for late-onset infectious keratitis after DSAEK.
Topics: Administration, Oral; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Corneal Stroma; Corneal Ulcer; Descemet Stripping Endothelial Keratoplasty; Eye Infections, Fungal; Fluconazole; Humans; Infusions, Intralesional; Injections, Intraocular; Male; Microscopy, Confocal; Voriconazole | 2014 |
Nontraumatic paecilomyces anterior segment infection: a pathognomonic clinical appearance.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Eye Infections, Fungal; Female; Humans; Keratitis; Male; Middle Aged; Mycoses; Paecilomyces; Retrospective Studies; Scleritis; Voriconazole; Young Adult | 2014 |
In vitro activities of antifungal combinations against biofilms and planktonic forms of clinical Trichosporon asahii isolates.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Caspofungin; Drug Combinations; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Plankton; Trichosporon; Trichosporonosis; Voriconazole | 2014 |
Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Costs and Cost Analysis; Germany; Hematologic Diseases; Spain; Voriconazole | 2014 |
Caenorhabditis elegans: a simple nematode infection model for Penicillium marneffei.
Topics: Amphotericin B; Animals; Antifungal Agents; Caenorhabditis elegans; Disease Models, Animal; Fluconazole; Host-Pathogen Interactions; Hyphae; Itraconazole; Mycoses; Naphthalenes; Penicillium; Pigments, Biological; Survival Analysis; Terbinafine; Voriconazole | 2014 |
Comparison of Etests and Vitek 2 ® to broth microdilution for the susceptibility testing of Cryptococcus neoformans.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disk Diffusion Antimicrobial Tests; Fluconazole; Flucytosine; Humans; South Africa; Voriconazole | 2014 |
Toxicity of topical antifungal agents to stratified human cultivated corneal epithelial sheets.
Topics: Amphotericin B; Antifungal Agents; Cell Survival; Cells, Cultured; Echinocandins; Epithelium, Corneal; Humans; Lipopeptides; Micafungin; Ophthalmic Solutions; Voriconazole; Wound Healing | 2014 |
Invasive aspergillosis in liver transplant recipients: epidemiology, clinical characteristics, treatment, and outcomes in 116 cases.
Topics: Adult; Amphotericin B; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Cohort Studies; Female; Humans; Kaplan-Meier Estimate; Liver Failure; Liver Transplantation; Male; Middle Aged; Probability; Proportional Hazards Models; Renal Insufficiency; Transplant Recipients; Treatment Outcome; Voriconazole | 2015 |
Keratitis caused by Absidia corymbifera in an immunocompetent male with no corneal injuries.
Topics: Absidia; Administration, Ophthalmic; Adrenal Cortex Hormones; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Combined Modality Therapy; Corneal Transplantation; Corneal Ulcer; Drug Therapy, Combination; Humans; Immunocompetence; Male; Middle Aged; Mucormycosis; Ophthalmic Solutions; Staining and Labeling; Triazoles; Voriconazole | 2015 |
Exogenous fungal endophthalmitis: an analysis of isolates and susceptibilities to antifungal agents over a 20-year period (1990-2010).
Topics: Amphotericin B; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Voriconazole | 2015 |
Acremonium species associated fungemia: a novel pathogen in the immunosuppressed patient.
Topics: Acremonium; Aged; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Female; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Treatment Outcome; Voriconazole | 2014 |
Invasive aspergillosis presenting as swelling of the buccal mucosa in an immunocompetent individual.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Biopsy; Combined Modality Therapy; Contrast Media; Diagnosis, Differential; Diagnostic Imaging; Female; Granuloma; Humans; Mouth Mucosa; Voriconazole | 2015 |
In vitro susceptibility of amphotericin-B, voriconazole and caspofungin against Candida guilliermondii biofilms, isolated from dentals units water pipes, under different growth phases.
Topics: Algeria; Amphotericin B; Antifungal Agents; Biofilms; Candida; Caspofungin; Cross Infection; Dental Clinics; Dental Facilities; Dental Service, Hospital; Echinocandins; Equipment Contamination; Hospitals, University; Humans; Lipopeptides; Microbial Sensitivity Tests; Voriconazole; Water Quality | 2015 |
[Mixed types of pulmonary aspergillosis].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Glucocorticoids; Humans; Invasive Pulmonary Aspergillosis; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole | 2014 |
Treatment for a eumycetoma infection caused by Aspergillus in an immunocompromised host: a case report.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Fungi; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Mycetoma; United States; Voriconazole | 2015 |
Surveillance of antifungal susceptibilities in clinical isolates of Candida species at 36 hospitals in China from 2009 to 2013.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Child; Child, Preschool; China; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hospitals; Humans; Infant; Itraconazole; Middle Aged; Voriconazole; Young Adult | 2015 |
In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Mycoses; Phosphorylcholine; Scedosporium; Voriconazole | 2015 |
Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Cross-Sectional Studies; Humans; Lung Transplantation; Pre-Exposure Prophylaxis; Surveys and Questionnaires; United States; Voriconazole | 2015 |
Candidemia-induced pediatric sepsis and its association with free radicals, nitric oxide, and cytokine level in host.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Candida; Candidemia; Candidiasis; Child; Child, Preschool; Cross Infection; Cytokines; Female; Fluconazole; Free Radicals; Humans; Incidence; India; Infant; Infant, Newborn; Intensive Care Units; Interleukin-10; Interleukin-1beta; Male; Microbial Sensitivity Tests; Nitric Oxide; Nitric Oxide Synthase; Sepsis; Tumor Necrosis Factor-alpha; Voriconazole | 2015 |
Introduction of an antifungal stewardship programme targeting high-cost antifungals at a tertiary hospital in Cambridge, England.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Drug Prescriptions; Drug Utilization; Echinocandins; England; Female; Humans; Male; Middle Aged; Mycoses; Prospective Studies; Tertiary Care Centers; Voriconazole; Young Adult | 2015 |
In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Candida; China; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Mutation; Rhodotorula; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole | 2015 |
Phenotypic and molecular identification of Fonsecaea pedrosoi strains isolated from chromoblastomycosis patients in Mexico and Venezuela.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Ascomycota; Chromoblastomycosis; DNA, Ribosomal Spacer; Female; Humans; Itraconazole; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Mitosporic Fungi; Molecular Sequence Data; Phenotype; Sequence Analysis, DNA; Skin; Venezuela; Voriconazole | 2015 |
The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
Topics: Amphotericin B; Animals; Antifungal Agents; Caspofungin; Disease Models, Animal; Drug Resistance, Fungal; Echinocandins; Fluconazole; Immunocompromised Host; Kidney; Larva; Lipopeptides; Mice; Microbial Sensitivity Tests; Moths; Trichosporon; Trichosporonosis; Voriconazole | 2015 |
In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Epidermophyton; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Nitriles; Pyridines; Terbinafine; Tinea; Triazoles; Trichophyton; Voriconazole | 2015 |
Trichosporon inkin as an Emergent Pathogen in Patients With Severe Pemphigus.
Topics: Aged; Amphotericin B; Antifungal Agents; Child; Drug Resistance, Fungal; Fatal Outcome; Female; Humans; Male; Microbial Sensitivity Tests; Opportunistic Infections; Pemphigus; Severity of Illness Index; Trichosporon; Trichosporonosis; Voriconazole | 2015 |
Cph1p negatively regulates MDR1 involved in drug resistance in Candida albicans.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Drug Resistance, Multiple, Fungal; Fluconazole; Fungal Proteins; Gene Expression; Gene Expression Regulation, Fungal; Gene Knockout Techniques; Mice; Saccharomyces cerevisiae; Virulence; Voriconazole | 2015 |
[Genotypes and in vitro antifungal susceptibility of Cryptococcus isolates in Sichuan Province].
Topics: Amphotericin B; Antifungal Agents; China; Cryptococcus; Fluconazole; Flucytosine; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Polymorphism, Restriction Fragment Length; Voriconazole | 2015 |
In vitro activity of calcium sulfate and hydroxyapatite antifungal disks loaded with amphotericin B or voriconazole in consideration for adjunctive osteomyelitis management.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Calcium Sulfate; Cells, Cultured; Delayed-Action Preparations; Dental Materials; Humans; Hydroxyapatites; Microbial Sensitivity Tests; Osteoblasts; Osteomyelitis; Voriconazole | 2015 |
[Histoplasmosis: the multiple sides of an uncommon disease].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Deoxycholic Acid; Diagnosis, Differential; Drug Combinations; Female; Hepatitis B, Chronic; Hepatitis D, Chronic; Histoplasmosis; Homosexuality, Male; Humans; Immunocompromised Host; Invasive Fungal Infections; Italy; Male; Risk Factors; Thailand; Treatment Outcome; Voriconazole | 2015 |
Comparative antifungal susceptibility analysis of Candida albicans versus non-albicans Candida corneal isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Corneal Ulcer; Eye Infections, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Natamycin; Voriconazole | 2015 |
Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Humans; Microbial Sensitivity Tests; Voriconazole | 2015 |
Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report.
Topics: Adult; Amphotericin B; Amputation, Surgical; Antifungal Agents; Aspergillosis; Blast Injuries; Burns; Critical Illness; Debridement; Drug Monitoring; Fusariosis; Humans; Male; Mucormycosis; Mycoses; Voriconazole; War-Related Injuries; Wounds, Penetrating | 2015 |
Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Carcinoma; Caspofungin; Chemoradiotherapy; Chemotherapy, Adjuvant; Drug Resistance, Fungal; Echinocandins; Exophiala; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Lipopeptides; Male; Middle Aged; Mouth Diseases; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Opportunistic Infections; Phaeohyphomycosis; Radiotherapy, Intensity-Modulated; Voriconazole | 2015 |
Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised Patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Cost Savings; Decision Trees; Deoxycholic Acid; Drug Combinations; Echinocandins; Febrile Neutropenia; Galactose; Health Care Costs; Health Resources; Humans; Immunocompromised Host; Lipopeptides; Mannans; Survival Rate; Voriconazole | 2015 |
Optimization of polyene-azole combination therapy against aspergillosis using an in vitro pharmacokinetic-pharmacodynamic model.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Azoles; Drug Interactions; Drug Monitoring; Drug Resistance, Fungal; Drug Therapy, Combination; Half-Life; Humans; Microbial Sensitivity Tests; Models, Statistical; Monte Carlo Method; Polyenes; Voriconazole | 2015 |
Antifungal Treatment in Stem Cell Transplantation Centers in Turkey.
Topics: Adult; Allografts; Amphotericin B; Antifungal Agents; Child; Cross Infection; Diagnostic Tests, Routine; Drug Substitution; Drug Therapy, Combination; Drug Utilization; Febrile Neutropenia; Health Care Surveys; Health Facilities; Humans; Infection Control; Mycoses; Stem Cell Transplantation; Transplantation, Autologous; Turkey; Voriconazole | 2016 |
Prior in vitro exposure to voriconazole confers resistance to amphotericin B in Aspergillus fumigatus biofilms.
Topics: Amphotericin B; Aspergillus fumigatus; Biofilms; DNA, Fungal; Drug Resistance, Fungal; HSP90 Heat-Shock Proteins; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Tetrazolium Salts; Voriconazole | 2015 |
Current therapeutic protocols for chronic granulomatous fungal sinusitis.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Chronic Disease; Combined Modality Therapy; Female; Granuloma; Humans; Itraconazole; Male; Middle Aged; Mycoses; Sinusitis; Treatment Outcome; Voriconazole | 2015 |
Multidrug-resistant Trichosporon: an unusual fungal sepsis in preterm neonates.
Topics: Amphotericin B; Antifungal Agents; Communicable Diseases; Drug Administration Schedule; Drug Resistance, Fungal; Fatal Outcome; Guideline Adherence; Humans; Infant; Infant, Newborn; Infant, Premature; Sepsis; Trichosporon; Trichosporonosis; Voriconazole | 2015 |
First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA Mutational Analysis; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Promoter Regions, Genetic; Triazoles; Turkey; Voriconazole; Young Adult | 2015 |
First recovery of Rasamsonia argillacea species complex isolated in adolescent patient with cystic fibrosis in Slovenia--case report and review of literature.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Cystic Fibrosis; Echinocandins; Eurotiales; Humans; Lipopeptides; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Pharynx; Sequence Analysis, DNA; Slovenia; Voriconazole; Young Adult | 2015 |
In vitro and in vivo study on the effect of antifungal agents on hematopoietic cells in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Caspofungin; Dose-Response Relationship, Drug; Echinocandins; Female; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Granulocytes; Hematopoietic Stem Cells; Lipopeptides; Mice; Mice, Inbred C57BL; Voriconazole | 2015 |
Voriconazole: a novel treatment option for cryptococcal meningitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Carbon; China; Cryptococcus neoformans; Diagnostic Errors; Drug Therapy, Combination; Female; Fluconazole; Humans; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Risk Factors; Tertiary Care Centers; Time Factors; Voriconazole | 2015 |
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole | 2015 |
Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candida albicans; Candida glabrata; Candidiasis; Candidiasis, Invasive; Carrier State; Caspofungin; Critical Care; Echinocandins; Female; Fluconazole; Humans; Incidence; Intensive Care Units; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Sensitivity and Specificity; Singapore; Tertiary Care Centers; Voriconazole | 2015 |
Epidemiological and mycological characteristics of candidemia in patients with hematological malignancies attending a tertiary-care center in India.
Topics: Amphotericin B; Candida albicans; Candida tropicalis; Candidemia; Cross-Sectional Studies; Female; Hematologic Neoplasms; Humans; India; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nystatin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prevalence; Risk Factors; Tertiary Care Centers; Voriconazole | 2015 |
In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.
Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Genotype; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
Invasive Primary Colonic Aspergillosis in the Immunocompetent Host without Classical Risk Factors.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Colon; Colonic Diseases; Combined Modality Therapy; Humans; Immunocompetence; Laparotomy; Male; Middle Aged; Radiography; Treatment Outcome; Voriconazole | 2015 |
Invasive infection due to Saprochaete capitata in a young patient with hematological malignancies.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Lipopeptides; Lung; Male; Microbial Sensitivity Tests; Microbiological Techniques; Microscopy; Radiography, Thoracic; Saccharomycetales; Treatment Outcome; Voriconazole | 2015 |
In vitro interactions of antifungal agents and tacrolimus against Aspergillus biofilms.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Biofilms; Tacrolimus; Voriconazole | 2015 |
Clinical Characteristics, Laboratory Identification, and In Vitro Antifungal Susceptibility of Yarrowia (Candida) lipolytica Isolates Causing Fungemia: a Multicenter, Prospective Surveillance Study.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Base Sequence; Catheter-Related Infections; Catheterization, Central Venous; Catheterization, Peripheral; Child, Preschool; DNA, Ribosomal Spacer; Echinocandins; Female; Fungemia; Hospitalization; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Prospective Studies; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Voriconazole; Yarrowia | 2015 |
Atypical Clinical Presentation of a Newer Generation Anti-Fungal Drug-Resistant Fusarium Infection After a Modified Multi-Visceral Transplant.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Esophagus; Fatal Outcome; Female; Fusariosis; Humans; Immunocompromised Host; Middle Aged; Organ Transplantation; Palate, Hard; Treatment Failure; Voriconazole | 2015 |
In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
Cryptococcus uniguttulatus Meningitis.
Topics: Administration, Intravenous; Aged; Amphotericin B; Antifungal Agents; Cryptococcus; Drug Substitution; Female; Fluconazole; Glucocorticoids; Humans; Immunocompromised Host; Meningitis, Cryptococcal; Spinal Puncture; Treatment Outcome; Voriconazole | 2015 |
Evaluation of paper gradient concentration strips for antifungal combination testing of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Caspofungin; Chi-Square Distribution; Drug Synergism; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Reagent Kits, Diagnostic; Reproducibility of Results; Voriconazole | 2015 |
Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species.
Topics: Amphotericin B; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Nitriles; Pyridines; Species Specificity; Triazoles; Voriconazole | 2015 |
Pseudallescheria boydii with Aspergillus fumigatus and Aspergillus terreus in a Critically Ill Hematopoietic Stem Cell Recipient with ARDS.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; beta-Glucans; Clarithromycin; Coinfection; Critical Illness; Extracorporeal Membrane Oxygenation; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Linezolid; Male; Mannans; Meropenem; Pneumonia; Pseudallescheria; Severe Acute Respiratory Syndrome; Thienamycins; Transplant Recipients; Voriconazole | 2016 |
Comparison of two antifungal susceptibility testing of Candida sp. isolates using agar diffusion method: Neo-sensitabs® tablets and Bio-rad® disks.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Immunodiffusion; Microbial Sensitivity Tests; Prospective Studies; Tablets; Voriconazole | 2016 |
Aspergillus Mediastinitis after Orthotopic Heart Transplantation: A Case Report.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Combined Modality Therapy; Debridement; Drainage; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Transplantation; Humans; Mediastinitis; Middle Aged; Reoperation; Surgical Flaps; Surgical Wound Infection; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2015 |
In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Azoles; Coordination Complexes; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Peptides, Cyclic; Triazoles; Voriconazole | 2016 |
A Comparative Treatment Study of Intravitreal Voriconazole and Liposomal Amphotericin B in an Aspergillus fumigatus Endophthalmitis Model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Electroretinography; Endophthalmitis; Eye Infections, Fungal; Guinea Pigs; Intravitreal Injections; Voriconazole | 2015 |
Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Eye; Eye Infections, Fungal; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
Inhibition of heat-shock protein 90 enhances the susceptibility to antifungals and reduces the virulence of Cryptococcus neoformans/Cryptococcus gattii species complex.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Caenorhabditis elegans; Cell Membrane; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Ergosterol; Fluconazole; HSP90 Heat-Shock Proteins; Humans; Itraconazole; Melanins; Microbial Sensitivity Tests; Plankton; Voriconazole | 2016 |
Diagnosis and management of aspergillosis in the Netherlands: a national survey.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Humans; Netherlands; Surveys and Questionnaires; Voriconazole | 2016 |
Virulence and Resistance to Antifungal Therapies of Scopulariopsis Species.
Topics: Amphotericin B; Animals; Antifungal Agents; Cyclophosphamide; Disease Models, Animal; Drug Resistance, Fungal; Humans; Immunocompromised Host; Male; Mice; Mycoses; Neutropenia; Scopulariopsis; Species Specificity; Survival Analysis; Triazoles; Virulence; Voriconazole | 2016 |
Coccidioidomycosis in infants: A retrospective case series.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Coccidioidomycosis; Cough; Diagnosis, Differential; Echinocandins; Endemic Diseases; Female; Fever; Fluconazole; Humans; Infant; Lipopeptides; Lung Diseases, Fungal; Male; Retrospective Studies; Treatment Outcome; Voriconazole | 2016 |
Aspergillus mediastinitis after cardiac surgery.
Topics: Adult; Amphotericin B; Aspergillosis; Aspergillus fumigatus; Cardiac Surgical Procedures; Caspofungin; Echinocandins; Female; Humans; Lipopeptides; Mediastinitis; Voriconazole | 2016 |
In vitro antifungal susceptibility of clinical species belonging to Aspergillus genus and Rhizopus oryzae.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Base Sequence; Caspofungin; DNA, Fungal; Echinocandins; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Rhizopus; Tubulin; Voriconazole | 2016 |
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
Acute isolated appendicitis due to Aspergillus carneus in a neutropenic child with acute myeloid leukemia.
Topics: Acute Disease; Acyclovir; Amphotericin B; Antifungal Agents; Appendicitis; Aspergillosis; Aspergillus; Child; Ciprofloxacin; Fluconazole; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Voriconazole | 2016 |
In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus, an opportunistic fungal pathogen.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Environmental Microbiology; Humans; Iran; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Opportunistic Infections; Triazoles; Voriconazole | 2016 |
In Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus Species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Benzoxazoles; Caspofungin; Drug Combinations; Drug Synergism; Echinocandins; Fungal Proteins; Gene Expression; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; TOR Serine-Threonine Kinases; Triazoles; Voriconazole | 2016 |
Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
Topics: Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Echinocandins; Fluconazole; HEK293 Cells; Humans; Itraconazole; Lipopeptides; Micafungin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Triazoles; Voriconazole | 2016 |
Voriconazole combined with low-dose amphotericin B liposome for treatment of cryptococcal meningitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Humans; Male; Meningitis, Cryptococcal; Voriconazole | 2016 |
Emerging pan-resistance in Trichosporon species: a case report.
Topics: Amphotericin B; Antifungal Agents; Cholangitis; Drug Resistance, Fungal; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Peritonitis; Phylogeny; Trichosporon; Trichosporonosis; Voriconazole | 2016 |
Evaluation of antifungal combination against Cryptococcus spp.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Drug Combinations; Drug Synergism; Fluconazole; Flucytosine; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Typing; Naphthalenes; Polymorphism, Restriction Fragment Length; Terbinafine; Voriconazole | 2016 |
Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India.
Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Genotype; Humans; India; Itraconazole; Male; Microbial Sensitivity Tests; Mycological Typing Techniques; Phenotype; Sequence Analysis, DNA; Triazoles; Trichosporon; Trichosporonosis; Voriconazole | 2016 |
Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Drug Resistance, Fungal; Eye Diseases; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Natamycin; Opportunistic Infections; Peptide Hydrolases; Phospholipases; Virulence; Virulence Factors; Voriconazole | 2016 |
Fungal infection of cystic fibrosis patients - single center experience.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Candida albicans; Candida tropicalis; Cystic Fibrosis; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Scedosporium; Triazoles; Voriconazole; Yeasts | 2016 |
Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Species Specificity; Triazoles; Voriconazole | 2016 |
Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fusariosis; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Treatment Outcome; Voriconazole; Young Adult | 2016 |
In vitro resistance of clinical Fusarium species to amphotericin B and voriconazole using the EUCAST antifungal susceptibility method.
Topics: Adult; Aged, 80 and over; Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Female; Fusariosis; Fusarium; Humans; Male; Microbial Sensitivity Tests; Voriconazole; Young Adult | 2016 |
Identification of Ebsulfur Analogues with Broad-Spectrum Antifungal Activity.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Candida; Fluconazole; HEK293 Cells; Hemolysis; Heterocyclic Compounds, 2-Ring; Humans; Itraconazole; Mice; Microbial Sensitivity Tests; Reactive Oxygen Species; Structure-Activity Relationship; Thiazoles; Triazoles; Voriconazole | 2016 |
A Comparative Study of the Effects of Intravitreal Anidulafungin, Voriconazole, and Amphotericin B in an Experimental Candida Endophthalmitis Model.
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Conjunctiva; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Intravitreal Injections; Iris; Male; Rabbits; Vitreous Body; Voriconazole | 2017 |
Lasiodiplodia species fungal osteomyelitis in a multiple myeloma patient.
Topics: Aged; Amphotericin B; Amputation, Surgical; Antifungal Agents; Antineoplastic Agents; Ascomycota; Biopsy; Blood Cell Count; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Multiple Myeloma; Osteomyelitis; Skin; Toes; Transplantation, Autologous; Treatment Refusal; Voriconazole | 2016 |
Favorable Outcomes of Filamentous Fungal Endophthalmitis Following Aggressive Management.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Female; Fusarium; Humans; Intravitreal Injections; Male; Microbial Sensitivity Tests; Middle Aged; Phyllachorales; Retrospective Studies; Scedosporium; Treatment Outcome; Voriconazole; Young Adult | 2016 |
Airway Obstruction Due to Invasive Tracheobronchial Aspergillosis.
Topics: Aged; Amphotericin B; Antifungal Agents; Bronchoscopy; Caspofungin; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Lipopeptides; Male; Pulmonary Aspergillosis; Tomography Scanners, X-Ray Computed; Voriconazole | 2016 |
Breakthrough invasive fungal diseases during voriconazole treatment for aspergillosis: A 5-year retrospective cohort study.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Female; Humans; Incidence; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prevalence; Retrospective Studies; Survival Analysis; Voriconazole | 2017 |
Disseminated penicilliosis due to Penicillium chrysogenum in a pediatric patient with Henoch-Schönlein syndrome.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Child; Echinocandins; Fever; Glomerulonephritis; Humans; Hyalohyphomycosis; IgA Vasculitis; Immunocompromised Host; Kidney Failure, Chronic; Lipopeptides; Male; Penicillium chrysogenum; Spleen; Splenectomy; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole | 2016 |
Antifungal susceptibility testing of Malassezia yeast: comparison of two different methodologies.
Topics: Agar; Amphotericin B; Antifungal Agents; Culture Media; Fluconazole; Itraconazole; Malassezia; Miconazole; Microbial Sensitivity Tests; Voriconazole | 2017 |
Treatment-related myelodysplastic syndrome (t-MDS)/acute myeloid leukemia (AML) in children with cancer: A single-center experience.
Topics: Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Humans; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasms, Second Primary; Retrospective Studies; Voriconazole | 2016 |
Combined antifungal therapy against systemic murine infections by rare Cryptococcus species.
Topics: Administration, Intravenous; Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Fluconazole; Immunocompromised Host; Lung; Mice; Microbial Sensitivity Tests; Spleen; Voriconazole | 2017 |
Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species.
Topics: Amphotericin B; Antifungal Agents; Fungal Proteins; Fusarium; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2017 |
The First Isolation of Aspergillus allahabadii from a Cormorant with Pulmonary Aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Bird Diseases; Birds; Child; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Pulmonary Aspergillosis; Voriconazole | 2016 |
Tintelnotia, a new genus in Phaeosphaeriaceae harbouring agents of cornea and nail infections in humans.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Cornea; Echinocandins; Eye Infections, Fungal; Female; Humans; Itraconazole; Keratitis; Lipopeptides; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Phylogeny; Terbinafine; Triazoles; Voriconazole | 2017 |
Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungal Proteins; Gene Expression; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; RNA, Messenger; Sequence Analysis, DNA; Voriconazole | 2017 |
Invasive pulmonary aspergillosis after near-drowning.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fatal Outcome; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Near Drowning; Shock, Septic; Voriconazole | 2016 |
[A rare and mortal infection agent in patients with hematological malignancies: Saprochaete capitata].
Topics: Adult; Amphotericin B; Animals; Antifungal Agents; Caspofungin; Catheter-Related Infections; Echinocandins; Fatal Outcome; Female; Fungemia; Humans; Leukemia; Lipopeptides; Moths; Mycoses; Opportunistic Infections; Saccharomycetales; Voriconazole; Young Adult | 2016 |
Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Echinocandins; Female; Fluconazole; Fungemia; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Invasive Fungal Infections; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Registries; Saccharomycetales; Voriconazole; Young Adult | 2017 |
In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
Topics: Amidines; Amphotericin B; Animals; Antifungal Agents; Brain; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Disease Models, Animal; Drug Discovery; Drug Resistance, Fungal; Fluconazole; Humans; Lung; Lung Diseases, Fungal; Mice; Microbial Sensitivity Tests; Voriconazole | 2017 |
Fungal Contamination of Methylprednisolone Causing Recurrent Lumbosacral Intradural Abscess.
Topics: Abscess; Aged; Amphotericin B; Antifungal Agents; Ascomycota; Drug Contamination; Female; Humans; Meningitis, Fungal; Methylprednisolone; Recurrence; Voriconazole | 2017 |
Does a triple combination have better activity than double combinations against multiresistant fungi? Experimental in vitro evaluation.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Drug Synergism; Echinocandins; Voriconazole | 2017 |
New pharmacological opportunities for the treatment of invasive mould diseases.
Topics: Amphotericin B; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Echinocandins; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Triazoles; Voriconazole | 2017 |
Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Intensive Care Units; Microbial Sensitivity Tests; Voriconazole | 2017 |
Assessment of high-priced systemic antifungal prescriptions.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Middle Aged; Multiple Organ Failure; Mycoses; Organ Transplantation; Retrospective Studies; Survival Rate; Treatment Outcome; Voriconazole; Young Adult | 2017 |
A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidemia; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Infant; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Peru; Prospective Studies; Triazoles; Voriconazole; Young Adult | 2017 |
The Use of FDG PET-CT Imaging for the Assessment of Early Antifungal Treatment Response in Disseminated Fusariosis.
Topics: Amphotericin B; Antifungal Agents; Child; Female; Fluorodeoxyglucose F18; Fusariosis; Fusarium; Humans; Positron Emission Tomography Computed Tomography; Skin; Treatment Outcome; Voriconazole | 2017 |
Endomyocardial and pericardial aspergillosis in critically ill patients.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Critical Illness; Echinocandins; Female; Heart Diseases; Humans; Immunocompetence; Immunocompromised Host; Incidence; Invasive Fungal Infections; Lipopeptides; Male; Middle Aged; Myocardium; Pericardium; Risk Factors; Voriconazole | 2017 |
Diversity, in-vitro virulence traits and antifungal susceptibility pattern of gastrointestinal yeast flora of healthy poultry, Gallus gallus domesticus.
Topics: Amphotericin B; Animals; Antifungal Agents; Biodiversity; Biofilms; Caspofungin; Chickens; Colony Count, Microbial; Drug Resistance, Fungal; Echinocandins; Fluconazole; Gastrointestinal Microbiome; Lipopeptides; Microbial Sensitivity Tests; Nepal; Poultry; Virulence; Virulence Factors; Voriconazole; Yeasts | 2017 |
Candidiasis: Prevalence and resistance profiling in a tertiary care hospital of Pakistan.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Cross-Sectional Studies; Drug Resistance, Fungal; Fluconazole; Humans; Ketoconazole; Kidney Failure, Chronic; Kidney Transplantation; Microbial Sensitivity Tests; Pakistan; Prevalence; Prospective Studies; Tertiary Care Centers; Voriconazole | 2017 |
Claviform aspergillus-related vegetation in the left ventricle of a patient with systemic lupus erythematosus.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Echocardiography; Female; Heart Diseases; Heart Ventricles; Humans; Lupus Erythematosus, Systemic; Voriconazole | 2018 |
Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis.
Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Fusariosis; Fusarium; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Nails; Naphthalenes; Onychomycosis; Terbinafine; Voriconazole | 2017 |
Respiratory Tract Infection Caused by Fonsecaea monophora After Kidney Transplantation.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Brazil; DNA, Ribosomal Spacer; Female; Humans; Kidney Transplantation; Lung Diseases, Fungal; Middle Aged; Toxoplasma; Toxoplasmosis, Cerebral; Voriconazole | 2017 |
Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillus; Clinical Decision-Making; Critical Illness; Delayed Diagnosis; Drug Therapy, Combination; Echinocandins; Female; Fungal Proteins; Humans; Intensive Care Units; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prognosis; Respiratory System; Treatment Outcome; Voriconazole | 2017 |
Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a
Topics: Aged; Alleles; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Azoles; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Lipopeptides; Male; Microbial Sensitivity Tests; Mutation; Treatment Outcome; Triazoles; Voriconazole | 2017 |
Prevalence and antifungal susceptibility of Candida species in a tertiary care hospital in Islamabad, Pakistan.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidiasis; Candidiasis, Vulvovaginal; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Fungal; Female; Fluconazole; Humans; Infant; Infant, Newborn; Inpatients; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Outpatients; Pakistan; Prevalence; Prospective Studies; Respiratory Tract Infections; Tertiary Care Centers; Urinary Tract Infections; Voriconazole; Young Adult | 2017 |
Proteomic profiling of the antifungal drug response of Aspergillus fumigatus to voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Electrophoresis, Gel, Two-Dimensional; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Proteomics; RNA, Fungal; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Terbinafine; Up-Regulation; Voriconazole | 2017 |
Effects of Photodynamic Therapy on the Growth and Antifungal Susceptibility of Scedosporium and Lomentospora spp.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Humans; Immunocompromised Host; Itraconazole; Methylene Blue; Microbial Sensitivity Tests; Photochemotherapy; Photosensitizing Agents; Scedosporium; Triazoles; Voriconazole | 2017 |
In vitro evaluation of antimicrobial agents on Acanthamoeba sp. and evidence of a natural resilience to amphotericin B.
Topics: Acanthamoeba castellanii; Acanthamoeba Keratitis; Amebiasis; Amphotericin B; Anti-Infective Agents; Benzamidines; Humans; Inhibitory Concentration 50; Parasitic Sensitivity Tests; Voriconazole | 2017 |
[A case of pulmonary alternariosis complicated with aspergillosis].
Topics: Alternariosis; Amphotericin B; Antifungal Agents; Aspergillosis; Female; Humans; Lung Diseases, Fungal; Middle Aged; Treatment Outcome; Voriconazole | 2017 |
Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Child; Cryptococcus; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Follow-Up Studies; Humans; Intracranial Pressure; Male; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Middle Aged; Tertiary Care Centers; Treatment Outcome; Voriconazole | 2018 |
[Vertebral osteomyelitis due to Candida tropicalis secondary to candidemia. A case report].
Topics: Adult; Amphotericin B; Antifungal Agents; Candida tropicalis; Candidemia; Humans; Male; Osteomyelitis; Voriconazole | 2017 |
Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study.
Topics: Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillus; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Male; Neutropenia; Nitriles; Pyridines; Transaminases; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2018 |
Outbreak of invasive aspergillosis in heart transplant recipients: The role of screening computed tomography scans in asymptomatic patients and universal antifungal prophylaxis.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Asymptomatic Diseases; Cohort Studies; Disease Outbreaks; Echinocandins; Female; Galactose; Heart Transplantation; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Mass Screening; Micafungin; Middle Aged; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Transplant Recipients; Voriconazole | 2018 |
Do antibacterial and antifungal combinations have better activity against clinically relevant fusarium species? in vitro synergism.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Drug Synergism; Drug Therapy, Combination; Echinocandins; Fusarium; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Voriconazole | 2018 |
Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cross-Sectional Studies; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Hospitals, University; Humans; Immunocompromised Host; Iran; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2017 |
Endogenous Fusarium Endophthalmitis During Treatment for Acute Myeloid Leukemia, Successfully Treated with 25-Gauge Vitrectomy and Antifungal Medications.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Dermatomycoses; Endophthalmitis; Fusariosis; Fusarium; Humans; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Splenic Diseases; Treatment Outcome; Vitrectomy; Voriconazole | 2018 |
[Treatment of Invasive Fungal Infection in Childhood Acute Lymphoblastic Leukemia with Amphotericin B and Voriconazole].
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Child; Humans; Invasive Fungal Infections; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Voriconazole | 2017 |
Identification and antifungal susceptibility of Candida species isolated from the urine of patients in a university hospital in Brazil.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis; Drug Resistance, Fungal; Electrophoresis, Agar Gel; Female; Fluconazole; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Random Amplified Polymorphic DNA Technique; Treatment Outcome; Urinary Tract Infections; Voriconazole; Young Adult | 2017 |
Modulatory effect of voriconazole on the production of proinflammatory cytokines in experimental cryptococcosis in mice with severe combined immunodeficiency.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Inflammation; Lung; Lung Diseases, Fungal; Mice; Severe Combined Immunodeficiency; Voriconazole | 2018 |
[Tintelnotia destructans: new enemy at the gates].
Topics: Amphotericin B; Antifungal Agents; Eye Infections, Fungal; Humans; Keratitis; Voriconazole | 2018 |
Successful treatment of cerebral aspergillosis: case report of a patient with T-cell large granular lymphocytic leukemia (T-LGL).
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Brain; Humans; Leukemia, Large Granular Lymphocytic; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, X-Ray Computed; Voriconazole | 2017 |
3,5-Dicaffeoylquinic Acid Disperses Aspergillus Fumigatus Biofilm and Enhances Fungicidal Efficacy of Voriconazole and Amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Biofilms; Biomass; Blood Cells; Chlorogenic Acid; Fungal Proteins; Gene Expression Regulation, Fungal; Hemolysis; Humans; Microbial Sensitivity Tests; Polysaccharides; Voriconazole | 2018 |
[In vitro susceptibility of Cuban Aspergillus spp. strains of clinical and environmental origin].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Cuba; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Environmental Microbiology; Hospitals; Humans; Itraconazole; Microbial Sensitivity Tests; Voriconazole | 2017 |
Double invasive fungal infection due to dematiaceous moulds in a renal transplant patient.
Topics: Alternaria; Alternariosis; Amphotericin B; Antifungal Agents; Ascomycota; Fatal Outcome; Humans; Immunocompromised Host; Invasive Fungal Infections; Kidney Transplantation; Knee; Lung Diseases, Fungal; Male; Middle Aged; Pneumonia; Risk Factors; Voriconazole | 2018 |
Topics: Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Endophthalmitis; Eye; Female; Fusarium; Humans; Hyphae; Immunocompromised Host; Leukemia, Myeloid, Acute; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole | 2018 |
The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis, Invasive; Caspofungin; Drug Resistance, Fungal; Female; Fluconazole; Hospitals; Humans; Infant, Newborn; Infant, Premature; Iran; Itraconazole; Male; Microbial Sensitivity Tests; Voriconazole | 2018 |
Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Echinocandins; HIV Infections; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Reagent Kits, Diagnostic; Talaromyces; Voriconazole | 2018 |
A proposal for antifungal epidemiological cut-off values against Histoplasma capsulatum var. capsulatum based on the susceptibility of isolates from HIV-infected patients with disseminated histoplasmosis in Northeast Brazil.
Topics: Amphotericin B; Antifungal Agents; Brazil; Caspofungin; Echinocandins; Fluconazole; Histoplasma; Histoplasmosis; HIV; HIV Infections; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Retrospective Studies; Voriconazole | 2018 |
Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Critical Illness; Echinocandins; Extracorporeal Membrane Oxygenation; Female; Galactose; Humans; Immunocompromised Host; Influenza, Human; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Micafungin; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Voriconazole; Young Adult | 2018 |
[Fungal keratitis: A 5-year monocentric retrospective study on Reunion Island].
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Corneal Injuries; Eye Infections, Fungal; Female; Fusariosis; Hospitals, University; Humans; Keratitis; Male; Middle Aged; Retrospective Studies; Reunion; Voriconazole; Wound Infection | 2018 |
Relevance of antifungal penetration in biofilm-associated resistance of Candida albicans and non-albicans Candida species.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Candida albicans; Candidiasis; Drug Resistance, Fungal; Humans; Voriconazole | 2018 |
An unexpected diagnosis in a patient with 2 left atrial pathological masses found by echocardiography.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Echocardiography; Endocarditis; Fatal Outcome; Female; Heart Atria; Humans; Micafungin; Middle Aged; Myxoma; Voriconazole | 2018 |
Failure of voriconazole therapy due to acquired azole resistance in Aspergillus fumigatus in a kidney transplant recipient with chronic necrotizing aspergillosis.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Invasive Pulmonary Aspergillosis; Kidney Transplantation; Male; Mutation; Prognosis; Voriconazole | 2018 |
Disseminated Exophiala dermatitidis causing septic arthritis and osteomyelitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Arthritis, Infectious; Exophiala; Female; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Osteomyelitis; Phaeohyphomycosis; Triazoles; Voriconazole | 2018 |
Mycotic Keratitis Caused by Fusarium solani sensu stricto (FSSC5): A Case Series.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Eye Infections, Fungal; Eye Injuries; Female; Fungal Proteins; Fusariosis; Fusarium; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Netherlands; Peptide Elongation Factor 1; Sequence Analysis, DNA; Treatment Outcome; Turkey; Voriconazole | 2018 |
A Case of Conjunctival Ulcer and Uveitis Caused by Acrophialophora Sp. in an Immunocompromised Patient: a Case Report and Riterature Review.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Ascomycota; Child; Child, Preschool; Cluster Analysis; Conjunctival Diseases; DNA, Fungal; DNA, Ribosomal Spacer; Eye Infections, Fungal; Female; Humans; Immunocompromised Host; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; RNA, Ribosomal; Sequence Analysis, DNA; Treatment Outcome; Ulcer; Uveitis; Voriconazole | 2018 |
Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Ascomycota; Brazil; Caspofungin; Chromoblastomycosis; DNA, Fungal; DNA, Intergenic; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Voriconazole | 2018 |
Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Candida glabrata; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Itraconazole; Lanosterol; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Sterol 14-Demethylase; Triazoles; Voriconazole | 2018 |
Treatment of Suspected Invasive Fungal Infection in War Wounds.
Topics: Administration, Topical; Afghan Campaign 2001-; Amphotericin B; Antifungal Agents; beta-Cyclodextrins; Debridement; Excipients; Humans; Mycoses; Recurrence; Risk Factors; Tobramycin; Treatment Outcome; Triazoles; Vancomycin; Voriconazole; Wounds and Injuries | 2018 |
Lack of correlation of ECV and outcome in an in vivo murine model of systemic fusariosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Fusariosis; Fusarium; Mice; Voriconazole | 2018 |
Invasive Curvularia Infection in Pediatric Patients With Hematologic Malignancy Identified by Fungal Sequencing.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Child; Dermatomycoses; Female; Humans; Immunocompromised Host; Male; Opportunistic Infections; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; RNA, Ribosomal, 28S; Sequence Analysis, DNA; Voriconazole | 2019 |
Impact of Antifungal Compounds on Viability and Anti-
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Cell Survival; Deoxycholic Acid; Doxorubicin; Drug Combinations; Fluconazole; Humans; Killer Cells, Natural; Microbial Sensitivity Tests; Polyethylene Glycols; Triazoles; Voriconazole | 2019 |
Clinical Significance of the Floral Shift in Candidiasis.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Fluconazole; Humans; Nystatin; Oils, Volatile; Voriconazole | 2018 |
Disseminated blastomycosis with cutaneous lesions mimicking tuberculosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Brain; Diagnosis, Differential; Histocytochemistry; Humans; Male; Skin; Treatment Outcome; Tuberculosis, Cutaneous; Voriconazole | 2018 |
[Successful treatment of disseminated fusariosis in a febrile neutropenic patient with combined antifungal therapy of voriconazol plus amphotericin B deoxycholate].
Topics: Adolescent; Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fusariosis; Humans; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Voriconazole | 2018 |
Antifungal susceptibility of yeasts isolated from anthropogenic watershed.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fresh Water; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Reference Values; Sequence Analysis, DNA; Voriconazole; Yeasts | 2019 |
Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
Topics: Amphotericin B; Antifungal Agents; Brazil; Clinical Laboratory Techniques; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Flucytosine; Humans; Microbial Sensitivity Tests; Voriconazole | 2019 |
In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Central Nervous System Infections; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neoformans; Humans; Voriconazole | 2019 |
Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Case-Control Studies; Cost-Benefit Analysis; Decision Trees; Female; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Quality-Adjusted Life Years; Sweden; Triazoles; Voriconazole | 2019 |
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult | 2019 |
[Cerebral cryptococcosis and immune reconstitution inflammatory syndrome. Case report].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Meningitis, Cryptococcal; Middle Aged; Voriconazole | 2018 |
Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Female; Hematologic Diseases; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Invasive Fungal Infections; Male; Mycoses; Retrospective Studies; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Voriconazole | 2019 |
Antifungal Drugs Influence Neutrophil Effector Functions.
Topics: Amphotericin B; Antifungal Agents; Interleukin-8; Neutrophils; Nitriles; Phagocytosis; Pyridines; Triazoles; Voriconazole | 2019 |
[Cryptococcal meningoencephalitis in an immunocompetent patient caused by late onset exacerbation].
Topics: Adult; Amphotericin B; Antifungal Agents; Antigens, Fungal; Biomarkers; Cryptococcosis; Cryptococcus neoformans; Disease Progression; Humans; Immunocompetence; Immunoglobulin G; Magnetic Resonance Imaging; Male; Meningoencephalitis; Methylprednisolone; Neuroimaging; Pulse Therapy, Drug; Treatment Outcome; Voriconazole | 2019 |
Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres.
Topics: Amphotericin B; Antifungal Agents; Brazil; DNA, Fungal; DNA, Ribosomal; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Mycological Typing Techniques; Tertiary Care Centers; Trichosporon; Trichosporonosis; Voriconazole | 2019 |
Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Caspofungin; Catheter-Related Infections; Catheters; Citric Acid; Ethanol; Fluconazole; Micafungin; Nitroglycerin; Pharmaceutical Solutions; Voriconazole | 2019 |
Successful treatment with voriconazole combined with amphotericin B-liposome for fluconazole-resistant pulmonary cryptococcosis after renal transplantation.
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Combined Modality Therapy; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Female; Fluconazole; Humans; Kidney Transplantation; Lung Diseases, Fungal; Radiography, Thoracic; Treatment Outcome; Voriconazole; Young Adult | 2019 |
Evaluation of Candida colonization and use of the Candida Colonization Index in a paediatric Intensive Care Unit: a prospective observational study.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Child; Child, Preschool; Disease Susceptibility; Feasibility Studies; Female; Fluconazole; Humans; Infant; Intensive Care Units, Pediatric; Itraconazole; Male; Microbial Sensitivity Tests; Organ Specificity; Prospective Studies; Sensitivity and Specificity; Voriconazole | 2019 |
Genomewide Elucidation of Drug Resistance Mechanisms for Systemically Used Antifungal Drugs Amphotericin B, Caspofungin, and Voriconazole in the Budding Yeast.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Resistance, Fungal; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Saccharomycetales; Voriconazole | 2019 |
Antimicrobial Disposition During Pediatric Continuous Renal Replacement Therapy Using an Ex Vivo Model.
Topics: Amphotericin B; Anti-Infective Agents; Caspofungin; Continuous Renal Replacement Therapy; Dose-Response Relationship, Drug; Humans; Meropenem; Metabolic Clearance Rate; Models, Biological; Pediatrics; Piperacillin; Voriconazole | 2019 |
Amphotericin B Induction with Voriconazole Consolidation as Salvage Therapy for
Topics: Amphotericin B; Antifungal Agents; Arthritis, Infectious; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Humans; Middle Aged; Osteomyelitis; Salvage Therapy; Voriconazole | 2019 |
Epidemiological aspects and characterization of the resistance profile of
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brazil; Child; Child, Preschool; Female; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Voriconazole; Young Adult | 2019 |
Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Candida parapsilosis; Candida tropicalis; Candidiasis; Candidiasis, Invasive; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Microbial Sensitivity Tests; Sterol 14-Demethylase; Voriconazole | 2020 |
Characterization of virulence factors, antifungal resistance with ERG-11 gene among Candida species isolated from pulmonary samples.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillus; Bacteria; Biofilms; Candida; Candida albicans; Coagulase; Drug Resistance, Fungal; Fluconazole; Genotype; Humans; Microbial Sensitivity Tests; Middle Aged; Transcriptional Regulator ERG; Virulence Factors; Voriconazole; Young Adult | 2019 |
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole | 2019 |
Evaluation of the expanding spectrum of sertraline against uncommon fungal pathogens.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Drug Repositioning; Drug Synergism; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Sertraline; Voriconazole | 2020 |
Invasive Pulmonary Aspergillosis Due to Aspergillus awamori: Role of Calcium Oxalate Crystal Precipitation Mimicking Mucormycosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Biomarkers; Burkitt Lymphoma; Calcium Oxalate; Diagnosis, Differential; Genes, Fungal; Humans; Invasive Pulmonary Aspergillosis; Lung; Male; Middle Aged; Mucormycosis; Voriconazole | 2020 |
In vitro antifungal activity of luliconazole against nondermatophytic moulds.
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2020 |
Molecular identification and antifungal susceptibility testing of Pucciniomycotina red yeast clinical isolates from Rio de Janeiro, Brazil.
Topics: Amphotericin B; Antifungal Agents; Blood Culture; Brazil; Diffusion; DNA, Intergenic; Humans; Microbial Sensitivity Tests; Mycoses; Rhodotorula; Voriconazole | 2020 |
Cryptococcosis in Patients following Kidney Transplantation: A 9-Year Retrospective Clinical Analysis at a Chinese Tertiary Hospital.
Topics: Adult; Amphotericin B; Antifungal Agents; China; Cryptococcosis; Cryptococcus; Female; Fluconazole; Humans; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Tertiary Care Centers; Voriconazole | 2019 |
Cutaneous fusariosis caused by Fusarium lichenicola in a child with hyper-immunoglobulin E syndrome.
Topics: Administration, Cutaneous; Administration, Oral; Amphotericin B; Antifungal Agents; Biopsy; Child, Preschool; DNA Mutational Analysis; Drug Therapy, Combination; Exome Sequencing; Face; Female; Fusariosis; Fusarium; Humans; Imidazoles; Injections, Intralesional; Job Syndrome; Skin; STAT3 Transcription Factor; Treatment Outcome; Voriconazole | 2020 |
Efficacy of voriconazole in vitro and in invertebrate model of cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Cryptococcosis; Cryptococcus gattii; Disease Models, Animal; Fluconazole; Humans; Larva; Microbial Sensitivity Tests; Moths; Voriconazole | 2020 |
Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2020 |
Invasive Scedosporium spp. and Lomentospora prolificans infections in pediatric patients: Analysis of 55 cases from FungiScope® and the literature.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Female; Humans; Infant; Male; Mycoses; Risk Factors; Scedosporium; Voriconazole | 2020 |
Cost-Effectiveness of Antifungal Supplementation of Corneal Cold Storage Media.
Topics: Aged; Amphotericin B; Antifungal Agents; Caspofungin; Cornea; Cost-Benefit Analysis; Cryopreservation; Descemet Stripping Endothelial Keratoplasty; Drug Combinations; Drug Costs; Eye Infections, Fungal; Fuchs' Endothelial Dystrophy; Health Services Research; Humans; Keratoplasty, Penetrating; Male; Organ Preservation Solutions; Postoperative Complications; Voriconazole | 2020 |
Necessity to identify candida species accurately with minimum inhibitory concentration determination in each case of bloodstream infections.
Topics: Amphotericin B; Antifungal Agents; Bacteremia; Candida; Candida tropicalis; Candidiasis; Caspofungin; Cross-Sectional Studies; Fluconazole; Humans; Intensive Care Units; Microbial Sensitivity Tests; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Voriconazole | 2020 |
Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Cross-Sectional Studies; Drug Resistance, Fungal; Female; Fluconazole; Follow-Up Studies; Humans; Incidence; Infant, Newborn; Itraconazole; Lebanon; Microbial Sensitivity Tests; Pregnancy; Prevalence; Vaginal Discharge; Voriconazole | 2020 |
Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection.
Topics: Adolescent; Adult; Allografts; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2018 |
MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; United Kingdom; Voriconazole | 2020 |
Efflux pump inhibition controls growth and enhances antifungal susceptibility of
Topics: Amphotericin B; Antifungal Agents; Biofilms; Drug Resistance, Fungal; Drug Synergism; Fungal Proteins; Fusarium; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Promethazine; Voriconazole | 2020 |
Successful allogeneic stem cell transplantation in a case with acute myeloid leukemia and invasive Schizophyllum commune rhinosinusitis.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Middle Aged; Molecular Diagnostic Techniques; Rhinitis; Schizophyllum; Sinusitis; Transplantation, Homologous; Treatment Outcome; Voriconazole | 2020 |
Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidemia; Drug Resistance, Multiple, Fungal; Echinocandins; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Turkey; Voriconazole | 2020 |
Aspergillus endophthalmitis: Potential role for vitreous galactomannan testing?
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Endophthalmitis; Eye Infections, Fungal; Female; Galactose; Humans; Male; Mannans; Middle Aged; Visual Acuity; Vitrectomy; Vitreous Body; Voriconazole | 2020 |
Potential benefit of combination antifungal therapy in
Topics: Abscess; Amphotericin B; Antifungal Agents; Aortic Valve; Aortic Valve Stenosis; Aspergillosis; Aspergillus fumigatus; Azoles; Computed Tomography Angiography; Drug Therapy, Combination; Endocarditis; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Intracranial Embolism; Male; Middle Aged; Postoperative Complications; Prosthesis-Related Infections; Treatment Outcome; Voriconazole | 2020 |
COCCIDIOIDAL ENDOPHTHALMITIS: EXCELLENT RECOVERY OF VISION WITH AGGRESSIVE USE OF INTRAVITREAL ANTIFUNGALS AND VITRECTOMY.
Topics: Adult; Amphotericin B; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Male; Vitrectomy; Voriconazole | 2022 |
Combined Intrastromal Voriconazole and Amphotericin B Treatment for Persistent Fungal Keratitis.
Topics: Amphotericin B; Antifungal Agents; Eye Infections, Fungal; Humans; Keratitis; Voriconazole | 2020 |
A novel silkworm infection model with fluorescence imaging using transgenic Trichosporon asahii expressing eGFP.
Topics: Amphotericin B; Animals; Antifungal Agents; Bombyx; Disease Models, Animal; Fluconazole; Green Fluorescent Proteins; Hyphae; Microbial Sensitivity Tests; Optical Imaging; Organisms, Genetically Modified; Survival Analysis; Trichosporon; Trichosporonosis; Voriconazole | 2020 |
Case Report: Beyond the Blood-retina Barrier: Intravitreal Caspofungin for Fungal Endophthalmitis.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Blood-Retinal Barrier; Candida; Candidiasis; Caspofungin; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Male; Visual Acuity; Vitrectomy; Voriconazole | 2020 |
Trichosporon Asahii fungaemia in an immunocompetent polytrauma patient who received multiple antibiotics.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Basidiomycota; Drug Resistance, Multiple, Fungal; Fungemia; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multiple Trauma; Trichosporonosis; Voriconazole | 2020 |
Contact lens-related fungal keratitis.
Topics: Amphotericin B; Antifungal Agents; Contact Lenses, Extended-Wear; Eye Infections, Fungal; Female; Humans; Keratitis; Voriconazole; Young Adult | 2020 |
Efficacy of liposomal amphotericin against febrile neutropenia in pediatric patients receiving prophylactic voriconazole.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Febrile Neutropenia; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Voriconazole; Young Adult | 2021 |
Case Report: Chronic Fungal Meningitis Masquerading as Tubercular Meningitis.
Topics: Amphotericin B; Antifungal Agents; Antitubercular Agents; Ascomycota; Brain; Brain Abscess; Diagnosis, Differential; Humans; Male; Meningitis; Meningitis, Fungal; Middle Aged; Phaeohyphomycosis; Steroids; Tuberculosis, Meningeal; Voriconazole | 2020 |
First case report of Cryptococcus laurentii knee infection in a previously healthy patient.
Topics: Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Arthritis, Infectious; Cryptococcosis; Cryptococcus; Debridement; Diagnostic Errors; Fluconazole; Focal Infection; Humans; Knee; Male; Skin Diseases, Bacterial; Voriconazole | 2020 |
Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: II. Therapies for allergic bronchopulmonary aspergillosis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Amphotericin B; Anti-Infective Agents; Antibodies, Monoclonal; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Child; Cystic Fibrosis; Female; Humans; Itraconazole; Omalizumab; Voriconazole | 2020 |
Antifungal susceptibility profile and molecular identification of Cyp51C mutations in clinical and environmental isolates of Aspergillus flavus from Argentina.
Topics: Amphotericin B; Antifungal Agents; Argentina; Aspergillosis; Aspergillus flavus; Cytochrome P450 Family 51; Drug Resistance, Fungal; Environmental Microbiology; Environmental Monitoring; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole | 2021 |
Purpureocillium roseum sp. nov. A new ocular pathogen for humans and mice resistant to antifungals.
Topics: Aged; Amphotericin B; Animals; Antifungal Agents; Cornea; DNA, Fungal; Drug Resistance, Fungal; Female; Humans; Hypocreales; Itraconazole; Keratitis; Mexico; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycological Typing Techniques; Mycoses; Phylogeny; Voriconazole | 2021 |
A Neonate With Fungal Lung Nodules Mimicking Pulmonary Malignancy.
Topics: Amphotericin B; Antifungal Agents; Humans; Infant, Newborn; Male; Pulmonary Aspergillosis; Voriconazole | 2020 |
Successful Outcome of Disseminated Fusarium musae Fungemia with Skin Localization Treated with Liposomal Amphotericin B and Voriconazole in a Patient with Acute Myeloid Leukemia.
Topics: Amphotericin B; Antifungal Agents; Fungemia; Fusariosis; Fusarium; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Voriconazole | 2020 |
Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Caspofungin; DNA, Fungal; DNA, Ribosomal Spacer; Fluconazole; Humans; Imidazoles; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Rhodotorula; Species Specificity; Triazoles; Voriconazole | 2020 |
Isavuconazole as Salvage Therapy for Refractory Pediatric Coccidioidal Meningitis.
Topics: Amphotericin B; Antifungal Agents; Child; Coccidioides; Coccidioidomycosis; Deoxycholic Acid; Drug Combinations; Humans; Meningitis, Fungal; Nitriles; Pyridines; Salvage Therapy; Triazoles; Voriconazole | 2021 |
Species distribution and antifungal susceptibility of
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Child; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Lebanon; Male; Microbial Sensitivity Tests; Middle Aged; Voriconazole; Young Adult | 2021 |
Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope® and the literature.
Topics: Amphotericin B; Antifungal Agents; Humans; Hypocreales; Microbial Sensitivity Tests; Paecilomyces; Voriconazole | 2021 |
Voriconazole Versus Amphotericin B as Induction Therapy for Talaromycosis in HIV/AIDS Patients: A Retrospective Study.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Humans; Induction Chemotherapy; Mycoses; Retrospective Studies; Talaromyces; Voriconazole | 2021 |
Case Report: Endogenous Candida Endophthalmitis in Cornelia de Lange Syndrome: Atypical Stellate Neuroretinitis.
Topics: Administration, Ophthalmic; Amphotericin B; Antifungal Agents; Bacteremia; Candida albicans; Candidemia; Candidiasis; Child, Preschool; De Lange Syndrome; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Intravitreal Injections; Klebsiella; Klebsiella Infections; Retinitis; Voriconazole | 2021 |
Activity of MSI-78, h-Lf1-11 and cecropin B antimicrobial peptides alone and in combination with voriconazole and amphotericin B against clinical isolates of Fusarium solani.
Topics: Amphotericin B; Antifungal Agents; Drug Combinations; Drug Synergism; Fusarium; Humans; Microbial Sensitivity Tests; Pore Forming Cytotoxic Proteins; Voriconazole | 2021 |
In Vitro Effects of Farnesol Alone and in Combination with Antifungal Drugs Against Aspergillus Clinical Isolates.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Resistance, Fungal; Drug Synergism; Farnesol; Humans; Voriconazole | 2021 |
Successful Treatment of Antifungal Combination Therapy with Inhaled Liposomal Amphotericin B and Oral Voriconazole for Intractable Chronic Progressive Pulmonary Aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Humans; Male; Middle Aged; Pulmonary Aspergillosis; Voriconazole | 2021 |
Fatal disseminated aspergillosis in an immunocompetent patient with COVID-19 due to Aspergillus ochraceus.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus ochraceus; Biomarkers; Brain Abscess; Bronchoalveolar Lavage Fluid; COVID-19; COVID-19 Nucleic Acid Testing; Fatal Outcome; Galactose; Humans; Immunocompetence; Invasive Fungal Infections; Lung Diseases, Fungal; Male; Mannans; SARS-CoV-2; Voriconazole | 2021 |
Crazy-paving patterns as rare radiological manifestations of pulmonary cryptococcosis: a case report.
Topics: Amphotericin B; Antifungal Agents; Bronchoscopy; Cryptococcosis; Flucytosine; Humans; Lung Diseases, Fungal; Male; Middle Aged; Tomography, X-Ray Computed; Voriconazole | 2021 |
Invasive cerebral phaeohyphomycosis in a Chinese boy with CARD9 deficiency and showing unique radiological features, managed with surgical excision and antifungal treatment.
Topics: Administration, Intravenous; Amphotericin B; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; CARD Signaling Adaptor Proteins; Cerebral Phaeohyphomycosis; Child; China; Humans; Male; Mutation, Missense; Radiography; Treatment Outcome; Voriconazole | 2021 |
Clinical utility of antifungal susceptibility testing in patients with fungal rhinosinusitis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Mycoses; Sinusitis; Triazoles; Voriconazole | 2021 |
Pseudocanariomyces americanus, gen. nov., sp. nov., A New Thielavia-Like Species in the Chaetomiaceae: Identification and Management of a Prosthetic Hip Infection.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Female; Humans; Microbial Sensitivity Tests; Phylogeny; Voriconazole | 2021 |
Genotypic diversity of Iranian Cryptococcus neoformans using multilocus sequence typing (MLST) and susceptibility to antifungals.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Flucytosine; Genetic Loci; Genetic Variation; Genotype; Imidazoles; Iran; Itraconazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mycological Typing Techniques; Voriconazole | 2021 |
Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal
Topics: Adult; Amphotericin B; Antifungal Agents; Biofilms; Biomass; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Middle Aged; Polymorphism, Restriction Fragment Length; Vagina; Virulence; Voriconazole; Young Adult | 2021 |
Molecular and MALDI-ToF MS differentiation and antifungal susceptibility of prevalent clinical Fusarium species in China.
Topics: Amphotericin B; Antifungal Agents; China; Fusarium; Humans; Imidazoles; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Terbinafine; Voriconazole | 2021 |
Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection.
Topics: Adult; Amphotericin B; Antifungal Agents; Chemical and Drug Induced Liver Injury; COVID-19; Female; Fusarium; Humans; SARS-CoV-2; Sepsis; Voriconazole | 2021 |
The effect of biosynthesized selenium nanoparticles on the expression of CYP51A and HSP90 antifungal resistance genes in Aspergillus fumigatus and Aspergillus flavus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Itraconazole; Microbial Sensitivity Tests; Nanoparticles; Selenium; Triazoles; Voriconazole | 2022 |
Topics: Amphotericin B; Antifungal Agents; Benzoates; Biofilms; Cinnamates; Drug Combinations; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Terpenes; Voriconazole | 2021 |
Antifungal Susceptibility of 182 Fusarium Species Isolates from 20 European Centers: Comparison between EUCAST and Gradient Concentration Strip Methods.
Topics: Amphotericin B; Antifungal Agents; Fusarium; Microbial Sensitivity Tests; Voriconazole | 2021 |
Endogenous Trichosporon Asahii Retinitis.
Topics: Amphotericin B; Antifungal Agents; Basidiomycota; Blast Crisis; Caspofungin; Cerebrospinal Fluid; Child; Drug Therapy, Combination; Eye Infections, Fungal; Fatal Outcome; Female; Fungemia; Humans; Leukemia, Myeloid, Acute; Retinitis; Trichosporonosis; Voriconazole | 2022 |
Efficacy of voriconazole and amphotericin B in corneal preservative media.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Humans; Microbial Sensitivity Tests; Voriconazole | 2022 |
A 67-Year-Old Male Patient With COVID-19 With Worsening Respiratory Function and Acute Kidney Failure.
Topics: Acute Kidney Injury; Aged; Amphotericin B; Antibodies, Monoclonal, Humanized; Antifungal Agents; Atrial Fibrillation; Bronchoscopy; COVID-19; Dexamethasone; Diabetes Mellitus, Type 2; Fatal Outcome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mucormycosis; Nitriles; Obesity; Oxygen Inhalation Therapy; Pulmonary Aspergillosis; Pyridines; Respiration, Artificial; SARS-CoV-2; Smoking; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2022 |
Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim.
Topics: Acetamides; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Azoles; Biofilms; Drug Resistance, Fungal; Fungal Proteins; Microbial Sensitivity Tests; Piperazines; Pyrimidines; Pyrroles; Voriconazole | 2022 |
Comparison of Six Antifungal Susceptibilities of 11
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Caspofungin; Drug Resistance, Fungal; Fluconazole; Micafungin; Microbial Sensitivity Tests; Voriconazole | 2022 |
Prevalence and susceptibility profiles of oral yeast species isolated from a healthy adult Thai cohort.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida tropicalis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Prevalence; Thailand; Voriconazole | 2022 |
Topics: Amphotericin B; Antifungal Agents; Child; Chorioretinitis; Humans; Male; Retrospective Studies; Voriconazole | 2023 |
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus oryzae; Clotrimazole; Econazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Terbinafine; Tolnaftate; Voriconazole | 2022 |
Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Candidiasis, Invasive; Critical Illness; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Risk Factors; Voriconazole | 2022 |
Malassezia species: the need to establish epidemiological cutoff values.
Topics: Amphotericin B; Animals; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Voriconazole | 2022 |
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Everolimus; Microbial Sensitivity Tests; Voriconazole | 2022 |
Amphotericin B plus fluorocytosine combined with voriconazole for the treatment of non-HIV and non-transplant-associated cryptococcal meningitis: a retrospective study.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Hypokalemia; Meningitis, Cryptococcal; Retrospective Studies; Treatment Outcome; Voriconazole | 2022 |
Antifungal prescription practices and consumption in a tertiary care hospital of a developing country.
Topics: Adult; Amphotericin B; Antifungal Agents; Child; Developing Countries; Fluconazole; Humans; Prescriptions; Tertiary Care Centers; Voriconazole | 2022 |
Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China.
Topics: Amphotericin B; Antifungal Agents; Cohort Studies; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Infertility; Meningitis, Cryptococcal; Prospective Studies; Voriconazole | 2022 |
Distribution, trends, and antifungal susceptibility of Candida species causing candidemia in Japan, 2010-2019: A retrospective observational study based on national surveillance data.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidemia; Drug Resistance, Fungal; Fluconazole; Humans; Japan; Micafungin; Microbial Sensitivity Tests; Voriconazole | 2022 |
COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; COVID-19; Female; Fluconazole; Humans; Iran; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Pulmonary Aspergillosis; SARS-CoV-2; Voriconazole | 2023 |
A longitudinal study of Candida bloodstream infections in a Japanese university hospital: species distribution, drug susceptibility, clinical features, and mortality predictors.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida glabrata; Candidemia; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Japan; Longitudinal Studies; Micafungin; Microbial Sensitivity Tests; Retrospective Studies; Voriconazole | 2022 |
A critical role of calcineurin in stress responses, hyphal formation, and virulence of the pathogenic fungus Trichosporon asahii.
Topics: Amphotericin B; Antifungal Agents; Basidiomycota; Caffeine; Calcineurin; Calcium; Calcium Chloride; Congo Red; Cornea; Corneal Diseases; Dithiothreitol; Eye Diseases, Hereditary; Fluconazole; Monensin; Sodium Chloride; Sodium Dodecyl Sulfate; Sorbitol; Trichosporon; Tunicamycin; Virulence; Voriconazole | 2022 |
Biased Genotype Distributions of Candida albicans Strains Associated with 649 Clinical Vulvovaginal Candidiasis in China.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Voriconazole | 2022 |
Acquired fluconazole resistance and genetic clustering in Diutina (Candida) catenulata from clinical samples.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candida parapsilosis; Candida tropicalis; DNA, Intergenic; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Voriconazole; Yeasts | 2023 |
Spectrum of signs, symptoms, and treatment in amphotericin B-resistant
Topics: Amphotericin B; Antifungal Agents; Cataract; Endophthalmitis; Eye Infections, Fungal; Humans; Retrospective Studies; Trichosporon; Vitrectomy; Voriconazole | 2022 |
Dihydroorotate dehydrogenase inhibitor olorofim has potent in vitro activity against Microascus/Scopulariopsis, Rasamsonia, Penicillium and Talaromyces species.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Dihydroorotate Dehydrogenase; Humans; Microbial Sensitivity Tests; Penicillium; Pyrimidines; Scopulariopsis; Talaromyces; Voriconazole | 2023 |
Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India.
Topics: Adult; Amphotericin B; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Fluconazole; Humans; Itraconazole; Middle Aged; Natamycin; Prospective Studies; Tertiary Care Centers; Voriconazole; Young Adult | 2022 |
Molecular identification, phylogeny and antifungal susceptibilities of dematiaceous fungi isolated from human keratomycosis.
Topics: Amphotericin B; Antifungal Agents; Eye Infections, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Phylogeny; Voriconazole | 2023 |
Pharmacodynamic and immunological interactions of amphotericin B formulations and voriconazole with human neutrophils against mature Scedosporium apiospermum and Fusarium spp. biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Fungi; Fusarium; Humans; Interleukin-10; Neutrophils; Scedosporium; Voriconazole | 2023 |
Endogenous Fungal Endophthalmitis following COVID-19 Hospitalization: Evidence from a Year-Long Observational Study.
Topics: Adult; Amphotericin B; COVID-19; Endophthalmitis; Eye Infections, Fungal; Female; Hospitalization; Humans; Male; Middle Aged; Prospective Studies; Treatment Outcome; Vitrectomy; Voriconazole | 2023 |
Analysis of the synergistic antifungal activity of everolimus and antifungal drugs against dematiaceous fungi.
Topics: Amphotericin B; Antifungal Agents; Everolimus; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Voriconazole | 2023 |
Fungal keratitis caused by Coniochaeta mutabilis-A case report.
Topics: Amphotericin B; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Keratitis; Male; Middle Aged; Voriconazole | 2023 |
In vitro antifungal and antibiofilm activities of auranofin against itraconazole-resistant Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Auranofin; Itraconazole; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2023 |
Galleria mellonella as an alternative in vivo model to study implant-associated fungal infections.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Fluconazole; Humans; Larva; Mammals; Microbial Sensitivity Tests; Voriconazole | 2023 |
Phenotypic and genotypic characterization of virulence markers and antifungal susceptibility of oral Candida species from diabetic and non-diabetic hemodialysis patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Peptide Hydrolases; Phospholipases; Virulence; Voriconazole | 2023 |
Aspergillus welwitschiae; an otomycosis predominant agent, new epidemiological and antifungal susceptibility data from Iran.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus niger; Calmodulin; Female; Humans; Iran; Itraconazole; Male; Microbial Sensitivity Tests; Nystatin; Otomycosis; Voriconazole | 2023 |
Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Program (2018-2021) and application of single-site epidemiological c
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Caspofungin; Drug Resistance, Fungal; Fungi; Itraconazole; Microbial Sensitivity Tests; Voriconazole | 2023 |
Antifungal susceptibility patterns for Aspergillus, Scedosporium, and Exophiala isolates recovered from cystic fibrosis patients against amphotericin B, and three triazoles and their impact after long-term therapies.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Azoles; Cystic Fibrosis; Exophiala; Itraconazole; Scedosporium; Triazoles; Voriconazole | 2023 |
In vitro sensitivity of Malassezia furfur isolates from HIV-positive and negative patients to antifungal agents
Topics: Amphotericin B; Animals; Antifungal Agents; Dermatitis, Seborrheic; Fluconazole; HIV Infections; Humans; Itraconazole; Malassezia; Saccharomyces cerevisiae; Voriconazole | 2023 |
Botryosphaeria dothidea Mycotic Keratitis: A Novel Phytopathogen Causing Human Infection.
Topics: Adult; Amphotericin B; Antifungal Agents; Ascomycota; Corneal Ulcer; Eye Infections, Fungal; Humans; Keratitis; Male; Voriconazole | 2024 |
Molecular fingerprinting by multi-locus sequence typing identifies microevolution and nosocomial transmission of
Topics: Aged; Amphotericin B; Candida; Candida glabrata; Cross Infection; Fluconazole; Humans; Kuwait; Multilocus Sequence Typing; Phylogeny; Voriconazole | 2023 |
Epidemiology and antifungal susceptibilities of clinically isolated
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Humans; Microbial Sensitivity Tests; Retrospective Studies; Voriconazole | 2023 |
Fusariosis in Mexico: A 10-year retrospective series.
Topics: Amphotericin B; Antifungal Agents; Burns; Febrile Neutropenia; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Mexico; Retrospective Studies; Voriconazole | 2023 |
Clinical characteristics of tracheobronchial
Topics: Amphotericin B; Antifungal Agents; China; Humans; Middle Aged; Voriconazole | 2023 |